Composition comprising a biological control agent and an insecticide

ABSTRACT

The present invention relates to a composition comprising at least one biological control agent selected from the group consisting of  Paecilomyces lilacinus  strain 251 (AGAL No. 89/030550),  Trichoderma atroviride  SC1 (CBS No. 122089), and  Coniothyrium minitans  CON/M/91-08 (DSM 9660) and/or a mutant of these strains having all the identifying characteristics of the respective strain, and/or a metabolite produced by the respective strain that exhibits activity against nematodes, insects and/or phytopathogens, and at least one insecticide (I) selected from the group consisting of and at least one insecticide (I) selected from the group consisting of juvenile hormone mimics, miscellaneous non-specific (multi-site) inhibitors, selective homopteran feeding blockers, mite growth inhibitors, microbial disruptors of insect midgut membranes, inhibitors of mitochondrial ATP synthase, uncouplers of oxidative phoshorylation via disruption of the proton gradient, inhibitors of chitin biosynthesis (type 0), inhibitors of chitin biosynthesis (type 1), moulting disruptors, ecdysone receptor agonists, octopamine receptor agonists, mitochondrial complex III electron transport inhibitors, mitochondrial complex I electron transport inhibitors, inhibitors of acetyl CoA carboxylase, mitochondrial complex IV electron transport inhibitors, mitochondrial complex II electron transport inhibitors, and further insecticides in a synergistically effective amount, with the proviso that the composition does not comprise  Coniothyrium minitans  CON/M/91-08 (DSM 9660) and Fluopyram (I247). Furthermore, the present invention relates to a kit of parts comprising said composition and the use of said composition.

The present invention relates to a composition comprising at least onebiological control agent selected from specific microorganisms and/or amutant of these strains having all the identifying characteristics ofthe respective strain, and/or at least one metabolite produced by therespective strain that exhibits activity against insects, nematodesand/or phytopathogens and at least one specified insecticide in asynergistically effective amount. Furthermore, the present inventionrelates to the use of this composition as well as a method for reducingoverall damage of plants and plant parts.

Synthetic insecticides or fungicides often are non-specific andtherefore can act on organisms other than the target ones, includingother naturally occurring beneficial organisms. Because of theirchemical nature, they may be also toxic and non-biodegradable. Consumersworldwide are increasingly conscious of the potential environmental andhealth problems associated with the residuals of chemicals, particularlyin food products. This has resulted in growing consumer pressure toreduce the use or at least the quantity of chemical (i.e. synthetic)pesticides. Thus, there is a need to manage food chain requirementswhile still allowing effective pest control.

A further problem arising with the use of synthetic insecticides orfungicides is that the repeated and exclusive application of aninsecticide or fungicides often leads to selection of resistantmicroorganisms. Normally, such strains are also cross-resistant againstother active ingredients having the same mode of action. An effectivecontrol of the pathogens with said active compounds is then not possibleany longer. However, active ingredients having new mechanisms of actionare difficult and expensive to develop.

The risk of resistance development in pathogen populations as well asenvironmental and human health concerns have fostered interest inidentifying alternatives to synthetic insecticides and fungicides formanaging plant diseases. The use of biological control agents (BCAs) isone alternative. However, the effectiveness of most BCAs is not at thesame level as for conventional insecticides and fungicides, especiallyin case of severe infection pressure. Consequently, known biologicalcontrol agents, their mutants and metabolites produced by them are, inparticular in low application rates, not entirely satisfactory.

Thus, there is a constant need for developing new, alternative plantprotection agents which in some areas at least help to fulfill theabove-mentioned requirements.

Paecilomyces lilacinus strain 251 is known from WO 91/02051 asbiological nematicide. It was found in 1979 and is approved for use as anematicide e.g. in Bulgaria and Italy as well as in Belgium. The strainhas been isolated from a Meloidogyne egg mass in Los Banos, Philippines(cf. WO 91/02051) and has been deposited with the Australian GovernmentAnalytical Laboratories (AGAL) in 1989 under the accession No.89/030550.

WO 2009/116106 relates to the strain Trichoderma atroviride SC1 which iseffective for biocontrol of fungal diseases in plants. It has first beenisolated from decayed hazelnut wood in northern Italy in 2000 and hasbeen deposited at the “Centraalbureeau voor Schimmelcultures” under thedeposition number CBS No. 122089 in 2007.

A further known biological control agent is the strain Coniothyriumminitans CON/M/91-08 (cf. WO 96/21358) which has been deposited underthe number DSM 9660 with the German Collection of Microorganisms andCell Cultures in Braunschweig. It is used as a biological controlagainst the fungal pathogens Sclerotinia sclerotiorum andSclerotiniaminor (causal agents of white mold on many plant species).

In view of this, it was in particular an object of the present inventionto provide compositions which exhibit activity against insects, mites,nematodes and/or phytopathogens. Moreover, it was a further particularobject of the present invention, to reduce the application rates andbroaden the activity spectrum of the biological control agents andinsecticides, and thereby to provide a composition which, preferably ata reduced total amount of active compounds applied, has improvedactivity against insects, mites, nematodes and/or phytopathogens. Inparticular, it was a further object of the present invention to providea composition which, when applied to a crop, results in a decreasedamount of residues in the crop, thereby reducing the risk of resistanceformation and nevertheless provides efficient disease control.

Accordingly, it was found that these objects at least partly are solvedby the compositions according to the invention as defined in thefollowing. The composition according to the present invention preferablyfulfills the above-described needs. It has been surprisingly discoveredthat the application of the composition according to the presentinvention in a simultaneous or sequential way to plants, plant parts,harvested fruits, vegetables and/or plant's locus of growth preferablyallows better control of insects, mites, nematodes and/or phytopathogensthan it is possible with the strains, their mutants and/or theirmetabolites produced by the strains on the one hand and with theindividual insecticides on the other hand, alone (synergistic mixtures).By applying the biological control agent and the insecticide accordingto the invention the activity against insects, mites, nematodes and/orphytopathogens is preferably increased in a superadditive manner.

As a consequence, the composition according to the present inventionpreferably allows a reduced total amount of active compounds to be usedand thus the crops which have been treated by this compositionpreferably show a decreased amount of residues in the crop. Accordingly,the risk of resistance formation of harmful microorganisms is decreased.

The present invention is directed to a composition comprising at leastone biological control agent selected from the group consisting ofPaecilomyces lilacinus strain 251 (AGAL No. 89/030550), Trichodermaatroviride SC1 (CBS No. 122089), and Coniothyrium minitans CON/M/91-08(DSM 9660) and/or a mutant of these strains having all the identifyingcharacteristics of the respective strain, and/or at least one metaboliteproduced by the respective strain that exhibits activity againstnematodes, insects and/or phytopathogens, and at least one insecticide(I) selected from the group consisting of juvenile hormone mimics,miscellaneous non-specific (multi-site) inhibitors, selective homopteranfeeding blockers, mite growth inhibitors, microbial disruptors of insectmidgut membranes, inhibitors of mitochondrial ATP synthase, uncouplersof oxidative phoshorylation via disruption of the proton gradient,inhibitors of chitin biosynthesis (type 0), inhibitors of chitinbiosynthesis (type 1), moulting disruptors, ecdysone receptor agonists,octopamine receptor agonists, mitochondrial complex III electrontransport inhibitors, mitochondrial complex I electron transportinhibitors, inhibitors of acetyl CoA carboxylase, mitochondrial complexIV electron transport inhibitors, mitochondrial complex II electrontransport inhibitors, and further insecticides in a synergisticallyeffective amount, with the proviso that the composition does notcomprise Coniothyrium minitans CON/M/91-08 (DSM 9660) and Fluopyram(I247).

Furthermore, the present invention relates to a kit of parts comprisingat least one of the specific biological control agents and at least oneinsecticide (I), with the proviso that the kit of parts does notcomprise Coniothyrium minitans CON/M/91-08 (DSM 9660) and Fluopyram(I247). The present invention is further directed to the use of saidcomposition for reducing overall damage of plants and plant parts aswell as losses in harvested fruits or vegetables caused by insects,mites, nematodes and/or phytopathogens.

Moreover, the present invention provides a method for reducing overalldamage of plants and plant parts as well as losses in harvested fruitsor vegetables caused by insects, mites, nematodes and/or phytopathogensas well as a seed treated with the composition according to the presentinvention.

Biological Control Agents

In general “pesticidal” means the ability of a substance to increasemortality or inhibit the growth rate of plant pests. The term is usedherein, to describe the property of a substance to exhibit activityagainst insects, mites, nematodes and/or phytopathogens. In the sense ofthe present invention the term “pests” include insects, mites, nematodesand/or phytopathogens.

As used herein, “biological control” is defined as control of a pathogenand/or insect and/or an acarid and/or a nematode by the use of a secondorganism. Known mechanisms of biological control include bacteria thatcontrol root rot by out-competing fungi for space or nutrients on thesurface of the root. Bacterial toxins, such as antibiotics, have beenused to control pathogens. The toxin can be isolated and applieddirectly to the plant or the bacterial species may be administered so itproduces the toxin in situ. Other means of exerting biological controlinclude the application of certain fungi producing ingredients activeagainst a target phytopathogen, insect, mite or nematode, or attackingthe target pest/pathogen. “biological control” as used in connectionwith the present invention may also encompass microorganisms having abeneficial effect on plant health, growth, vigor, stress response oryield.

Application routes include spray application soil application and seedtreatment.

The term “metabolite” refers to any compound, substance or byproduct ofa fermentation of a said microorganism that has pesticidal activity.

The term “mutant” refers to a variant of the parental strain as well asmethods for obtaining a mutant or variant in which the pesticidalactivity is greater than that expressed by the parental strain. The“parent strain” is defined herein as the original strain beforemutagenesis. To obtain such mutants the parental strain may be treatedwith a chemical such as N-methyl-N′-nitro-N-nitrosoguanidine,ethylmethanesulfone, or by irradiation using gamma, x-ray, orUV-irradiation, or by other means well known to those skilled in theart.

A “variant” is a strain having all the identifying characteristics ofthe respective Accession Numbers as indicated in this text and can beidentified as having a genome that hybridizes under conditions of highstringency to the genome of the respective Accession Numbers.

“Hybridization” refers to a reaction in which one or morepolynucleotides react to form a complex that is stabilized via hydrogenbonding between the bases of the nucleotide residues. The hydrogenbonding may occur by Watson-Crick base pairing, Hoogstein binding, or inany other sequence-specific manner. The complex may comprise two strandsforming a duplex structure, three or more strands forming amulti-stranded complex, a single self-hybridizing strand, or anycombination of these. Hybridization reactions can be performed underconditions of different “stringency”. In general, a low stringencyhybridization reaction is carried out at about 40° C. in 10×SSC or asolution of equivalent ionic strength/temperature. A moderate stringencyhybridization is typically performed at about 50° C. in 6×SSC, and ahigh stringency hybridization reaction is generally performed at about60° C. in 1×SSC.

A variant of the indicated Accession Number may also be defined as astrain having a genomic sequence that is greater than 85%, morepreferably greater than 90% or more preferably greater than 95% sequenceidentity to the genome of the indicated Accession Number. Apolynucleotide or polynucleotide region (or a polypeptide or polypeptideregion) has a certain percentage (for example, 80%, 85%, 90%, or 95%) of“sequence identity” to another sequence means that, when aligned, thatpercentage of bases (or amino acids) are the same in comparing the twosequences. This alignment and the percent homology or sequence identitycan be determined using software programs known in the art, for example,those described in Current Protocols in Molecular Biology (F. M. Ausubelet al., eds., 1987) Supplement 30, section 7.7.18, Table 7.7.1.

AGAL is the abbreviation for “Australian Analytical Laboratories” whichtoday is named “National Measurement Institute (NMI)” having the address1, Suakin Street, Pymble NSW 2073, Australia.

CBS is the abbreviation for “Centraalbureau voor Schimmelcultures”, aninternational depositary authority for the purposes of deposingmicroorganism strains under the Budapest treaty on the internationalrecognition of the deposit of microorganisms for the purposes of patentprocedure, having the address Uppsalalaan 8, 3584 CT Utrecht,Netherlands.

DMS is the abbreviation for “Deutsche Sammlung von Mikroorganismen andZellkulturen GmbH” located at Inhoffenstr. 78 in 38124 Braunschweig,Germany.

The biological control agents used in the present invention are known inthe art as follows:

Paecilomyces lilacinus Strain 251

Paecilomyces lilacinus, which was recently re-classified asPrupureocillium lilacinum, generally is a widely distributed saprophyticsoil fungus which is readily isolatable throughout the world.Paecilomyces lilacinus strain 251 (in the following sometimes referredto as B1) has been shown to be effective under field conditions againstplant pathogenic or rather parasitic nematodes which attack a variety ofagriculturally important crops including banana, potato, pineapple,cotton, coffee, rice, black pepper, okra, avocado, tomato etc. (WO91/02051). It is effective against many types of parasitic nematodes,including root knot (Meloidogyne), sting (Belonolaimus), burrowing(Radopholus), cyst (Globodera and Heterodera), root lesion(Pratylenchus) and other economically important nematodes species.

In general, the combination according to the invention is effectiveagainst nematodes of the species Meloidogyne such as the SouthernRoot-Knot nematode (Meloidogyne incognita), Javanese Root-Knot nematode(Meloidogyne javanica), Northern Root-Knot Nematode (Meloidogyne hapla)and Peanut Root-Knot Nematode (Meloidogyne arenaria); nematodes of thespecies Ditylenchus such as Ditylenchus destructor and Ditylenchusdipsaci; nematodes of the species Pratylenchus such as the CobRoot-Lesion Nematode (Pratylenchus penetrans), Chrysanthemum Root-LesionNematode (Pratylenchus fallax), Pratylenchus coffeae, Pratylenchus loosiand Walnut Root-Lesion Nematode (Pratylenchus vulnus); Nematodes of thespecies Globodera such as Globodera rostochiensis and Globodera pallida;Nematodes of the species Heterodera such as Heterodera glycinesHeterodera schachtii; Nematodes of the species Aphelenchoides such asthe Rice White-tip Nematode (Aphelenchoides besseyi), Aphelenchoidesritzemabosi and Aphelenchoides fragariae; Nematodes of the speciesAphelenchus such as Aphelenchus avenae; Nematodes of the speciesRadopholus, such as the Burrowing-Nematode (Radopholus similis);Nematodes of the species Tylenchulus such as Tylenchulus semipenetrans;Nematodes of the species Rotylenchulus such as Rotylenchulus reniformis;Nematodes living in trees such as Bursaphelenchus xylophilus and the RedRing Nematode (Bursaphelenchus cocophilus) etc.

Exemplary commercial products containing Paecilomyces lilacinus strain251 are BioAct® WG and MeloCon WG. The activity of Paecilomyceslilacinus strain 251 is described inter alia in A. Khan et al., FEMSMicrobiology Letters, 227, 107-111, 2003 and S. Kiewnick at al.Biological Control 38, 179-187, 2006. Its isolation and characteristicproperties are disclosed in WO 91/02051, which is incorporated herein byreference. The strain has been deposited with the Australian GovernmentAnalytical Laboratories (AGAL) in 1989 under the accession No.89/030550.

Paecilomyces lilacinus strain 251 of the invention is known and can becultivated and caused to sporulate using methods well known in the artas described e.g. in WO 91/02051. Harvesting of spores is preferablyperformed under conditions that do not promote heat, including shaking,scraping, washing and centrifugation. The spore material is then driedby a suitable process such as air drying, freeze drying or desiccationwith a suitable desiccant and can be reformulated by addition of inertfiller or new growth material to provide a suitable number of spores perunit amount of product.

Usually the strain is formulated on a carrier, preferably awater-soluble sugar carrier, in a concentration of between 1×10⁵ andabout 1×10¹⁰ spores/g of carrier, preferably between 5×10⁷ and about5×10⁹ spores/g carrier. However, also formulations up to about 1×10¹⁰spores/g, about 2×10¹⁰ spores/g, about 5×10¹⁰ spores/g, about 1×10¹¹spores/g or even about 2×10¹¹ spores/g or about 3×10¹¹ spores/g may beobtained. The carrier may e.g. be selected from polysaccharides or crudeplant products such as cornmeal to assist fungal growth. Likewise wholeseeds such as wheat or sesame may be used to present the fungus. Mineralmatter such as silica and vermiculite may also be added. Paecilomyceslilacinus strain 251 may be formulated as a powder or in pelleted form.In this case the carrier is preferably formulated so that slow releaseof the spores is obtained over a considerable period of time followingapplication. The infective propagules of Paecilomyces lilacinus strain251 may be applied to the crop either in liquid suspension, optionallyin association with a suitable nematicidal carrier or, less preferred,as solid formulation, and in association with a suitable excipient.

The final dosage of infective propagules of Paecilomyces lilacinusstrain 251 is normally in the order of between 1× about 10⁵ and about1×10⁷, preferably between about 1×10⁵ and about 1×10⁶ spores per gram ofsoil for nursery applications and for field applications.

It may be applied to crops using any of the methods well known in theart. It may be advantageous to apply the inventive composition to theenvironment of the roots so minimizing the root damage caused bynematodes. This may be achieved by coating of the seeds with theinventive composition so that emergence of roots results in a fungalinoculum in their environment; by dipping or spraying the root regionsof seedlings or seed trays in a nursery situation, or by application ofthe composition at the site of planting, either in aqueous suspension orin solid form. It is particularly preferred that the inventivecomposition is specifically applied to the regions of the plantrhizosphere affected by nematodes. The composition may be applied as asoil drench or through drip (trickle) or sprinkler (microjet) irrigationsystem. Vegetables and other transplants can be treated just beforetransplanting with a soil drench to protect from nematodes entering thedeveloping root ball in the field. Nonfumigated field soils should betreated with the composition two weeks before seeding or transplantingto reduce initial nematode infestation. Application can then be repeatede.g. at 6 weeks intervals.

The spores of Paecilomyces lilacinus strain 251 germinate upon contactwith nematode eggs, juvenile stages and adults in the soil. The growingfungus engulfs and penetrates the nematode over a period of severaldays, killing it by consuming its body contents.

Paecilomyces lilacinus strain 251 is an obligate parasite of nematodes;it does not colonize the root or feed on root exudates. In the absenceof nematodes, spores of Paecilomyces lilacinus strain 251 decline in thesoil over a period of 3 to 6 weeks at a rate depending on soil type andtemperature.

According to the invention Paecilomyces lilacinus strain 251 encompassesmutants having all identifying characteristics of the respective strain,and/or at least one metabolite produced by the respective strain thatexhibits activity against nematodes and/or insects.

Trichoderma atroviride SC1

Trichoderma is a cosmopolitan fungal genus, which can colonize soils,rhizospheres and phyllospheres. Trichoderma species are frequently foundon decaying wood and vegetable material. Several Trichoderma strains areeconomically important producers of industrial enzymes. Some Trichodermastrains have already been used as biocontrol agents against numerousplant pathogens and quite a few have been developed for use ascommercial (i.e. Trichoderma harzianum, known as Trichodex® or Trianum®,Trichoderma virens, known as SoilGard®, and Trichoderma atroviride,known as Esquive®) biocontrol products for field and greenhouse crops.

Trichoderma atroviride SC1 (in the following sometimes referred to asB2) is known to suppress and to prevent the development of plantpathogens, in particular fruits and root rots, such as those caused byBotrytis cinerea and Armillaria spp., powdery mildews and wood diseases(Esca disease) (WO2009/116106 which is incorporated herein byreference). It is deposited under the accession number CBS No. 122089.

As most Trichoderma spp., Trichoderma atroviride SC1 is a mesophilicfungus and able to utilize a wide range of compounds as carbon andnitrogen sources. Accordingly, it persists in soil at effective levelsfor long periods (more than one year).

However, fungal growth in culture media is superior with the addition ofsome nitrogen sources such as yeast extract, nitrite, tryptone, peptone,glutamine and asparagine or some carbon sources such as mannose,galactose, sucrose, malt extract, cellobiose glucose and threalose. Forthe preparation of Trichoderma atroviride SC1 compositions the sporesare cultured by methods known to those skilled in the art. For exampleit can be effected by inoculation of Trichoderma atroviride SC1 on acommon nutrient substrate in liquid suspension or on solid substrate toobtain preferably at least 10²-10³ conidia/(ml or g) (activeconcentration), preferably about 1×10⁴ to about 1×10⁸ conidia/(ml or g)which are then used in a composition preferably comprising an effectiveamount of this strain in a quantity of at least 10²-10³ conidia/(ml org), preferably about 1×10⁴ 1×10⁸ conidia/(ml or g). Other cultivationmethods are disclosed in WO2009/116106.

For soil applications a final concentration of conidia in the soil ofbetween about 1×10² and about 1×10⁵ spores/(ml or g) is envisaged. Uponfoliar application, the amount applied ranges between about 1×10″ andabout 1×10′³ spores/hectare, preferably about 1×10¹² spores/hectare.

Plant treatment and/or prevention is carried out by using Trichodermaatroviride SC1 cultures grown in liquid or semi-solid media or on asolid substrate and by applying this suspension onto parts of the plantor applying the enriched substrate on or into the sol in close proximityof the plant in need of such a treatment. The treatment can be affectedby applying agricultural compositions to plants, on the leaves ofplants, on wounds made during cutting or pruning, or to the sol tosuppress the development of fungal diseases on roots. The treatment canbe carried out during plant vegetative period or during dormancy. Thetreatment can be applied once (i.e. at planting time in soil) orrepeatedly as needed.

According to the invention Trichoderma atroviride SC1 encompassesmutants having all identifying characteristics of the respective strain,and/or at least one metabolite produced by the respective strain thatexhibits activity against pathogenic fungi.

Coniothyrium minitans Strain CON/M/91-08

The naturally occurring fungus Coniothyrium minitans has been firstidentified in 1947 and can be found in soils world-wide. It attacks anddestroys the sclerotia (overwintering or survival structures) ofSclerotinia sclerotiorum, Sclerotinia minor, other Sclerotinia speciesand Sclerotium cepivorum. These pathogens have a wide host range ofseveral hundred species of plants (including many vegetables andornamentals). They commonly cause white mold on cole crops and beans,and are occasionally found on tomatoes and peppers. Additionally, theycause leaf drop on lettuce and white mold in carrots. Normally, thesesclerotia will germinate in the spring and summer, producing spores thatinfect many crops, enabling white mold disease to develop. The strainConiothyrum minitans strain CON/M/91-08 (in the following sometimesreferred to as B13) is commercially available as Contans®.

Coniothyrium minitans strain CON/M/91-08 can be cultured as described inWO 96/21358 which is incorporated herein by reference. For example thisstrain can be cultured on suitable substrates, such as seeds of grain,bran, straw or other plant materials, or also with the help of agarculture media that are customary in mycology, such as potato dextroseagar, or malt peptone agar, or on suitable support materials to which aculture medium has been added, as well as in liquid nutrient mediawithout the addition of agar.

Usually the strain is formulated on a carrier, preferably awater-soluble sugar carrier, in a concentration of between 1×10⁹ andabout 1×10¹⁵ spores/g of carrier, preferably between 1×10¹⁰ and about1×10¹³ spores/g carrier. Most preferably, the concentration lies betweenabout 1×10⁸ and about 1×10¹⁰ spores/g of carrier, such as at about 1×10⁹spores/g carrier. In particular the water-soluble sugar is glucose.

According to the invention Coniothyrium minitans strain CON/M/91-08encompasses mutants having all identifying characteristics of therespective strain, and/or at least one metabolite produced by therespective strain that exhibits activity against Sclerotinia spp., suchas Sclerotinia sclerotiorum and/or Sclerotinia minor and/or Sclerotiumcepivorum.

According to one embodiment of the present invention the biologicalcontrol agent comprises not only the isolated, pure culture(s) of therespective microorganism(s), but also their suspensions in a whole brothculture or a metabolite-containing supernatant or a purified metaboliteobtained from whole broth culture of the strain. “Whole broth culture”refers to a liquid culture containing both cells and media.“Supernatant” refers to the liquid broth remaining when cells grown inbroth are removed by centrifugation, filtration, sedimentation, or othermeans well known in the art.

The above-mentioned metabolites produced by the nonpathogenicmicroorganisms include antibiotics, enzymes, siderophores and growthpromoting agents.

According to the invention, the biological control agent may be employedor used in any physiologic state such as active or dormant.

Preferably, the biological control agent is Paecilomyces lilacinusstrain 251 (AGAL No. 89/030550), and/or a mutant of this strain havingall the identifying characteristics of this strain, and/or at least onemetabolite produced by this strain that exhibits activity againstnematodes, insects and/or phytopathogenes. In particular, this strain,its mutant and/or metabolite as defined above is preferred in case ofthe seed treatment and the seed treated with the composition accordingto the present invention. In another preferred embodiment, the strain,its mutant and/or metabolite as defined above is used in soil or foliarapplications.

Insecticides

“Insecticides” as well as the term “insecticidal” refers to the abilityof a substance to increase mortality or inhibit growth rate of insects.As used herein, the term “insects” includes all organisms in the class“Insecta”. The term “pre-adult” insects refers to any form of anorganism prior to the adult stage, including, for example, eggs, larvae,and nymphs.

“Nematicides” and “nematicidal” refers to the ability of a substance toincrease mortality or inhibit the growth rate of nematodes. In general,the term “nematode” comprises eggs, larvae, juvenile and mature forms ofsaid organism.

“Acaricide” and “acaricidal” refers to the ability of a substance toincrease mortality or inhibit growth rate of (ecto)parasites belongingto the class Arachnida, sub-class Acari.

The active ingredients specified herein by their “common name” are knownand described, for example, in the Pesticide Manual (“The PesticideManual”, 14th Ed., British Crop Protection Council 2006) or can besearched in the internet (e.g. http://www.alanwood.net/pesticides).

The term “at least one” indicates that in any case a substance asspecified, such as a metabolite or insecticide, is present in thecomposition according to the invention. However, more than one such as(at least) two, (at least) three, (at least) four, (at least) 5 or evenmore such substances may be present in the composition according to theinvention.

Insecticide (I)

According to the invention, the at least one insecticide (I) is selectedfrom the group consisting of juvenile hormone mimics, miscellaneousnon-specific (multi-site) inhibitors, selective homopteran feedingblockers, mite growth inhibitors, microbial disruptors of insect midgutmembranes, inhibitors of mitochondrial ATP synthase, uncouplers ofoxidative phoshorylation via disruption of the proton gradient,inhibitors of chitin biosynthesis (type 0), inhibitors of chitinbiosynthesis (type 1), moulting disruptors, ecdysone receptor agonists,octopamine receptor agonists, mitochondrial complex III electrontransport inhibitors, mitochondrial complex I electron transportinhibitors, inhibitors of acetyl CoA carboxylase, mitochondrial complexIV electron transport inhibitors, mitochondrial complex II electrontransport inhibitors, and further insecticides.

Preferably, the juvenile hormone mimic is selected from the groupconsisting of a juvenile hormon analogue, Fenoxycarb (I159) orPyriproxyfen (I160).

In a preferred embodiment the juvenile hormone mimic is selected fromthe group consisting of Hydroprene (I156), Kinoprene (I157), Methoprene(I158), Fenoxycarb (I159), and Pyriproxyfen (I160).

Preferably, the miscellaneous non-specific (multi-site) inhibitor isselected from the group consisting of an alkyl halides, Chloropicrin(I162), Sulfuryl fluoride (I163), Borax (I164), and Tartar emetic(I165).

In a preferred embodiment the miscellaneous non-specific (multi-site)inhibitor is selected from the group consisting of Methyl bromide(I161), Chloropicrin (I162), Sulfuryl fluoride (I163), Borax (I164), andTartar emetic (I165).

Preferably, the selective homopteran feeding blocker is selected fromthe group consisting of Pymetrozine (I166) and Flonicamid (I167).

Preferably, the mite growth inhibitor is selected from the groupconsisting of Clofentezine (I168), Hexythiazox (I169), Diflovidazin(I170), and Etoxazole (I171).

Preferably, the microbial disruptor of insect midgut membranes isselected from the group consisting of Bacillus thuringiensis subspeciesisraelensis (I172), Bacillus thuringiensis subspecies aizawai (I173),Bacillus thuringiensis subspecies kurstaki (I174), Bacillusthuringiensis subspecies tenebrionis (I175), B.t. crop proteins: Cry1Ab,Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1/35Ab1 (I176), and Bacillus sphaericus (I177).

Preferably, the inhibitor of mitochondrial ATP synthase is selected fromthe group consisting of Diafenthiuron (I178) and organotin miticides,Fenbutatin oxide (I181) and Tetradifon (I183). Still preferably, themitochondrial ATP synthase is selected from the group consisting ofDiafenthiuron (I178), Azocyclotin (I179), Cyhexatin (I180), Fenbutatinoxide (I181), Propargite (I182), and Tetradifon (I183).

Preferably, the uncoupler of oxidative phoshorylation via disruption ofthe proton gradient is selected from the group consisting ofChlorfenapyr (I184), DNOC (I185), and Sulfluramid (I186).

Preferably, the Inhibitor of chitin biosynthesis, type 0, is selectedfrom the group consisting of Bistrifluron (I191), Chlorfluazuron (I192),Diflubenzuron (I193), Flucycloxuron (I194), Flufenoxuron (I195),Hexaflumuron (I196), Lufenuron (I197), Novaluron (I198), Noviflumuron(I199), Teflubenzuron (I200), and Triflumuron (I201).

Preferably, the inhibitor of chitin biosynthesis, type 1, is Buprofezin(I202).

Preferably, the moulting disruptor is Cyromazine (I203).

Preferably, the ecdysone receptor agonists is selected from the groupconsisting of Chromafenozide (I204), Halofenozide (I205),Methoxyfenozide (I206), and Tebufenozide (I207).

Preferably, the octopamine receptor agonist is Amitraz (I208).

Preferably, the mitochondrial complex III electron transport inhibitoris selected from the group consisting of Hydramethylnon (I209),Acequinocyl (I210), and Fluacrypyrim (I211).

Preferably, the mitochondrial complex I electron transport inhibitor isselected from the group consisting of METI acaricides, and Rotenone(Derris) (I218). Still preferably, the mitochondrial complex I electrontransport inhibitor is selected from the group consisting of Fenazaquin(I212), Fenpyroximate (I213), Pyrimidifen (I214), Pyridaben (I215),Tebufenpyrad (I216), Tolfenpyrad (I217), and Rotenone (Derris) (I218).

Preferably, the inhibitors of acetyl CoA carboxylase are tetronic andtetramic acid derivatives. Still preferably, the inhibitor of acetyl CoAcarboxylase is selected from the group consisting of Spirodiclofen(I221), Spiromesifen (I222), and Spirotetramat (I223).

Preferably, the mitochondrial complex IV electron transport inhibitorsare phosphines or Cyanide (I228). Still preferably, the mitochondrialcomplex IV electron transport inhibitor is selected from the groupconsisting of Aluminium phosphide (I224), Calcium phosphide (I225),Phosphine (I226), Zinc phosphide (I227), and Cyanide (I228).

Preferably, the mitochondrial complex II electron transport inhibitorsare beta-ketonitrile derivatives. Still preferably, the mitochondrialcomplex II electron transport inhibitor is selected from the groupconsisting of Cyenopyrafen (I229) and Cyflumetofen (I230).

Further active ingredients with unknown or uncertain mode of action asunderstood as further insecticides are selected from the groupconsisting of Amidoflumet (I234), Azadirachtin (I235), Benclothiaz(I236), Benzoximate (I237), Bifenazate (I238), Bromopropylate (I239),Chinomethionat (I240), Cryolite (I241), Dicofol (I242), Diflovidazin(I243), Fluensulfone (I244), Flufenerim (I245), Flufiprole (I246),Fluopyram (I247), Fufenozide (I248), lmidaclothiz (I249), Iprodione(I250), Meperfluthrin (I251), Pyridalyl (I252), Pyrifluquinazon (I253),Tetramethylfluthrin (I254), and iodomethane (I255); furthermore productsbased on Bacillus firmus (including but not limited to strain CNCM1-1582, such as, for example, VOTiVO™, BioNem) (I256) or one of thefollowing known active compounds:3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I257) (known from WO2005/077934),4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I258) (known from WO2007/115644),4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one(I259) (known from WO2007/115644),4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I260) (known from WO2007/115644),4-{[(6-chlorpyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I261) (known from WO2007/115644), Flupyradifurone (I262),4-{[(6-chlor-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one(I263) (known from WO2007/115643),4-{[(5,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I264) (known from WO2007/115646),4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I265) (known from WO2007/115643),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I266) (known from EP-A-0 539 588),4-{[(6-chlorpyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I267)(known from EP-A-0 539 588),{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(I268) (known from WO2007/149134) and its diastereomers{[(1R)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(A) (I269), and{[(1S)-1-(6-chloropyridin-3-yl)ethyl](methyl(oxido-λ4-sulfanylidene}cyanamide(B) (I270) (also known from WO2007/149134) as well as diastereomers[(R)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-Λ4-sulfanylidene]cyanamide (A1)) (I271), and[(S)-methyl (oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide (A2) (I272), referred toas group of diastereomers A (known from WO2010/074747, WO2010/074751),[(R)-methyl (oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide (B1) (I273), and[(S)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B2) (I274), referred to as group of diastereomers B (also known fromWO2010/074747, WO2010/074751), and11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one(I275) (known from WO2006/089633),3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one(I276) (known from WO2008/067911),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277) (known from WO2006/043635), Afidopyropen[(3S,4aR,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate (I278) (known from WO2008/066153),2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide (I279) (knownfrom WO2006/056433),2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide (I280) (knownfrom WO2006/100288), 2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (I281) (known from WO2005/035486),4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine1,1-dioxide (I282) (known from WO2007/057407),N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine(I283) (known from WO2008/104503),{1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone(I284) (known from WO2003/106457),3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one(I285) (known from WO2009/049851),3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (I286) (known from WO2009/049851),4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine(I287) (known from WO2004/099160),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile(I288) (known from WO2005/063094), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile (I289) (known fromWO2005/063094), 8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6-(trifluoromethyl)pyridazin-3-yl]-3-azabicyclo[3.2.1]octane (I290) (known fromWO2007/040280), Flometoquin (I291), PF1364 (CAS-Reg. No. 1204776-60-2)(I292) (known from JP2010/018586),5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I293) (known from WO2007/075459),5-[5-(2-chloropyridin-4-yl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I294) (known from WO2007/075459),4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamide(I295) (known from WO2005/085216),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one(I296),4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one(I297),4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one(I298),4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one(I299) (all known from WO2010/005692), PyflubumideN-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H-pyrazole-4-carboxamide(I300) (known from WO2002/096882), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I301) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate(I302) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I303) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate(I304) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate(I305) (known from WO2005/085216), (5RS,7RS;5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine(I306) (known from WO2007/101369),2-{6-[2-(5-fluoropyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine(I307) (known from WO2010/006713),2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine (I308)(known from WO2010/006713),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I311) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I312) (known from WO2010/069502),(1E)-N-[(6-chloropyridin-3-yl)methyl]-N′-cyano-N-(2,2-difluoroethyl)ethanimidamide(I313) (known from WO2008/009360),N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I314) (known from CN102057925), and methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylate(I315) (known from WO2011/049233).

In a preferred embodiment the insecticide (I) is selected from the groupconsisting of Diafenthiuron (I178), Chlorfenapyr (I184), Lufenuron(I197), Triflumuron (I201), Buprofezin (I202), Methoxyfenozide (I206),Fenpyroximate (I213), Tebufenpyrad (I216), Spirodiclofen (I221),Spiromesifen (I222), Spirotetramate (I223), Cyenopyrafen (I229),Cyflumentofen (I230), Flometoquin (I291), Fluensulfone (I244), Fluopyram(I247), Flupyradifurone (I262), Pyflubumide (I300), Pyrifluquinazone(I253),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277), Afidopyropen (I278). However, the composition according to thepresent invention does not comprise Coniothyrium minitans CON/M/91-08(DSM 9660) and Fluopyram (I247) at the same time.

In one embodiment of the present invention, the insecticide (I), e.g.,the insecticide (I) for use in seed treatment or for foliar or soilapplications, is selected from the group consisting of B. firmus (I256)and Fluopyram (I247). However, this preferred composition for seedtreatment according to the present invention does not compriseConiothyrium minitans CON/M/91-08 (DSM 9660) and Fluopyram (I247) at thesame time.

In another embodiment of the present invention, the insecticide (I)),e.g., the insecticide (I) for use in seed treatment or for foliar orsoil applications, is selected from the group consisting ofSpirotetramat (I223), Spiromesifen (I222), Fluopyram (I247 m, preferablythe composition does not comprise Fluopyram and Contans at the sametime), Flupyradifurone (I262),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) and a mixture of 1309 and 1310.

Compositions According to the Present Invention

According to the present invention the composition comprises at leastone biological control agent selected from the group consisting ofPaecilomyces lilacinus strain 251 (AGAL No. 89/030550), Trichodermaatroviride SC1 (CBS No. 122089), and Coniothyrium minitans CON/M/91-08(DSM 9660) and/or a mutant of these strains having all the identifyingcharacteristics of the respective strain, and/or at least one metaboliteproduced by the respective strain that exhibits activity againstnematodes, insects and/or phytopathogens, and at least one insecticide(I) selected from the group consisting selected from the groupconsisting of juvenile hormone mimics, miscellaneous non-specific(multi-site) inhibitors, selective homopteran feeding blockers, mitegrowth inhibitors, microbial disruptors of insect midgut membranes,inhibitors of mitochondrial ATP synthase, uncouplers of oxidativephoshorylation via disruption of the proton gradient, inhibitors ofchitin biosynthesis (type 0), inhibitors of chitin biosynthesis (type1), moulting disruptors, ecdysone receptor agonists, octopamine receptoragonists, mitochondrial complex III electron transport inhibitors,mitochondrial complex I electron transport inhibitors, inhibitors ofacetyl CoA carboxylase, mitochondrial complex IV electron transportinhibitors, mitochondrial complex II electron transport inhibitors, andfurther insecticides in a synergistically effective amount, with theproviso that the composition does not comprise Coniothyrium minitansCON/M/91-08 (DSM 9660) and Fluopyram (I247).

A “synergistically effective amount” according to the present inventionrepresents a quantity of a combination of a biological control agent andan insecticide that is statistically significantly more effectiveagainst insects, mites, nematodes and/or phytopathogens than thebiological control agent or the insecticide only.

In a preferred embodiment the composition according to the presentinvention comprises the following combinations:

B1+I156, B1+I157, B1+I158, B1+I159, B1+I160, B1+I161, B1+I162, B1+I163,B1+I164, B1+I165, B1+I166, B1+I167, B1+I168, B1+I169, B1+I170, B1+I171,B1+I172, B1+I173, B1+I174, B1+I175, B1+I176, B1+I177, B1+I178, B1+I179,B1+I180, B1+I181, B1+I182, B1+I183, B1+I184, B1+I185, B1+I186, B1+I191,B1+I192, B1+I193, B1+I194, B1+I195, B1+I196, B1+I197, B1+I198, B1+I199,B1+I200, B1+I201, B1+I202, B1+I203, B1+I204, B1+I205, B1+I206, B1+I207,B1+I208, B1+I209, B1+I210, B1+I211, B1+I212, B1+I213, B1+I214, B1+I215,B1+I216, B1+I217, B1+I218, B1+I221, B1+I222, B1+I223, B1+I224, B1+I225,B1+I226, B1+I227, B1+I228, B1+I229, B1+I230, B1+I234, B1+I235, B1+I236,B1+I237, B1+I238, B1+I239, B1+I240, B1+I241, B1+I242, B1+I243, B1+I244,B1+I245, B1+I246, B1+I247, B1+I248, B1+I249, B1+I250, B1+I251, B1+I252,B1+I253, B1+I254, B1+I255, B1+I256, B1+I257, B1+I258, B1+I259, B1+I260,B1+I261, B1+I262, B1+I263, B1+I264, B1+I265, B1+I266, B1+I267, B1+I268,B1+I269, B1+I270, B1+I271, B1+I272, B1+I273, B1+I274, B1+I275, B1+I276,B1+I277, B1+I278, B1+I279, B1+I280, B1+I282, B1+I283, B1+I284, B1+I285,B1+I286, B1+I287, B1+I288, B1+I289, B1+I290, B1+I291, B1+I292, B1+I293,B1+I294, B1+I295, B1+I296, B1+I297, B1+I298, B1+I299, B1+I300, B1+I301,B1+I302, B1+I303, B1+I304, B1+I305, B1+I306, B1+I307, B1+I308, B1+I309,B1+I310, B1+I311, B1+I312, B1+I313, B1+I314, B1+I315;

B2+I156, B2+I157, B2+I158, B2+I159, B2+I160, B2+I161, B2+I162, B2+I163,B2+I164, B2+I165, B2+I166, B2+I167, B2+I168, B2+I169, B2+I170, B2+I171,B2+I172, B2+I173, B2+I174, B2+I175, B2+I176, B2+I177, B2+I178, B2+I179,B2+I180, B2+I181, B2+I182, B2+I183, B2+I184, B2+I185, B2+I186, B2+I191,B2+I192, B2+I193, B2+I194, B2+I195, B2+I196, B2+I197, B2+I198, B2+I199,B2+I200, B2+I201, B2+I202, B2+I203, B2+I204, B2+I205, B2+I206, B2+I207,B2+I208, B2+I209, B2+I210, B2+I211, B2+I212, B2+I213, B2+I214, B2+I215,B2+I216, B2+I217, B2+I218, B2+I221, B2+I222, B2+I223, B2+I224, B2+I225,B2+I226, B2+I227, B2+I228, B2+I229, B2+I230, B2+I234, B2+I235, B2+I236,B2+I237, B2+I238, B2+I239, B2+I240, B2+I241, B2+I242, B2+I243, B2+I244,B2+I245, B2+I246, B2+I247, B2+I248, B2+I249, B2+I250, B2+I251, B2+I252,B2+I253, B2+I254, B2+I255, B2+I256, B2+I257, B2+I258, B2+I259, B2+I260,B2+I261, B2+I262, B2+I263, B2+I264, B2+I265, B2+I266, B2+I267, B2+I268,B2+I269, B2+I270, B2+I271, B2+I272, B2+I273, B2+I274, B2+I275, B2+I276,B2+I277, B2+I278, B2+I279, B2+I280, B2+I282, B2+I283, B2+I284, B2+I285,B2+I286, B2+I287, B2+I288, B2+I289, B2+I290, B2+I291, B2+I292, B2+I293,B2+I294, B2+I295, B2+I296, B2+I297, B2+I298, B2+I299, B2+I300, B2+I301,B2+I302, B2+I303, B2+I304, B2+I305, B2+I306, B2+I307, B2+I308, B2+I309,B2+I310, B2+I311, B2+I312, B2+I313, B2+I314, B2+I315;

B3+I156, B3+I157, B3+I158, B3+I159, B3+I160, B3+I161, B3+I162, B3+I163,B3+I164, B3+I165, B3+I166, B3+I167, B3+I168, B3+I169, B3+I170, B3+I171,B3+I172, B3+I173, B3+I174, B3+I175, B3+I176, B3+I177, B3+I178, B3+I179,B3+I180, B3+I181, B3+I182, B3+I183, B3+I184, B3+I185, B3+I186, B3+I191,B3+I192, B3+I193, B3+I194, B3+I195, B3+I196, B3+I197, B3+I198, B3+I199,B3+I200, B3+I201, B3+I202, B3+I203, B3+I204, B3+I205, B3+I206, B3+I207,B3+I208, B3+I209, B3+I210, B3+I211, B3+I212, B3+I213, B3+I214, B3+I215,B3+I216, B3+I217, B3+I218, B3+I221, B3+I222, B3+I223, B3+I224, B3+I225,B3+I226, B3+I227, B3+I228, B3+I229, B3+I230, B3+I234, B3+I235, B3+I236,B3+I237, B3+I238, B3+I239, B3+I240, B3+I241, B3+I242, B3+I243, B3+I244,B3+I245, B3+I246, B3+I248, B3+I249, B3+I250, B3+I251, B3+I252, B3+I253,B3+I254, B3+I255, B3+I256, B3+I257, B3+I258, B3+I259, B3+I260, B3+I261,B3+I262, B3+I263, B3+I264, B3+I265, B3+I266, B3+I267, B3+I268, B3+I269,B3+I270, B3+I271, B3+I272, B3+I273, B3+I274, B3+I275, B3+I276, B3+I277,B3+I278, B3+I279, B3+I280, B3+I282, B3+I283, B3+I284, B3+I285, B3+I286,B3+I287, B3+I288, B3+I289, B3+I290, B3+I291, B3+I292, B3+I293, B3+I294,B3+I295, B3+I296, B3+I297, B3+I298, B3+I299, B3+I300, B3+I301, B3+I302,B3+I303, B3+I304, B3+I305, B3+I306, B3+I307, B3+I308, B3+I309, B3+I310,B3+I311, B3+I312, B3+I313, B3+I314, B3+I315.

In another preferred embodiment the composition according to the presentinvention comprises the following combinations:

B1+I156, B1+I157, B1+I158, B1+I159, B1+I160, B1+I161, B1+I162, B1+I163,B1+I164, B1+I165, B1+I166, B1+I167, B1+I168, B1+I169, B1+I170, B1+I171,B1+I172, B1+I173, B1+I174, B1+I175, B1+I176, B1+I177, B1+I178, B1+I179,B1+I180, B1+I181, B1+I182, B1+I183, B1+I184, B1+I185, B1+I186, B1+I191,B1+I192, B1+I193, B1+I194, B1+I195, B1+I196, B1+I197, B1+I198, B1+I199,B1+I200, B1+I201, B1+I202, B1+I203, B1+I204, B1+I205, B1+I206, B1+I207,B1+I208, B1+I209, B1+I210, B1+I211, B1+I212, B1+I213, B1+I214, B1+I215,B1+I216, B1+I217, B1+I218, B1+I221, B1+I222, B1+I223, B1+I224, B1+I225,B1+I226, B1+I227, B1+I228, B1+I229, B1+I230, B1+I234, B1+I235, B1+I236,B1+I237, B1+I238, B1+I239, B1+I240, B1+I241, B1+I242, B1+I243, B1+I244,B1+I245, B1+I246, B1+I247, B1+I248, B1+I249, B1+I250, B1+I251, B1+I252,B1+I253, B1+I254, B1+I255, B1+I256, B1+I257, B1+I258, B1+I259, B1+I260,B1+I261, B1+I262, B1+I263, B1+I264, B1+I265, B1+I266, B1+I267, B1+I268,B1+I269, B1+I270, B1+I271, B1+I272, B1+I273, B1+I274, B1+I275, B1+I276,B1+I277, B1+I278, B1+I279, B1+I280, B1+I282, B1+I283, B1+I284, B1+I285,B1+I286, B1+I287, B1+I288, B1+I289, B1+I290, B1+I291, B1+I292, B1+I293,B1+I294, B1+I295, B1+I296, B1+I297, B1+I298, B1+I299, B1+I300, B1+I301,B1+I302, B1+I303, B1+I304, B1+I305, B1+I306, B1+I307, B1+I308, B1+I309,B1+I310, B1+I311, B1+I312, B1+I313, B1+I314, B1+I315.

In a highly preferred embodiment the present invention relates to acomposition comprising the following combinations:

B1+I178, B1+I184, B1+I197, B1+I201, B1+I202, B1+I206, B1+I213, B1+I216,B1+I221, B1+I222, B1+I223, B1+I229, B1+I230, B1+I244, B1+I247, B1+I253,B1+I262, B1+I277, B1+I278, B1+I291, B1+I300, B1+I309, B1+I310;

B2+I178, B2+I184, B2+I197, B2+I201, B2+I202, B2+I206, B2+I213, B2+I216,B2+I221, B2+I222, B2+I223, B2+I229, B2+I230, B2+I244, B2+I247, B2+I253,B2+I262, B2+I277, B2+I278, B2+I291, B2+I300, B2+I309, B2+I310;

B3+I178, B3+I184, B3+I197, B3+I201, B3+I202, B3+I206, B3+I213, B3+I216,B3+I221, B3+I222, B3+I223, B3+I229, B3+I230, B3+I244, B3+I253, B3+I262,B3+I277, B3+I278, B3+I291, B3+I300, B3+I309, B3+I310.

In another highly preferred embodiment the present invention relates toa composition comprising the following combinations:

B1+I178, B1+I184, B1+I197, B1+I201, B1+I202, B1+I206, B1+I213, B1+I216,B1+I221, B1+I222, B1+I223, B1+I229, B1+I230, B1+I244, B1+I247, B1+I253,B1+I262, B1+I277, B1+I278, B1+I291, B1+I300, B1+I309, B1+I310.

In one embodiment of the present invention, the composition used in seedtreatment, comprises the following combinations:

B1+I256, B1+I247.

In another embodiment, the composition used in foliar or oil applicationor seed treatment comprises the following combinations:

B1+I277, B1+I222, B1+I262, B1+I247, B1+I310

B3+I277, B3+I222, B3+I223, B3+I262, B3+I309+I310 In a preferredembodiment the composition according the present invention furthercomprising at least one additional insecticide (II) and/or at least onefungicide, with the proviso that insecticide (II) is not identical toinsecticide (1) and the biological control agent is not identical to thefungicide.

Insecticide (II)

Insecticide (II) differs from insecticide (I). In a preferred embodimentof the present invention the insecticide (II) is a syntheticinsecticide. As used herein, the term “synthetic” defines a compoundthat has not been obtained from a biological control agent. Especially asynthetic insecticide or fungicide is no metabolite of the biologicalcontrol agents according to the present invention.

According to one embodiment of the present invention preferredinsecticides are selected from the group consisting of

(1) Acetylcholinesterase (AChE) Inhibitors, for Example

carbamates, e.g. Alanycarb (I1), Aldicarb (I2), Bendiocarb (I3),Benfuracarb (I4), Butocarboxim (I5), Butoxycarboxim (I6), Carbaryl (I7),Carbofuran (I8), Carbosulfan (I9), Ethiofencarb (I10), Fenobucarb (I11),Formetanate (I12), Furathiocarb (I13), lsoprocarb (I14), Methiocarb(I15), Methomyl (I16), Metolcarb (I17), Oxamyl (I18), Pirimicarb (I19),Propoxur (I20), Thiodicarb (I21), Thiofanox (I22), Triazamate (I23),Trimethacarb (I24), XMC (I25), and Xylylcarb (I26); ororganophosphates, e.g. Acephate (I27), Azamethiphos (I28),Azinphos-ethyl (I29), Azinphos-methyl (I30), Cadusafos (I31),Chlorethoxyfos (I32), Chlorfenvinphos (I33), Chlormephos (I34),Chlorpyrifos (I35), Chlorpyrifos-methyl (I36), Coumaphos (I37),Cyanophos (I38), Demeton-S-methyl (I39), Diazinon (I40), Dichlorvos/DDVP(I41), Dicrotophos (I42), Dimethoate (I43), Dimethylvinphos (I44),Disulfoton (I45), EPN (I46), Ethion (I47), Ethoprophos (I48), Famphur(I49), Fenamiphos (I50), Fenitrothion (I51), Fenthion (I52), Fosthiazate(I53), Heptenophos (I54), Imicyafos (I55), lsofenphos (I56), IsopropylO-(methoxyaminothio-phosphoryl) salicylate (I57), Isoxathion (I58),Malathion (I59), Mecarbam (I60), Methamidophos (I61), Methidathion(I62), Mevinphos (I63), Monocrotophos (I64), Naled (I65), Omethoate(I66), Oxydemeton-methyl (I67), Parathion (I68), Parathion-methyl (I69),Phenthoate (I70), Phorate (I71), Phosalone (I72), Phosmet (I73),Phosphamidon (I74), Phoxim (I75), Pirimiphos-methyl (I76), Profenofos(I77), Propetamphos (I78), Prothiofos (I79), Pyraclofos (I80),Pyridaphenthion (I81), Quinalphos (I82), Sulfotep (I83), Tebupirimfos(I84), Temephos (I85), Terbufos (I86), Tetrachlorvinphos (I87),Thiometon (I88), Triazophos (I89), Trichlorfon (I90), and Vamidothion(I91);

(2) GABA-Gated Chloride Channel Antagonists, for Example

cyclodiene organochlorines, e.g. Chlordane (I92) and Endosulfan (I93);orphenylpyrazoles (fiproles), e.g. Ethiprole (I94) and Fipronil (I95);(3) Sodium channel modulators/voltage-dependent sodium channel blockers,for example pyrethroids, e.g. Acrinathrin (I96), Allethrin (I97),d-cis-trans Allethrin (I98), d-trans Allethrin (I99), Bifenthrin (I100),Bioallethrin (I101), Bioallethrin S-cyclopentenyl isomer (I102),Bioresmethrin (I103), Cycloprothrin (I104), Cyfluthrin (I105),beta-Cyfluthrin (I106), Cyhalothrin (I107), lambda-Cyhalothrin (I108),gamma-Cyhalothrin (I109), Cypermethrin (I110), alpha-Cypermethrin(I111), beta-Cypermethrin (I112), theta-Cypermethrin (I113),zeta-Cypermethrin (I114), Cyphenothrin [(1R)-trans isomers](I115),Deltamethrin (I116), Empenthrin [(EZ)-(1R) isomers) (I117),Esfenvalerate (I118), Etofenprox (I119), Fenpropathrin (I120),Fenvalerate (I121), Flucythrinate (I122), Flumethrin (I123),tau-Fluvalinate (I124), Halfenprox (I125), lmiprothrin (I126), Kadethrin(I127), Permethrin (I128), Phenothrin [(1R)-trans isomer) (I129),Prallethrin (I130), Pyrethrine (pyrethrum) (I131), Resmethrin (I132),Silafluofen (I133), Tefluthrin (I134), Tetramethrin (I135), Tetramethrin[(1R) isomers)](I136), Tralomethrin (I137), and Transfluthrin (I138); orDDT (I139); or Methoxychlor (I140);(4) Nicotinic acetylcholine receptor (nAChR) agonists, for exampleneonicotinoids, e.g. Acetamiprid (I141), Clothianidin (I142),Dinotefuran (I143), Imidacloprid (I144), Nitenpyram (I145), Thiacloprid(I146), and Thiamethoxam (I147); or Nicotine (I148); or Sulfoxaflor(I149).(5) Nicotinic acetylcholine receptor (nAChR) allosteric activators, forexample spinosyns, e.g. Spinetoram (I150) and Spinosad (I151);(6) Chloride channel activators, for example avermectins/milbemycins,e.g. Abamectin (I152), Emamectin benzoate (I153), Lepimectin (I154), andMilbemectin (I155);(7) Juvenile hormone mimics, for example juvenile hormon analogues, e.g.Hydroprene (I156), Kinoprene (I157), and Methoprene (I158); orFenoxycarb (I159); or Pyriproxyfen (I160);(8) Miscellaneous non-specific (multi-site) inhibitors, for examplealkyl halides, e.g. Methyl bromide (I161) and other alkyl halides; orChloropicrin (I162); or Sulfuryl fluoride (I163); or Borax (I164); orTartar emetic (I165);(9) Selective homopteran feeding blockers, e.g. Pymetrozine (I166); orFlonicamid (I167);(10) Mite growth inhibitors, e.g. Clofentezine (I168), Hexythiazox(I169), and Diflovidazin (I170); or Etoxazole (I171);(11) Microbial disruptors of insect midgut membranes, e.g. Bacillusthuringiensis subspecies israelensis (I172), Bacillus thuringiensissubspecies aizawai (I173), Bacillus thuringiensis subspecies kurstaki(I174), Bacillus thuringiensis subspecies tenebrionis (I175), and B. t.crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A,Cry3Ab, Cry3Bb, Cry34 Ab1/35Ab1 (I176); or Bacillus sphaericus (I177);(I2) Inhibitors of mitochondrial ATP synthase, for example Diafenthiuron(I178); or organotin miticides, e.g. Azocyclotin (I179), Cyhexatin(I180), and Fenbutatin oxide (I181); or Propargite (I182); or Tetradifon(I183);(13) Uncouplers of oxidative phoshorylation via disruption of the protongradient, for example Chlorfenapyr (I184), DNOC (I185), and Sulfluramid(I186);(14) Nicotinic acetylcholine receptor (nAChR) channel blockers, forexample Bensultap (I187), Cartap hydrochloride (I188), Thiocyclam(I189), and Thiosultap-sodium (I190);(15) Inhibitors of chitin biosynthesis, type 0, for example Bistrifluron(I191), Chlorfluazuron (I192), Diflubenzuron (I193), Flucycloxuron(I194), Flufenoxuron (I195), Hexaflumuron (I196), Lufenuron (I197),Novaluron (I198), Noviflumuron (I199), Teflubenzuron (I200), andTriflumuron (I201);(16) Inhibitors of chitin biosynthesis, type 1, for example Buprofezin(I202);(17) Moulting disruptors, for example Cyromazine (I203);(18) Ecdysone receptor agonists, for example Chromafenozide (I204),Halofenozide (I205), Methoxyfenozide (I206), and Tebufenozide (I207);(19) Octopamine receptor agonists, for example Amitraz (I208);(20) Mitochondrial complex III electron transport inhibitors, forexample Hydramethylnon (I209); or Acequinocyl (I210); or Fluacrypyrim(I211);(21) Mitochondrial complex I electron transport inhibitors, for exampleMETI acaricides, e.g. Fenazaquin (I212), Fenpyroximate (I213),Pyrimidifen (I214), Pyridaben (I215), Tebufenpyrad (I216), andTolfenpyrad (I217); or Rotenone (Derris) (I218);(22) Voltage-dependent sodium channel blockers, e.g. lndoxacarb (I219);or Metaflumizone (I220);(23) Inhibitors of acetyl CoA carboxylase, for example tetronic andtetramic acid derivatives, e.g. Spirodiclofen (I221), Spiromesifen(I222), and Spirotetramat (I223);(24) Mitochondrial complex IV electron transport inhibitors, for examplephosphines, e.g. Aluminium phosphide (I224), Calcium phosphide (I225),Phosphine (I226), and Zinc phosphide (I227); or Cyanide (I228);(25) Mitochondrial complex II electron transport inhibitors, for examplebeta-ketonitrile derivatives, e.g. Cyenopyrafen (I229) and Cyflumetofen(I230);(26) Ryanodine receptor modulators, for example diamides, e.g.Chlorantraniliprole (I231), Cyantraniliprole (I232), and Flubendiamide(I233);

Further active ingredients with unknown or uncertain mode of action, forexample Amidoflumet (I234), Azadirachtin (I235), Benclothiaz (I236),Benzoximate (I237), Bifenazate (I238), Bromopropylate (I239),Chinomethionat (I240), Cryolite (I241), Dicofol (I242), Diflovidazin(I243), Fluensulfone (I244), Flufenerim (I245), Flufiprole (I246),Fluopyram (I247), Fufenozide (I248), lmidaclothiz (I249), Iprodione(I250), Meperfluthrin (I251), Pyridalyl (I252), Pyrifluquinazon (I253),Tetramethylfluthrin (I254), and iodomethane (I255); furthermore productsbased on Bacillus firmus (including but not limited to strain CNCMI-1582, such as, for example, VOTiVO™, BioNem) (I256) or one of thefollowing known active compounds:3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I257) (known from WO2005/077934),4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I258) (known from WO2007/115644),4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one(I259) (known from WO2007/115644),4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I260) (known from WO2007/115644),4-{[(6-chlorpyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I261) (known from WO2007/115644), Flupyradifurone (I262),4-{[(6-chlor-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one(I263) (known from WO2007/115643),4-{[(5,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I264) (known from WO2007/115646),4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I265) (known from WO2007/115643),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I266) (known from EP-A-0 539 588),4-{[(6-chlorpyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I267)(known from EP-A-0 539 588),{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(I268) (known from WO2007/149134) and its diastereomers{[(1R)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(A) (I269), and{[(1S)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(B) (I270) (also known from WO2007/149134) as well as diastereomers[(R)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A1)) (I271), and[(S)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A2) (I272), referred to as group of diastereomers A (known fromWO2010/074747, WO2010/074751), [(R)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide (B1) (I273), and[(S)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B2) (I274), referred to as group of diastereomers B (also known fromWO2010/074747, WO2010/074751), and11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one(I275) (known from WO2006/089633),3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one(I276) (known from WO2008/067911),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277) (known from WO2006/043635), Afidopyropen[(3S,4aR,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate (I278) (known from WO2008/066153),2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide (I279) (knownfrom WO2006/056433),2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide (I280) (knownfrom WO2006/100288), 2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (I281) (known from WO2005/035486),4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine1,1-dioxide (I282) (known from WO2007/057407),N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine(I283) (known from WO2008/104503),{1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone(I284) (known from WO2003/106457),3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one(I285) (known from WO2009/049851),3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (I286) (known from WO2009/049851),4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine(I287) (known from WO2004/099160),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile(I288) (known from WO2005/063094), (2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl) malononitrile (I289) (known fromWO2005/063094), 8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6-(trifluoromethyl)pyridazin-3-yl]-3-azabicyclo[3.2.1]octane (I290) (known fromWO2007/040280), Flometoquin (I291), PF1364 (CAS-Reg. No. 1204776-60-2)(I292) (known from JP2010/018586),5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I293) (known from WO2007/075459),5-[5-(2-chloropyridin-4-yl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I294) (known from WO2007/075459),4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamide(I295) (known from WO2005/085216),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one(I296),4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one(I297),4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one(I298),4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one(I299) (all known from WO2010/005692), PyflubumideN-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H-pyrazole-4-carboxamide (I300)(known from WO2002/096882), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I301) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate(I302) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I303) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate(I304) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate(I305) (known from WO2005/085216), (5RS,7RS;5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine(I306) (known from WO2007/101369),2-{6-[2-(5-fluoropyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine(I307) (known from WO2010/006713),2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine (I308)(known from WO2010/006713),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I311) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I312) (known from WO2010/069502),(1E)-N-[(6-chloropyridin-3-yl)methyl]-N′-cyano-N-(2,2-difluoroethyl)ethanimidamide(I313) (known from WO2008/009360),N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I314) (known from CN102057925), and methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylate(I315) (known from WO2011/049233).

In one embodiment of the present invention the additional insecticide(II) is selected from the group consisting of Abamectin (I152), Acephate(I27), Acetamiprid (I141), Acrinathrin (I96), Alpha-Cypermethrin (I111),Beta-Cyfluthrin (I106), Bifenthrin (I100), Buprofezin (I202),Clothianidin (I142), Chlorantraniliprole (I231), Chlorfenapyr (I184),Chlorpyrifos (I35), Carbofuran (I8), Cyantraniliprole (I232),Cyenopyrafen (I229), Cyflumentofen (I230), Cyfluthrin (I105),Cypermethrin (I110), Deltamethrin (I116), Diafenthiuron (I178),Dinotefuran (I143), Emamectin-benzoate (I153), Ethiprole (I94),Fenpyroximate (I213), Fipronil (I95), Flometoquin (I291), Flubendiamide(I233), Fluensulfone (I244), Fluopyram (I247), Flupyradifurone (I262),Gamma-Cyhalothrin (I109), Imidacloprid (I144), lndoxacarb (I219),Lambda-Cyhalothrin (I108), Lufenuron (I197), Metaflumizone (I220),Methiocarb (I15), Methoxyfenozide (I206), Milbemectin (I155), Profenofos(I77), Pyflubumide (I300), Pyrifluquinazone (I253), Spinetoram (I150),Spinosad (I151), Spirodiclofen (I221), Spiromesifen (I222),Spirotetramate (I223), Sulfoxaflor (I149), Tebufenpyrad (I216),Tefluthrin (I134), Thiacloprid (I146), Thiamethoxam (I147), Thiodicarb(I21), Triflumuron (I201),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502) and1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277).

According to another embodiment the composition according to theinvention further comprises at least one fungicide, with the proviso thebiological control agent is not identical to the fungicide.

Fungicides

In general, “fungicidal” means the ability of a substance to increasemortality or inhibit the growth rate of fungi.

The term “fungus” or “fungi” includes a wide variety of nucleatedsporebearing organisms that are devoid of chlorophyll. Examples of fungiinclude yeasts, molds, mildews, rusts, and mushrooms.

Preferably, the fungicide is selected so as not to have any fungicidalactivity against the biological control agent according to the presentinvention.

According to one embodiment of the present invention preferredfungicides are selected from the group consisting of

(1) Inhibitors of the ergosterol biosynthesis, for example (F1)aldimorph (1704-28-5), (F2) azaconazole (60207-31-0), (F3) bitertanol(55179-31-2), (F4) bromuconazole (116255-48-2), (F5) cyproconazole(113096-99-4), (F6) diclobutrazole (75736-33-3), (F7) difenoconazole(119446-68-3), (F8) diniconazole (83657-24-3), (F9) diniconazole-M(83657-18-5), (F10) dodemorph (1593-77-7), (F11) dodemorph acetate(31717-87-0), (F12) epoxiconazole (106325-08-0), (F13) etaconazole(60207-93-4), (F14) fenarimol (60168-88-9), (F15) fenbuconazole(114369-43-6), (F16) fenhexamid (126833-17-8), (F17) fenpropidin(67306-00-7), (F18) fenpropimorph (67306-03-0), (F19) fluquinconazole(136426-54-5), (F20) flurprimidol (56425-91-3), (F21) flusilazole(85509-19-9), (F22) flutriafol (76674-21-0), (F23) furconazole(112839-33-5), (F24) furconazole-cis (112839-32-4), (F25) hexaconazole(79983-71-4), (F26) imazalil (60534-80-7), (F27) imazalil sulfate(58594-72-2), (F28) imibenconazole (86598-92-7), (F29) ipconazole(125225-28-7), (F30) metconazole (125116-23-6), (F31) myclobutanil(88671-89-0), (F32) naftifine (65472-88-0), (F33) nuarimol (63284-71-9),(F34) oxpoconazole (174212-12-5), (F35) paclobutrazol (76738-62-0),(F36) pefurazoate (101903-30-4), (F37) penconazole (66246-88-6), (F38)piperalin (3478-94-2), (F39) prochloraz (67747-09-5), (F40)propiconazole (60207-90-1), (F41) prothioconazole (178928-70-6), (F42)pyributicarb (88678-67-5), (F43) pyrifenox (88283-41-4), (F44)quinconazole (103970-75-8), (F45) simeconazole (149508-90-7), (F46)spiroxamine (118134-30-8), (F47) tebuconazole (107534-96-3), (F48)terbinafine (91161-71-6), (F49) tetraconazole (112281-77-3), (F50)triadimefon (43121-43-3), (F51) triadimenol (89482-17-7), (F52)tridemorph (81412-43-3), (F53) triflumizole (68694-11-1), (F54)triforine (26644-46-2), (F55) triticonazole (131983-72-7), (F56)uniconazole (83657-22-1), (F57) uniconazole-p (83657-17-4), (F58)viniconazole (77174-66-4), (F59) voriconazole (137234-62-9), (F60)1-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-yl)cycloheptanol (129586-32-9),(F61) methyl1-(2,2-dimethyl-2,3-dihydro-1H-inden-1-yl)-1H-imidazole-5-carboxylate(110323-95-0), (F62)N′-{5-(difluoromethyl)-2-methyl-4-[3-(trimethylsilyl)propoxy]phenyl}-N-ethyl-N-methylimidoformamide,(F63)N-ethyl-N-methyl-N′-{2-methyl-5-(trifluoromethyl)-4-[3-(trimethylsilyl)propoxy]phenyl}imidoformamide,(F64)O-[1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl]1H-imidazole-1-carbothioate(111226-71-2);(2) inhibitors of the respiratory chain at complex I or II, for example(F65) bixafen (581809-46-3), (F66) boscalid (188425-85-6), (F67)carboxin (5234-68-4), (F68) diflumetorim (130339-07-0), (F69) fenfuram(24691-80-3), (F70) fluopyram (658066-35-4), (F71) flutolanil(66332-96-5), (F72) fluxapyroxad (907204-31-3), (F73) furametpyr(123572-88-3), (F74) furmecyclox (60568-05-0), (F75) isopyrazam (mixtureof syn-epimeric racemate 1RS,4SR,9RS and anti-epimeric racemate1RS,4SR,9SR) (881685-58-1), (F76) isopyrazam (anti-epimeric racemate 1RS,4SR,9SR), (F77) isopyrazam (anti-epimeric enantiomer 1R,4S,9S), (F78)isopyrazam (anti-epimeric enantiomer 1S,4R,9R), (F79) isopyrazam (synepimeric racemate 1 RS,4SR,9RS), (F80) isopyrazam (syn-epimericenantiomer 1R,4S,9R), (F81) isopyrazam (syn-epimeric enantiomer 1S,4R,9S), (F82) mepronil (55814-41-0), (F83) oxycarboxin (5259-88-1),(F84) penflufen (494793-67-8), (F85) penthiopyrad (183675-82-3), (F86)sedaxane (874967-67-6), (F87) thifluzamide (130000-40-7), (F88)1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxy)phenyl]-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, (F89)3-(difluoromethyl)-1-methyl-N-[2-(1,1,2,2-tetrafluoroethoxyl)phenyl]-1H-pyrazole-4-carboxamide,(F90)3-(difluoromethyl)-N-[4-fluoro-2-(1,1,2,3,3,3-hexafluoropropoxyl)phenyl]-1-methyl-1H-pyrazole-4-carboxamide,(F91)N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide(1092400-95-7), (F92)5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine(1210070-84-0), (F93) benzovindiflupyr,(F94)N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(F95)N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(F96)3-(Difluormethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid,(F97)1,3,5-Trimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid,(F98)1-Methyl-3-(trifluormethyl)-N-(1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid,(F99)1-Methyl-3-(trifluormethyl)-N-[(1S)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F100)1-Methyl-3-(trifluormethyl)-N-[(1R)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F101)3-(Difluormethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F102)3-(Difluormethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F103)1,3,5-Trimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F104)1,3,5-Trimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid;(3) inhibitors of the respiratory chain at complex Ill, for example(F105) ametoctradin (865318-97-4), (F106) amisulbrom (348635-87-0),(F107) azoxystrobin (131860-33-8), (F108) cyazofamid (120116-88-3),(F109) coumethoxystrobin (850881-30-0), (F110) coumoxystrobin(850881-70-8), (F111) dimoxystrobin (141600-52-4), (F112) enestroburin(238410-11-2), (F113) famoxadone (131807-57-3), (F114) fenamidone(161326-34-7), (F115) fenoxystrobin (918162-02-4), (F116) fluoxastrobin(361377-29-9), (F117) kresoxim-methyl (143390-89-0), (F118)metominostrobin (133408-50-1), (F119) orysastrobin (189892-69-1), (F120)picoxystrobin (117428-22-5), (F121) pyraclostrobin (175013-18-0), (F122)pyrametostrobin (915410-70-7), (F123) pyraoxystrobin (862588-11-2),(F124) pyribencarb (799247-52-2), (F125) triclopyricarb (902760-40-1),(F126) trifloxystrobin (141517-21-7), (F127)(2E)-2-(2-{[6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yl]oxy}phenyl)-2-(methoxyimino)-N-methylethanamide,(F128)(2E)-2-(methoxyimino)-N-methyl-2-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)ethanamide,(F129)(2E)-2-(methoxyimino)-N-methyl-2-{2-[(E)-({1-[3-(trifluoromethyl)phenyl]ethoxy}imino)methyl]phenyl}ethanamide(158169-73-4), (F130)(2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylethenyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide (326896-28-0), (F131)(2E)-2-{2-[({[(2E,3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylethanamide, (F132)2-chloro-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)pyridine-3-carboxamide(119899-14-8), (F133)5-methoxy-2-methyl-4-(2-{[({(1E)-1-[3-(trifluoromethyl)phenyl]ethylidene}amino)oxy]methyl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one,(F134) methyl (2E)-2-{2-[({cyclopropyl[(4-methoxyphenyl)imino]methyl}sulfanyl)methyl]phenyl}-3-methoxyprop-2-enoate (149601-03-6),(F135)N-(3-ethyl-3,5,5-trimethylcyclohexyl)-3-(formylamino)-2-hydroxybenzamide(226551-21-9), (F136)2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide(173662-97-0), (F137)(2R)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide(394657-24-0);(4) Inhibitors of the mitosis and cell division, for example (F138)benomyl (17804-35-2), (F139) carbendazim (10605-21-7), (F140)chlorfenazole (3574-96-7), (F141) diethofencarb (87130-20-9), (F142)ethaboxam (162650-77-3), (F143) fluopicolide (239110-15-7), (F144)fuberidazole (3878-19-1), (F145) pencycuron (66063-05-6), (F146)thiabendazole (148-79-8), (F147) thiophanate-methyl (23564-05-8), (F148)thiophanate (23564-06-9), (F149) zoxamide (156052-68-5), (F150)5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine (214706-53-3), (F151)3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine(1002756-87-7);(5) Compounds capable to have a multisite action, like for example(F152) bordeaux mixture (8011-63-0), (F153) captafol (2425-06-1), (F154)captan (133-06-2), (F155) chlorothalonil (1897-45-6), (F156) copperhydroxide (20427-59-2), (F157) copper naphthenate (1338-02-9), (F158)copper oxide (1317-39-1), (F159) copper oxychloride (1332-40-7), (F160)copper(2+) sulfate (7758-98-7), (F161) dichlofluanid (1085-98-9), (F162)dithianon (3347-22-6), (F163) dodine (2439-10-3), (F164) dodine freebase, (F165) ferbam (14484-64-1), (F166) fluorofolpet (719-96-0), (F167)folpet (133-07-3), (F168) guazatine (108173-90-6), (F169) guazatineacetate, (F170) iminoctadine (13516-27-3), (F171) iminoctadinealbesilate (169202-06-6), (F172) iminoctadine triacetate (57520-17-9),(F173) mancopper (53988-93-5), (F174) mancozeb (8018-01-7), (F175) maneb(12427-38-2), (F176) metiram (9006-42-2), (F177) metiram zinc(9006-42-2), (F178) oxine-copper (10380-28-6), (F179) propamidine(104-32-5), (F180) propineb (12071-83-9), (F181) sulphur and sulphurpreparations including calcium polysulphide (7704-34-9), (F182) thiram(137-26-8), (F183) tolylfluanid (731-27-1), (F184) zineb (12122-67-7),(F185) ziram (137-30-4);(6) Compounds capable to induce a host defense, like for example (F186)acibenzolar-S-methyl (135158-54-2), (F187) isotianil (224049-04-1),(F188) probenazole (27605-76-1), (F189) tiadinil (223580-51-6);(7) Inhibitors of the amino acid and/or protein biosynthesis, forexample (F190) andoprim (23951-85-1), (F191) blasticidin-S (2079-00-7),(F192) cyprodinil (121552-61-2), (F193) kasugamycin (6980-18-3), (F194)kasugamycin hydrochloride hydrate (19408-46-9), (F195) mepanipyrim(110235-47-7), (F196) pyrimethanil (53112-28-0), (F197)3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline(861647-32-7);(8) Inhibitors of the ATP production, for example (F198) fentin acetate(900-95-8), (F199) fentin chloride (639-58-7), (F200) fentin hydroxide(76-87-9), (F201) silthiofam (175217-20-6);(9) Inhibitors of the cell wall synthesis, for example (F202)benthiavalicarb (177406-68-7), (F203) dimethomorph (110488-70-5), (F204)flumorph (211867-47-9), (F205) iprovalicarb (140923-17-7), (F206)mandipropamid (374726-62-2), (F207) polyoxins (11113-80-7), (F208)polyoxorim (22976-86-9), (F209) validamycin A (37248-47-8), (F210)valifenalate (283159-94-4; 283159-90-0);(10) Inhibitors of the lipid and membrane synthesis, for example (F211)biphenyl (92-52-4), (F212) chloroneb (2675-77-6), (F213) dicloran(99-30-9), (F214) edifenphos (17109-49-8), (F215) etridiazole(2593-15-9), (F216) iodocarb (55406-53-6), (F217) iprobenfos(26087-47-8), (F218) isoprothiolane (50512-35-1), (F219) propamocarb(25606-41-1), (F220) propamocarb hydrochloride (25606-41-1), (F221)prothiocarb (19622-08-3), (F222) pyrazophos (13457-18-6), (F223)quintozene (82-68-8), (F224) tecnazene (117-18-0), (F225)tolclofos-methyl (57018-04-9);(11) Inhibitors of the melanine biosynthesis, for example (F226)carpropamid (104030-54-8), (F227) diclocymet (139920-32-4), (F228)fenoxanil (115852-48-7), (F229) phthalide (27355-22-2), (F230)pyroquilon (57369-32-1), (F231) tricyclazole (41814-78-2), (F232)2,2,2-trifluoroethyl{3-methyl-1-[(4-methylbenzoyl)amino]butan-2-yl}carbamate (851524-22-6);(12) Inhibitors of the nucleic acid synthesis, for example (F233)benalaxyl (71626-11-4), (F234) benalaxyl-M (kiralaxyl) (98243-83-5),(F235) bupirimate (41483-43-6), (F236) clozylacon (67932-85-8), (F237)dimethirimol (5221-53-4), (F238) ethirimol (23947-60-6), (F239)furalaxyl (57646-30-7), (F240) hymexazol (10004-44-1), (F241) metalaxyl(57837-19-1), (F242) metalaxyl-M (mefenoxam) (70630-17-0), (F243)ofurace (58810-48-3), (F244) oxadixyl (77732-09-3), (F245) oxolinic acid(14698-29-4);(13) Inhibitors of the signal transduction, for example (F246)chlozolinate (84332-86-5), (F247) fenpiclonil (74738-17-3), (F248)fludioxonil (131341-86-1), (F249) iprodione (36734-19-7), (F250)procymidone (32809-16-8), (F251) quinoxyfen (124495-18-7), (F252)vinclozolin (50471-44-8);(14) Compounds capable to act as an uncoupler, like for example (F253)binapacryl (485-31-4), (F254) dinocap (131-72-6), (F255) ferimzone(89269-64-7), (F256) fluazinam (79622-59-6), (F257) meptyldinocap(131-72-6);(15) Further compounds, like for example (F258) benthiazole(21564-17-0), (F259) bethoxazin (163269-30-5), (F260) capsimycin(70694-08-5), (F261) carvone (99-49-0), (F262) chinomethionat(2439-01-2), (F263) pyriofenone (chlazafenone) (688046-61-9), (F264)cufraneb (11096-18-7), (F265) cyflufenamid (180409-60-3), (F266)cymoxanil (57966-95-7), (F267) cyprosulfamide (221667-31-8), (F268)dazomet (533-74-4), (F269) debacarb (62732-91-6), (F270) dichlorophen(97-23-4), (F271) diclomezine (62865-36-5), (F272) difenzoquat(49866-87-7), (F273) difenzoquat methylsulphate (43222-48-6), (F724)diphenylamine (122-39-4), (F275) ecomate, (F276) fenpyrazamine(473798-59-3), (F277) flumetover (154025-04-4), (F278) fluoroimide(41205-21-4), (F279) flusulfamide (106917-52-6), (F280) flutianil(304900-25-2), (F281) fosetyl-aluminium (39148-24-8), (F282)fosetyl-calcium, (F283) fosetyl-sodium (39148-16-8), (F284)hexachlorobenzene (118-74-1), (F285) irumamycin (81604-73-1), (F286)methasulfocarb (66952-49-6), (F287) methyl isothiocyanate (556-61-6),(F288) metrafenone (220899-03-6), (F289) mildiomycin (67527-71-3),(F290) natamycin (7681-93-8), (F291) nickel dimethyldithiocarbamate(15521-65-0), (F292) nitrothal-isopropyl (10552-74-6), (F293)octhilinone (26530-20-1), (F294) oxamocarb (917242-12-7), (F295)oxyfenthiin (34407-87-9), (F296) pentachlorophenol and salts (87-86-5),(F297) phenothrin, (F298) phosphorous acid and its salts (13598-36-2),(F299) propamocarb-fosetylate, (F300) propanosine-sodium (88498-02-6),(F301) proquinazid (189278-12-4), (F302) pyrimorph (868390-90-3), (F303)(2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one(1231776-28-5), (F304)(2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one(1231776-29-6), (F305) pyrrolnitrine (1018-71-9), (F306) tebufloquin(376645-78-2), (F307) tecloftalam (76280-91-6), (F308) tolnifanide(304911-98-6), (F309) triazoxide (72459-58-6), (F310) trichlamide(70193-21-4), (F311) zarilamid (84527-51-5), (F312)(3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl2-methylpropanoate (517875-34-2), (F313)1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone(1003319-79-6), (F314)1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone(1003319-80-9), (F315)1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone(1003318-67-9), (F316) 1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl1H-imidazole-1-carboxylate (111227-17-9), (F317)2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine (13108-52-6), (F318)2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one (221451-58-7),(F319)2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone,(F320)2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone(1003316-53-7), (F321)2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone(1003316-54-8), (F322)2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone(1003316-51-5), (F323) 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, (F324)2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine,(F325) 2-phenylphenol and salts (90-43-7), (F326)3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline(861647-85-0), (F327) 3,4,5-trichloropyridine-2,6-dicarbonitrile(17824-85-0), (F328)3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine, (F329)3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine,(F330) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine,(F331) 5-amino-1,3,4-thiadiazole-2-thiol, (F332)5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide(134-31-6), (F333) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine(1174376-11-4), (F334) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine(1174376-25-0), (F335)5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, (F336) ethyl(2Z)-3-amino-2-cyano-3-phenylprop-2-enoate, (F337)N′-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide,(F338)N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,(F339)N-[(4-chlorophenyl) (cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,(F340)N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide,(F341)N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide,(F342)N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide,(F343)N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide(221201-92-9),(F344)N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide(221201-92-9), (F345)N′-{4-[(3-tert-butyl-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimidoformamide,(F346)N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide(922514-49-6),(F347)N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide(922514-07-6),(F348)N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide(922514-48-5), (F349) pentyl {6-[({[(1-methyl-1H-tetrazol-5-yl) (phenyl)methylidene]amino}oxy) methyl]pyridin-2-yl}carbamate, (F350)phenazine-1-carboxylic acid, (F351) quinolin-8-ol (134-31-6), (F352)quinolin-8-ol sulfate (2:1) (134-31-6), (F353) tert-butyl{6-[({[(1-methyl-1H-tetrazol-5-yl) (phenyl) methylene]amino}oxy)methyl]pyridin-2-yl}carbamate;(16) Further compounds, like for example (F354)1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,(F355)N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(F356)N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,(F357) 3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,(F358)N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,(F359)3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,(F360)5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,(F361)2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(F362)3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,(F363)N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,(F364)3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide,(F365)N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,(F366) 2-chloro-N-(4′-ethynylbiphenyl-2-yl) pyridine-3-carboxamide,(F367)2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(F368)4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide,(F369)5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,(F370)2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(F371)3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,(F372)5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,(F373)2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(F374)(5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone,(F375)N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulfonyl)valinamide(220706-93-4), (F376) 4-oxo-4-[(2-phenylethyl)amino]butanoic acid,(F377) but-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate,(F378) 4-Amino-5-fluoropyrimidin-2-ol (mesomere Form:6-Amino-5-fluoropyrimidin-2(1H)-on), (F379) propyl3,4,5-trihydroxybenzoate and (F380) Oryzastrobin.

All named fungicides of the classes (1) to (16) (i.e. F1 to F380) can,if their functional groups enable this, optionally form salts withsuitable bases or acids.

In a preferred embodiment of the present invention the at leastfungicide is a synthetic fungicide.

According to a preferred embodiment of the present invention thefungicide is selected from the group consisting of

(1) Inhibitors of the ergosterol biosynthesis, for example (F3)bitertanol, (F4) bromuconazole (116255-48-2), (F5) cyproconazole(113096-99-4), (F7) difenoconazole (119446-68-3), (F12) epoxiconazole(106325-08-0), (F16) fenhexamid (126833-17-8), (F17) fenpropidin(67306-00-7), (F18) fenpropimorph (67306-03-0), (F19) fluquinconazole(136426-54-5), (F22) flutriafol, (F26) imazalil, (F29) ipconazole(125225-28-7), (F30) metconazole (125116-23-6), (F31) myclobutanil(88671-89-0), (F37) penconazole (66246-88-6), (F39) prochloraz(67747-09-5), (F40) propiconazole (60207-90-1), (F41) prothioconazole(178928-70-6), (F44) quinconazole (103970-75-8), (F46) spiroxamine(118134-30-8), (F47) tebuconazole (107534-96-3), (F51) triadimenol(89482-17-7), (F55) triticonazole (131983-72-7);(2) inhibitors of the respiratory chain at complex I or II, for example(F65) bixafen (581809-46-3), (F66) boscalid (188425-85-6), (F67)carboxin (5234-68-4), (F70) fluopyram (658066-35-4), (F71) flutolanil(66332-96-5), (F72) fluxapyroxad (907204-31-3), (F73) furametpyr(123572-88-3), (F75) isopyrazam (mixture of syn-epimeric racemate1RS,4SR,9RS and anti-epimeric racemate 1RS,4SR,9SR) (881685-58-1), (F76)isopyrazam (anti-epimeric racemate 1 RS,4SR,9SR), (F77) isopyrazam(anti-epimeric enantiomer 1R,4S,9S), (F78) isopyrazam (anti-epimericenantiomer 1S,4R,9R), (F79) isopyrazam (syn epimeric racemate 1RS,4SR,9RS), (F80) isopyrazam (syn-epimeric enantiomer 1R,4S,9R), (F81)isopyrazam (syn-epimeric enantiomer 1 S,4R,9S), (F84) penflufen(494793-67-8), (F85) penthiopyrad (183675-82-3), (F86) sedaxane(874967-67-6), (F87) thifluzamide (130000-40-7), (F91)N-[1-(2,4-dichlorophenyl)-1-methoxypropan-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide(1092400-95-7), (F98)1-Methyl-3-(trifluormethyl)-N-(1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazol-4-carboxamid,(F99)1-Methyl-3-(trifluormethyl)-N-[(1S)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F100)1-Methyl-3-(trifluormethyl)-N-[(1R)-1,3,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F101)3-(Difluormethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid,(F102)3-(Difluormethyl)-1-methyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazol-4-carboxamid;(3) inhibitors of the respiratory chain at complex III, for example(F105) ametoctradin (865318-97-4), (F106) amisulbrom (348635-87-0),(F107) azoxystrobin (131860-33-8), (F108) cyazofamid (120116-88-3),(F111) dimoxystrobin (141600-52-4), (F112) enestroburin (238410-11-2),(F113) famoxadone (131807-57-3), (F114) fenamidone (161326-34-7), (F116)fluoxastrobin (361377-29-9), (F117) kresoxim-methyl (143390-89-0),(F118) metominostrobin (133408-50-1), (F119) orysastrobin (189892-69-1),(F120) picoxystrobin (117428-22-5), (F121) pyraclostrobin (175013-18-0),(F124) pyribencarb (799247-52-2), (F126) trifloxystrobin (141517-21-7);(4) Inhibitors of the mitosis and cell division, for example (F139)carbendazim (10605-21-7), (F140) chlorfenazole (3574-96-7), (F141)diethofencarb (87130-20-9), (F142) ethaboxam (162650-77-3), (F143)fluopicolide, (F144) fuberidazole (3878-19-1), (F145) pencycuron(66063-05-6), (F147) thiophanate-methyl (23564-05-8), (F149) zoxamide(156052-68-5);(5) Compounds capable to have a multisite action, like for example(F154) captan (133-06-2), (F155) chlorothalonil (1897-45-6), (F156)copper hydroxide (20427-59-2), (F159) copper oxychloride (1332-40-7),(F162) dithianon (3347-22-6), (F163) dodine (2439-10-3), (F167) folpet(133-07-3), (F168) guazatine (108173-90-6), (F172) iminoctadinetriacetate (57520-17-9), (F174) mancozeb (8018-01-7), (F180) propineb(12071-83-9), (F181) sulphur and sulphur preparations including calciumpolysulphide (7704-34-9), (F182) thiram (137-26-8);(6) Compounds capable to induce a host defense, like for example (F186)acibenzolar-S-methyl (135158-54-2), (F187) isotianil (224049-04-1),(F189) tiadinil (223580-51-6);(7) Inhibitors of the amino acid and/or protein biosynthesis, forexample (F192) cyprodinil (121552-61-2), (F196) pyrimethanil(53112-28-0);(8) Inhibitors of the cell wall synthesis, for example (F202)benthiavalicarb (177406-68-7), (F203) dimethomorph (110488-70-5), (F205)iprovalicarb (140923-17-7), (F206) mandipropa mid (374726-62-2), (F210)valifenalate (283159-94-4; 283159-90-0);(9) Inhibitors of the lipid and membrane synthesis, for example (F216)iodocarb (55406-53-6), (F217) iprobenfos (26087-47-8), (F220)propamocarb hydrochloride (25606-41-1), (F225) tolclofos-methyl;(10) Inhibitors of the melanine biosynthesis, for example (F226)carpropamid(11) Inhibitors of the nucleic acid synthesis, for example (F233)benalaxyl (71626-11-4), (F234) benalaxyl-M (kiralaxyl) (98243-83-5),(F239) furalaxyl (57646-30-7), (F240) hymexazol (10004-44-1), (F241)metalaxyl (57837-19-1), (F242) metalaxyl-M (mefenoxam) (70630-17-0),(F244) oxadixyl (77732-09-3);(12) Inhibitors of the signal transduction, for example (F247)fenpiclonil (74738-17-3), (F248) fludioxonil (131341-86-1), (F249)iprodione (36734-19-7), (F251) quinoxyfen (124495-18-7), (F252)vinclozolin (50471-44-8);(13) Compounds capable to act as an uncoupler, like for example (F256)fluazinam (79622-59-6);(14) Further compounds, like for example (F266) cymoxanil (57966-95-7),(F280) flutianil (304900-25-2), (F281) fosetyl-aluminium (39148-24-8),(F286) methasulfocarb (66952-49-6), (F287) methyl isothiocyanate(556-61-6), (F288) metrafenone (220899-03-6), (F298) phosphorous acidand its salts (13598-36-2), (F301) proquinazid (189278-12-4), (F309)triazoxide (72459-58-6) and (F319)2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetrone.

Further Additives

One aspect of the present invention is to provide a composition asdescribed above additionally comprising at least one auxiliary selectedfrom the group consisting of extenders, solvents, spontaneity promoters,carriers, emulsifiers, dispersants, frost protectants, thickeners andadjuvants. Those compositions are referred to as formulations.

Accordingly, in one aspect of the present invention such formulations,and application forms prepared from them, are provided as cropprotection agents and/or pesticidal agents, such as drench, drip andspray liquors, comprising the composition of the invention. Theapplication forms may comprise further crop protection agents and/orpesticidal agents, and/or activity-enhancing adjuvants such aspenetrants, examples being vegetable oils such as, for example, rapeseedoil, sunflower oil, mineral oils such as, for example, liquid paraffins,alkyl esters of vegetable fatty acids, such as rapeseed oil or soybeanoil methyl esters, or alkanol alkoxylates, and/or spreaders such as, forexample, alkylsiloxanes and/or salts, examples being organic orinorganic ammonium or phosphonium salts, examples being ammoniumsulphate or diammonium hydrogen phosphate, and/or retention promoterssuch as dioctyl sulphosuccinate or hydroxypropylguar polymers and/orhumectants such as glycerol and/or fertilizers such as ammonium,potassium or phosphorous fertilizers, for example.

Examples of typical formulations include water-soluble liquids (SL),emulsifiable concentrates (EC), emulsions in water (EW), suspensionconcentrates (SC, SE, FS, OD), water-dispersible granules (WG), granules(GR) and capsule concentrates (CS); these and other possible types offormulation are described, for example, by Crop Life International andin Pesticide Specifications, Manual on development and use of FAO andWHO specifications for pesticides, FAO Plant Production and ProtectionPapers-173, prepared by the FAO/WHO Joint Meeting on PesticideSpecifications, 2004, ISBN: 9251048576. The formulations may compriseactive agrochemical compounds other than one or more active compounds ofthe invention.

The formulations or application forms in question preferably compriseauxiliaries, such as extenders, solvents, spontaneity promoters,carriers, emulsifiers, dispersants, frost protectants, biocides,thickeners and/or other auxiliaries, such as adjuvants, for example. Anadjuvant in this context is a component which enhances the biologicaleffect of the formulation, without the component itself having abiological effect. Examples of adjuvants are agents which promote theretention, spreading, attachment to the leaf surface, or penetration.

These formulations are produced in a known manner, for example by mixingthe active compounds with auxiliaries such as, for example, extenders,solvents and/or solid carriers and/or further auxiliaries, such as, forexample, surfactants. The formulations are prepared either in suitableplants or else before or during the application.

Suitable for use as auxiliaries are substances which are suitable forimparting to the formulation of the active compound or the applicationforms prepared from these formulations (such as, e.g., usable cropprotection agents, such as spray liquors or seed dressings) particularproperties such as certain physical, technical and/or biologicalproperties.

Suitable extenders are, for example, water, polar and nonpolar organicchemical liquids, for example from the classes of the aromatic andnon-aromatic hydrocarbons (such as paraffins, alkylbenzenes,alkylnaphthalenes, chlorobenzenes), the alcohols and polyols (which, ifappropriate, may also be substituted, etherified and/or esterified), theketones (such as acetone, cyclohexanone), esters (including fats andoils) and (poly)ethers, the unsubstituted and substituted amines,amides, lactams (such as N-alkylpyrrolidones) and lactones, thesulphones and sulphoxides (such as dimethyl sulphoxide).

If the extender used is water, it is also possible to employ, forexample, organic solvents as auxiliary solvents. Essentially, suitableliquid solvents are: aromatics such as xylene, toluene oralkylnaphthalenes, chlorinated aromatics and chlorinated aliphatichydrocarbons such as chlorobenzenes, chloroethylenes or methylenechloride, aliphatic hydrocarbons such as cyclohexane or paraffins, forexample petroleum fractions, mineral and vegetable oils, alcohols suchas butanol or glycol and also their ethers and esters, ketones such asacetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone,strongly polar solvents such as dimethylformamide and dimethylsulphoxide, and also water.

In principle it is possible to use all suitable solvents. Suitablesolvents are, for example, aromatic hydrocarbons, such as xylene,toluene or alkylnaphthalenes, for example, chlorinated aromatic oraliphatic hydrocarbons, such as chlorobenzene, chloroethylene ormethylene chloride, for example, aliphatic hydrocarbons, such ascyclohexane, for example, paraffins, petroleum fractions, mineral andvegetable oils, alcohols, such as methanol, ethanol, isopropanol,butanol or glycol, for example, and also their ethers and esters,ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone orcyclohexanone, for example, strongly polar solvents, such as dimethylsulphoxide, and water.

All suitable carriers may in principle be used. Suitable carriers are inparticular: for example, ammonium salts and ground natural minerals suchas kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite ordiatomaceous earth, and ground synthetic minerals, such as finelydivided silica, alumina and natural or synthetic silicates, resins,waxes and/or solid fertilizers. Mixtures of such carriers may likewisebe used. Carriers suitable for granules include the following: forexample, crushed and fractionated natural minerals such as calcite,marble, pumice, sepiolite, dolomite, and also synthetic granules ofinorganic and organic meals, and also granules of organic material suchas sawdust, paper, coconut shells, maize cobs and tobacco stalks.

Liquefied gaseous extenders or solvents may also be used. Particularlysuitable are those extenders or carriers which at standard temperatureand under standard pressure are gaseous, examples being aerosolpropellants, such as halogenated hydrocarbons, and also butane, propane,nitrogen and carbon dioxide.

Examples of emulsifiers and/or foam-formers, dispersants or wettingagents having ionic or nonionic properties, or mixtures of thesesurface-active substances, are salts of polyacrylic acid, salts oflignosulphonic acid, salts of phenolsulphonic acid ornaphthalenesulphonic acid, polycondensates of ethylene oxide with fattyalcohols or with fatty acids or with fatty amines, with substitutedphenols (preferably alkylphenols or arylphenols), salts ofsulphosuccinic esters, taurine derivatives (preferably alkyltaurates),phosphoric esters of polyethoxylated alcohols or phenols, fatty acidesters of polyols, and derivatives of the compounds containingsulphates, sulphonates and phosphates, examples being alkylarylpolyglycol ethers, alkylsulphonates, alkyl sulphates, arylsulphonates,protein hydrolysates, lignin-sulphite waste liquors and methylcellulose.The presence of a surface-active substance is advantageous if one of theactive compounds and/or one of the inert carriers is not soluble inwater and if application takes place in water.

Further auxiliaries that may be present in the formulations and in theapplication forms derived from them include colorants such as inorganicpigments, examples being iron oxide, titanium oxide, Prussian Blue, andorganic dyes, such as alizarin dyes, azo dyes and metal phthalocyaninedyes, and nutrients and trace nutrients, such as salts of iron,manganese, boron, copper, cobalt, molybdenum and zinc.

Stabilizers, such as low-temperature stabilizers, preservatives,antioxidants, light stabilizers or other agents which improve chemicaland/or physical stability may also be present. Additionally present maybe foam-formers or defoamers.

Furthermore, the formulations and application forms derived from themmay also comprise, as additional auxiliaries, stickers such ascarboxymethylcellulose, natural and synthetic polymers in powder,granule or latex form, such as gum arabic, polyvinyl alcohol, polyvinylacetate, and also natural phospholipids, such as cephalins andlecithins, and synthetic phospholipids. Further possible auxiliariesinclude mineral and vegetable oils.

There may possibly be further auxiliaries present in the formulationsand the application forms derived from them. Examples of such additivesinclude fragrances, protective colloids, binders, adhesives, thickeners,thixotropic substances, penetrants, retention promoters, stabilizers,sequestrants, complexing agents, humectants and spreaders. Generallyspeaking, the active compounds may be combined with any solid or liquidadditive commonly used for formulation purposes.

Suitable retention promoters include all those substances which reducethe dynamic surface tension, such as dioctyl sulphosuccinate, orincrease the viscoelasticity, such as hydroxypropylguar polymers, forexample.

Suitable penetrants in the present context include all those substanceswhich are typically used in order to enhance the penetration of activeagrochemical compounds into plants. Penetrants in this context aredefined in that, from the (generally aqueous) application liquor and/orfrom the spray coating, they are able to penetrate the cuticle of theplant and thereby increase the mobility of the active compounds in thecuticle. This property can be determined using the method described inthe literature (Baur et al., 1997, Pesticide Science 51, 131-152).Examples include alcohol alkoxylates such as coconut fatty ethoxylate(10) or isotridecyl ethoxylate (I2), fatty acid esters such as rapeseedor soybean oil methyl esters, fatty amine alkoxylates such astallowamine ethoxylate (I5), or ammonium and/or phosphonium salts suchas ammonium sulphate or diammonium hydrogen phosphate, for example.

The formulations preferably comprise between 0.00000001% and 98% byweight of active compound or, with particular preference, between 0.01%and 95% by weight of active compound, more preferably between 0.5% and90% by weight of active compound, based on the weight of theformulation. The content of the active compound is defined as the sum ofthe at least one biological control agent and the at least oneinsecticide (I).

The active compound content of the application forms (crop protectionproducts) prepared from the formulations may vary within wide ranges.The active compound concentration of the application forms may besituated typically between 0.00000001% and 95% by weight of activecompound, preferably between 0.00001% and 1% by weight, based on theweight of the application form. Application takes place in a customarymanner adapted to the application forms.

Kit of Parts

Furthermore, in one aspect of the present invention a kit of parts isprovided comprising the composition according to the present inventionin a spatially separated arrangement.

In a further embodiment of the present invention the above-mentioned kitof parts further comprises at least one additional insecticide (II)and/or at least one fungicide, with the proviso that insecticide (II) isnot identical to insecticide (I) and the biological control agent is notidentical to the fungicide. The fungicide can be present either in thebiological control agent component of the kit of parts or in theinsecticide component of the kit of parts being spatially separated orin both of these components. Preferably, the fungicide is present in theinsecticide component. Moreover, the kit of parts according to thepresent invention can additionally comprise at least one auxiliaryselected from the group consisting of extenders, solvents, spontaneitypromoters, carriers, emulsifiers, dispersants, frost protectants,thickeners and adjuvants as mentioned below. This at least one auxiliarycan be present either in the biological control agent component of thekit of parts or in the insecticide component of the kit of parts beingspatially separated or in both of these components.

In another aspect of the present invention the composition as describedabove is used for reducing overall damage of plants and plant parts aswell as losses in harvested fruits or vegetables caused by insects,nematodes and/or phytopathogens.

Furthermore, in another aspect of the present invention the compositionas described above increases the overall plant health.

The term “plant health” generally comprises various sorts ofimprovements of plants that are not connected to the control of pests.For example, advantageous properties that may be mentioned are improvedcrop characteristics including: emergence, crop yields, protein content,oil content, starch content, more developed root system, improved rootgrowth, improved root size maintenance, improved root effectiveness,improved stress tolerance (e.g. against drought, heat, salt, UV, water,cold), reduced ethylene (reduced production and/or inhibition ofreception), tillering increase, increase in plant height, bigger leafblade, less dead basal leaves, stronger tillers, greener leaf color,pigment content, photosynthetic activity, less input needed (such asfertilizers or water), less seeds needed, more productive tillers,earlier flowering, early grain maturity, less plant verse (lodging),increased shoot growth, enhanced plant vigor, increased plant stand andearly and better germination.

With regard to the use according to the present invention, improvedplant health preferably refers to improved plant characteristicsincluding: crop yield, more developed root system (improved rootgrowth), improved root size maintenance, improved root effectiveness,tillering increase, increase in plant height, bigger leaf blade, lessdead basal leaves, stronger tillers, greener leaf color, photosyntheticactivity, more productive tillers, enhanced plant vigor, and increasedplant stand.

With regard to the present invention, improved plant health preferablyespecially refers to improved plant properties selected from crop yield,more developed root system, improved root growth, improved root sizemaintenance, improved root effectiveness, tillering increase, andincrease in plant height.

The effect of a composition according to the present invention on planthealth as defined herein can be determined by comparing plants which aregrown under the same environmental conditions, whereby a part of saidplants is treated with a composition according to the present inventionand another part of said plants is not treated with a compositionaccording to the present invention. Instead, said other part is nottreated at all or treated with a placebo (i.e., an application without acomposition according to the invention such as an application withoutall active ingredients (i.e. without a biological control agent asdescribed herein and without an insecticide as described herein), or anapplication without a biological control agent as described herein, oran application without an insecticide as described herein.

The composition according to the present invention may be applied in anydesired manner, such as in the form of a seed coating, soil drench,and/or directly in-furrow and/or as a foliar spray and applied eitherpre-emergence, post-emergence or both. In other words, the compositioncan be applied to the seed, the plant or to harvested fruits andvegetables or to the soil wherein the plant is growing or wherein it isdesired to grow (plant's locus of growth).

Reducing the overall damage of plants and plant parts often results inhealthier plants and/or in an increase in plant vigor and yield.

Preferably, the composition according to the present invention is usedfor treating conventional or transgenic plants or seed thereof.

In another aspect of the present invention a method for reducing overalldamage of plants and plant parts as well as losses in harvested fruitsor vegetables caused by insects, nematodes and/or phytopathogens isprovided comprising the step of simultaneously or sequentially applyingthe composition of the present invention and optionally at least oneadditional insecticide (II) and/or at least one fungicide on the plant,plant parts, harvested fruits, vegetables and/or plant's locus of growthin a synergistically effective amount.

The method of the present invention includes the following applicationmethods, namely both of the at least one biological control agent andthe at least one insecticide (I) mentioned before may be formulated intoa single, stable composition with an agriculturally acceptable shelflife (so called “solo-formulation”), or being combined before or at thetime of use (so called “combined-formulations”).

If not mentioned otherwise, the expression “combination” stands for thevarious combinations of the at least one biological control agent andthe at least one insecticide (I), and optionally at least one additionalinsecticide (II) and/or at least one fungicide, in a solo-formulation,in a single “ready-mix” form, in a combined spray mixture composed fromsolo-formulations, such as a “tank-mix”, and especially in a combineduse of the single active ingredients when applied in a sequentialmanner, i.e. one after the other within a reasonably short period, suchas a few hours or days, e.g. 2 hours to 7 days. The order of applyingthe composition according to the present invention is not essential forworking the present invention. Accordingly, the term “combination” alsoencompasses the presence of the at least one biological control agentand the at least one insecticide (I), and optionally the at least oneadditional insecticide (II) and/or at least one fungicide on or in aplant to be treated or its surrounding, habitat or storage space, e.g.after simultaneously or consecutively applying the at least onebiological control agent and the at least one insecticide (I), andoptionally the at least one additional insecticide (II) and/or at leastone fungicide to a plant its surrounding, habitat or storage space.

If the at least one biological control agent and the at least oneinsecticide (I), and optionally the at least one additional insecticide(II) and/or at least one fungicide are employed or used in a sequentialmanner, it is preferred to treat the plants or plant parts (whichincludes seeds and plants emerging from the seed), harvested fruits andvegetables according to the following method: Firstly applying the atleast one insecticide (I) and optionally the at least one additionalinsecticide (II) and/or at least one fungicide on the plant or plantparts, and secondly applying the biological control agent to the sameplant or plant parts. The time periods between the first and the secondapplication within a (crop) growing cycle may vary and depend on theeffect to be achieved. For example, the first application is done toprevent an infestation of the plant or plant parts with insects,nematodes and/or phytopathogens (this is particularly the case whentreating seeds) or to combat the infestation with insects, nematodesand/or phytopathogens (this is particularly the case when treatingplants and plant parts) and the second application is done to prevent orcontrol the infestation with insects, nematodes and/or phytopathogens.Control in this context means that the biological control agent is notable to fully exterminate the pests or phytopathogenic fungi but is ableto keep the infestation on an acceptable level.

By following the before mentioned steps, a very low level of residues ofthe at least one insecticide (I), and optionally at least one additionalinsecticide (II) and/or at least one fungicide on the treated plant,plant parts, and the harvested fruits and vegetables can be achieved.

If not mentioned otherwise the treatment of plants or plant parts (whichincludes seeds and plants emerging from the seed), harvested fruits andvegetables with the composition according to the invention is carriedout directly or by action on their surroundings, habitat or storagespace using customary treatment methods, for example dipping, spraying,atomizing, irrigating, evaporating, dusting, fogging, broadcasting,foaming, painting, spreading-on, watering (drenching), drip irrigating.It is furthermore possible to apply the at least one biological controlagent, the at least one insecticide (I), and optionally the at least oneadditional insecticide (II) and/or at least one fungicide assolo-formulation or combined-formulations by the ultra-low volumemethod, or to inject the composition according to the present inventionas a composition or as sole-formulations into the soil (in-furrow).

The term “plant to be treated” encompasses every part of a plantincluding its root system and the material—e.g., soil or nutritionmedium—which is in a radius of at least 10 cm, 20 cm, 30 cm around thecaulis or bole of a plant to be treated or which is at least 10 cm, 20cm, 30 cm around the root system of said plant to be treated,respectively.

The amount of the biological control agent which is used or employed incombination with an insecticide (I), optionally in the presence of atleast one additional insecticide (II) and/or at least one fungicide,depends on the final formulation as well as size or type of the plant,plant parts, seeds, harvested fruits and vegetables to be treated.

Usually, the biological control agent to be employed or used accordingto the invention is present in about 2% to about 80% (w/w), preferablyin about 5% to about 75% (w/w), more preferably about 10% to about 70%(w/w) of its solo-formulation or combined-formulation with the at leastone insecticide (I), and optionally the at least one additionalinsecticide (II) and/or at least one fungicide.

In a preferred embodiment Paecilomyces lilacinus strain 251 e.g. itsspores are present in a solo-formulation or the combined-formulation ina concentration of at least 10⁴ colony forming units per grampreparation (e.g. cells/g preparation, spores/g preparation), such as10⁴-10¹¹ cfu/g, preferably 10⁵-10¹⁰⁰ cfu/g, more preferably 10⁷-10⁸cfu/g, such as 10⁸ cfu/g, 10⁹ cfu/g, 5×10⁹ cfu/g, 10¹⁰ cfu/g or 5×10¹⁰cfu/g, Trichoderma atroviride SC1 e.g. its spores are present in asolo-formulation or the combined-formulation in a concentration of atleast 10′ colony forming units per gram preparation (e.g. cells/gpreparation, spores/g preparation), such as 10′-10⁵ cfu/g, preferably10²-10³ cfu/g, and Coniothyrium minitans CON/M/91-08 e.g. its spores arepresent in a solo-formulation or the combined-formulation in aconcentration of at least 10⁵ colony forming units per gram preparation(e.g. cells/g preparation, spores/g preparation), such as 10⁵-10¹⁷cfu/g, preferably 10⁷-10¹⁵ cfu/g, more preferably 10¹⁰-10¹³ cfu/g at thetime point of applying biological control agents on a plant or plantparts such as seeds, fruits or vegetables. Also references to theconcentration of biological control agents in form of, e.g., spores orcells—when discussing ratios between the amount of a preparation of atleast one biological control agent and the amount of the insecticide—aremade in view of the time point when the biological control agent isapplied on a plant or plant parts such as seeds, fruits or vegetables.

Also the amount of the at least one insecticide (I) which is used oremployed in combination with the biological control agent, optionally inthe presence of at least one additional insecticide (II) and/or at leastone fungicide, depends on the final formulation as well as size or typeof the plant, plant parts, seeds, harvested fruit or vegetable to betreated. Usually, the insecticide (I) to be employed or used accordingto the invention is present in about 0.1% to about 80% (w/w), preferably1% to about 60% (w/w), more preferably about 10% to about 50% (w/w) ofits solo-formulation or combined-formulation with the biological controlagent, and optionally at least one additional insecticide (II) and/or atleast one fungicide.

The at least one biological control agent and at least one insecticide(I), and if present also the at least one additional insecticide (II)and/or at least one fungicide are used or employed in a synergisticweight ratio. The skilled person is able to find out the synergisticweight ratios for the present invention by routine methods. The skilledperson understands that these ratios refer to the ratio within acombined-formulation as well as to the calculative ratio of the at leastone biological control agent described herein and the insecticide (I)when both components are applied as mono-formulations to a plant to betreated. The skilled person can calculate this ratio by simplemathematics since the volume and the amount of the biological controlagent and insecticide, respectively, in a mono-formulation is known tothe skilled person.

The ratio can be calculated based on the amount of the at least oneinsecticide (I), at the time point of applying said component of acombination according to the invention to a plant or plant part and theamount of a biological control agent shortly prior (e.g., 48 h, 24 h, 12h, 6 h, 2 h, 1 h) or at the time point of applying said component of acombination according to the invention to a plant or plant part.

The application of the at least one biological control agent and the atleast one insecticide (I) to a plant or a plant part can take placesimultaneously or at different times as long as both components arepresent on or in the plant after the application(s). In cases where thebiological control agent and the insecticide (I) are applied atdifferent times and the insecticide (I) is applied noticeable prior tothe biological control agent, the skilled person can determine theconcentration of the insecticide (I) on/in a plant by chemical analysisknown in the art, at the time point or shortly before the time point ofapplying the biological control agent. Vice versa, when the biologicalcontrol agent is applied to a plant first, the concentration of abiological control agent can be determined using test which are alsoknown in the art, at the time point or shortly before the time point ofapplying the insecticide (I).

In particular, in one embodiment the synergistic weight ratio of the atleast one biological control agent/spore preparation and the at leastone insecticide (I) lies in the range of 1:500 to 1000:1, preferably inthe range of 1:500 to 500:1, more preferably in the range of 1:500 to300:1. It has to be noted that these ratio ranges refer to thebiological control agent/spores preparation (to be combined with atleast one insecticide (I) or a preparation of at least one insecticide(I)) of around 10¹⁰ cells/spores per gram preparation of saidcells/spores. For example, a ratio of 100:1 means 100 weight parts of abiological control agent/spore preparation having a cell/sporeconcentration of 10¹⁰ cells/spores per gram preparation and 1 weightpart of the insecticide are combined (either as a solo formulation, acombined formulation or by separate applications to plants so that thecombination is formed on the plant).

In another embodiment, the synergistic weight ratio of the at least onebiological control agent/spore preparation to the insecticide (I) is inthe range of 1:100 to 35000:1, such as 25000:1 or 31250:1, preferably inthe range of 1:100 to 20.000:1, preferably in the range of 1:50 to10.000:1, such as 250:1, 500:1, 2.500:1, 1:6250, 8000:1, 1:10000 or12.500:1, or even in the range of 1:50 to 1000:1, such as 5:1, 10:1,20:1, 250:1 or 500:1, 1000:1. Once again the mentioned ratios rangesrefer to biological control agent/spore preparations of biologicalcontrol agents of around 10¹⁰ cells or spores per gram preparation ofsaid biological control agent or where defined elsewhere (see e.g.examples).

The cell/spore concentration of preparations can be determined byapplying methods known in the art. To compare weight ratios of thebiological control agent/spore preparation to the insecticide (I), theskilled person can easily determine the factor between a preparationhaving a biological control agent/spore concentration different from10¹⁰ cells/spores per gram cell/spore preparation and a preparationhaving a biological control agent/spore concentration of 10¹⁰cells/spores per gram preparation to calculate whether a ratio of abiological control agent/spore preparation to the insecticide is withinthe scope of the above listed ratio ranges.

In one embodiment of the present invention, the concentration of thebiological control agent after dispersal is at least 50 g/ha, such as50-7500 g/ha, 50-2500 g/ha, 50-1500 g/ha; at least 250 g/ha (hectare),at least 500 g/ha or at least 800 g/ha.

The application rate of composition to be employed or used according tothe present invention may vary. The skilled person is able to find theappropriate application rate by way of routine experiments.

Seed Treatment

In another aspect of the present invention a seed treated with thecomposition as described above is provided.

The control of insects, nematodes and/or phytopathogens by treating theseed of plants has been known for a long time and is a subject ofcontinual improvements.

Nevertheless, the treatment of seed entails a series of problems whichcannot always be solved in a satisfactory manner. Thus, it is desirableto develop methods for protecting the seed and the germinating plantthat remove the need for, or at least significantly reduce, theadditional delivery of crop protection compositions in the course ofstorage, after sowing or after the emergence of the plants. It isdesirable, furthermore, to optimize the amount of active ingredientemployed in such a way as to provide the best-possible protection to theseed and the germinating plant from attack by insects, nematodes and/orphytopathogens, but without causing damage to the plant itself by theactive ingredient employed. In particular, methods for treating seedought also to take into consideration the intrinsic insecticidal and/ornematicidal properties of pest-resistant or pest-tolerant transgenicplants, in order to achieve optimum protection of the seed and of thegerminating plant with a minimal use of crop protection compositions.

The present invention therefore also relates in particular to a methodfor protecting seed and germinating plants from attack by pests, bytreating the seed with at least one biological control agent as definedabove and/or a mutant of it having all identifying characteristics ofthe respective strain, and/or at least one metabolite produced by therespective strain that exhibits activity against insects, nematodesand/or phytopathogens and at least one insecticide (I) and optionally atleast one additional insecticide (II) and/or at least one fungicide ofthe invention. The method of the invention for protecting seed andgerminating plants from attack by pests encompasses a method in whichthe seed is treated simultaneously in one operation with the at leastone biological control agent and the at least one insecticide (I), andoptionally the at least one additional insecticide (II) and/or at leastone fungicide. It also encompasses a method in which the seed is treatedat different times with the at least one biological control agent andthe at least one insecticide (I), and optionally the at least oneadditional insecticide (II) and/or at least one fungicide.

The invention relates to the use of the composition of the invention fortreating seed for the purpose of protecting the seed and the resultantplant against insects, mites, nematodes and/or phytopathogens.

The invention also relates to seed which at the same time has beentreated with at least one biological control agent and at least oneinsecticide (I), and optionally at least one additional insecticide (II)and/or at least one fungicide. The invention further relates to seedwhich has been treated at different times with the at least onebiological control agent and the at least one insecticide (I), andoptionally at least one additional insecticide (II) and/or at least onefungicide. In the case of seed which has been treated at different timeswith the at least one biological control agent and the at least oneinsecticide (I), and optionally the at least one additional insecticide(II) and/or at least one fungicide, the individual active ingredients inthe composition of the invention may be present in different layers onthe seed.

Furthermore, the invention relates to seed which, following treatmentwith the composition of the invention, is subjected to a film-coatingprocess in order to prevent dust abrasion of the seed.

One of the advantages of the present invention is that, owing to theparticular systemic properties of the compositions of the invention, thetreatment of the seed with these compositions provides protection frominsects, nematodes and/or phytopathogens not only to the seed itself butalso to the plants originating from the seed, after they have emerged.In this way, it may not be necessary to treat the crop directly at thetime of sowing or shortly thereafter.

A further advantage is to be seen in the fact that, through thetreatment of the seed with composition of the invention, germination andemergence of the treated seed may be promoted.

It is likewise considered to be advantageous composition of theinvention may also be used, in particular, on transgenic seed.

It is also stated that the composition of the invention may be used incombination with agents of the signalling technology, as a result ofwhich, for example, colonization with symbionts is improved, such asrhizobia, mycorrhiza and/or endophytic bacteria, for example, isenhanced, and/or nitrogen fixation is optimized.

The compositions of the invention are suitable for protecting seed ofany variety of plant which is used in agriculture, in greenhouses, inforestry or in horticulture. More particularly, the seed in question isthat of cereals (e.g. wheat, barley, rye, oats and millet), maize,cotton, soybeans, rice, potatoes, sunflower, coffee, tobacco, canola,oilseed rape, beets (e.g. sugar beet and fodder beet), peanuts,vegetables (e.g. tomato, cucumber, bean, brassicas, onions and lettuce),fruit plants, lawns and ornamentals. Particularly important is thetreatment of the seed of cereals (such as wheat, barley, rye and oats)maize, soybeans, cotton, canola, oilseed rape and rice.

As already mentioned above, the treatment of transgenic seed with thecomposition of the invention is particularly important. The seed inquestion here is that of plants which generally contain at least oneheterologous gene that controls the expression of a polypeptide having,in particular, insecticidal and/or nematicidal properties. Theseheterologous genes in transgenic seed may come from microorganisms suchas Bacillus, Rhizobium, Pseudomonas, Serratia, Trichoderma, Clavibacter,Glomus or Gliocladium. The present invention is particularly suitablefor the treatment of transgenic seed which contains at least oneheterologous gene from Bacillus sp. With particular preference, theheterologous gene in question comes from Bacillus thuringiensis.

For the purposes of the present invention, the composition of theinvention is applied alone or in a suitable formulation to the seed. Theseed is preferably treated in a condition in which its stability is suchthat no damage occurs in the course of the treatment. Generallyspeaking, the seed may be treated at any point in time betweenharvesting and sowing. Typically, seed is used which has been separatedfrom the plant and has had cobs, hulls, stems, husks, hair or pulpremoved. Thus, for example, seed may be used that has been harvested,cleaned and dried to a moisture content of less than 15% by weight.Alternatively, seed can also be used that after drying has been treatedwith water, for example, and then dried again.

When treating seed it is necessary, generally speaking, to ensure thatthe amount of the composition of the invention, and/or of otheradditives, that is applied to the seed is selected such that thegermination of the seed is not adversely affected, and/or that the plantwhich emerges from the seed is not damaged. This is the case inparticular with active ingredients which may exhibit phytotoxic effectsat certain application rates.

The compositions of the invention can be applied directly, in otherwords without comprising further components and without having beendiluted. As a general rule, it is preferable to apply the compositionsin the form of a suitable formulation to the seed. Suitable formulationsand methods for seed treatment are known to the skilled person and aredescribed in, for example, the following documents: U.S. Pat. No.4,272,417 A, U.S. Pat. No. 4,245,432 A, U.S. Pat. No. 4,808,430 A, U.S.Pat. No. 5,876,739 A, US 2003/0176428 A1, WO 2002/080675 A1, WO2002/028186 A2.

The combinations which can be used in accordance with the invention maybe converted into the customary seed-dressing formulations, such assolutions, emulsions, suspensions, powders, foams, slurries or othercoating compositions for seed, and also ULV formulations.

These formulations are prepared in a known manner, by mixing compositionwith customary adjuvants, such as, for example, customary extenders andalso solvents or diluents, colorants, wetters, dispersants, emulsifiers,antifoams, preservatives, secondary thickeners, stickers, gibberellins,and also water.

Colorants which may be present in the seed-dressing formulations whichcan be used in accordance with the invention include all colorants whichare customary for such purposes. In this context it is possible to usenot only pigments, which are of low solubility in water, but alsowater-soluble dyes. Examples include the colorants known under thedesignations Rhodamin B, C.I. Pigment Red 112 and C.I. Solvent Red 1.

Wetters which may be present in the seed-dressing formulations which canbe used in accordance with the invention include all of the substanceswhich promote wetting and which are customary in the formulation ofactive agrochemical ingredients. Use may be made preferably ofalkylnaphthalenesulphonates, such as diisopropyl- ordiisobutyl-naphthalenesulphonates.

Dispersants and/or emulsifiers which may be present in the seed-dressingformulations which can be used in accordance with the invention includeall of the nonionic, anionic and cationic dispersants that are customaryin the formulation of active agrochemical ingredients. Use may be madepreferably of nonionic or anionic dispersants or of mixtures of nonionicor anionic dispersants. Suitable nonionic dispersants are, inparticular, ethylene oxide-propylene oxide block polymers, alkylphenolpolyglycol ethers and also tristryrylphenol polyglycol ethers, and thephosphated or sulphated derivatives of these. Suitable anionicdispersants are, in particular, lignosulphonates, salts of polyacrylicacid, and arylsulphonate-formaldehyde condensates.

Antifoams which may be present in the seed-dressing formulations whichcan be used in accordance with the invention include all of the foaminhibitors that are customary in the formulation of active agrochemicalingredients. Use may be made preferably of silicone antifoams andmagnesium stearate.

Preservatives which may be present in the seed-dressing formulationswhich can be used in accordance with the invention include all of thesubstances which can be employed for such purposes in agrochemicalcompositions. Examples include dichlorophen and benzyl alcoholhemiformal.

Secondary thickeners which may be present in the seed-dressingformulations which can be used in accordance with the invention includeall substances which can be used for such purposes in agrochemicalcompositions. Those contemplated with preference include cellulosederivatives, acrylic acid derivatives, xanthan, modified clays andhighly disperse silica.

Stickers which may be present in the seed-dressing formulations whichcan be used in accordance with the invention include all customarybinders which can be used in seed-dressing products. Preferred mentionmay be made of polyvinylpyrrolidone, polyvinyl acetate, polyvinylalcohol and tylose.

Gibberellins which may be present in the seed-dressing formulationswhich can be used in accordance with the invention include preferablythe gibberellins A1, A3 (=gibberellic acid), A4 and A7, with gibberellicacid being used with particular preference. The gibberellins are known(cf. R. Wegler, “Chemie der Pflanzenschutz-undSchädlingsbekämpfungsmittel”, Volume 2, Springer Verlag, 1970, pp.401-412).

The seed-dressing formulations which can be used in accordance with theinvention may be used, either directly or after prior dilution withwater, to treat seed of any of a wide variety of types. Accordingly, theconcentrates or the preparations obtainable from them by dilution withwater may be employed to dress the seed of cereals, such as wheat,barley, rye, oats and triticale, and also the seed of maize, rice,oilseed rape, peas, beans, cotton, sunflowers and beets, or else theseed of any of a very wide variety of vegetables. The seed-dressingformulations which can be used in accordance with the invention, ortheir diluted preparations, may also be used to dress seed of transgenicplants. In that case, additional synergistic effects may occur ininteraction with the substances formed through expression.

For the treatment of seed with the seed-dressing formulations which canbe used in accordance with the invention, or with the preparationsproduced from them by addition of water, suitable mixing equipmentincludes all such equipment which can typically be employed for seeddressing. More particularly, the procedure when carrying out seeddressing is to place the seed in a mixer, to add the particular desiredamount of seed-dressing formulations, either as such or followingdilution with water beforehand, and to carry out mixing until thedistribution of the formulation on the seed is uniform. This may befollowed by a drying operation.

The application rate of the seed-dressing formulations which can be usedin accordance with the invention may be varied within a relatively widerange. It is guided by the particular amount of the at least onebiological control agent and the at least one insecticide (I) in theformulations, and by the seed. The application rates in the case of thecomposition are situated generally at between 0.001 and 50 g perkilogram of seed, preferably between 0.01 and 15 g per kilogram of seed.

The composition according to the invention, in combination with goodplant tolerance and favourable toxicity to warm-blooded animals andbeing tolerated well by the environment, are suitable for protectingplants and plant organs, for increasing harvest yields, for improvingthe quality of the harvested material and for controlling animal pests,in particular insects, arachnids, helminths, nematodes and molluscs,which are encountered in agriculture, in horticulture, in animalhusbandry, in forests, in gardens and leisure facilities, in protectionof stored products and of materials, and in the hygiene sector. They canbe preferably employed as plant protection agents. In particular, thepresent invention relates to the use of the composition according to theinvention as pesticide.

The present composition preferably is active against normally sensitiveand resistant species and against all or some stages of development. Theabovementioned pests include:

pests from the phylum Arthropoda, especially from the class Arachnida,for example, Acarus spp., Aceria sheldoni, Aculops spp., Aculus spp.,Amblyomma spp., Amphitetranychus viennensis, Argas spp., Boophilus spp.,Brevipalpus spp., Bryobia graminum, Bryobia praetiosa, Centruroidesspp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoidespteronyssinus, Dermatophagoides farinae, Dermacentor spp., Eotetranychusspp., Epitrimerus pyri, Eutetranychus spp., Eriophyes spp., Glycyphagusdomesticus, Halotydeus destructor, Hemitarsonemus spp., Hyalomma spp.,Ixodes spp., Latrodectus spp., Loxosceles spp., Metatetranychus spp.,Neutrombicula autumnalis, Nuphersa spp., Oligonychus spp., Ornithodorusspp., Ornithonyssus spp., Panonychus spp., Phyllocoptruta oleivora,Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp.,Rhizoglyphus spp., Sarcoptes spp., Scorpio maurus, Steneotarsonemusspp., Steneotarsonemus spinki, Tarsonemus spp., Tetranychus spp.,Trombicula alfreddugesi, Vaejovis spp., Vasates lycopersici;

from the class Chilopoda, for example, Geophilus spp., Scutigera spp.;from the order or the class Collembola, for example, Onychiurus armatus;from the class Diplopoda, for example, Blaniulus guttulatus;from the class Insecta, e.g. from the order Blattodea, for example,Blattella asahinai, Blattella germanica, Blatta orientalis, Leucophaeamaderae, Panchlora spp., Parcoblatta spp., Periplaneta spp., Supellalongipalpa;from the order Coleoptera, for example, Acalymma vittatum,Acanthoscelides obtectus, Adoretus spp., Agelastica alni, Agriotes spp.,Alphitobius diaperinus, Amphimallon solstitialis, Anobium punctatum,Anoplophora spp., Anthonomus spp., Anthrenus spp., Apion spp., Apogoniaspp., Atomaria spp., Attagenus spp., Bruchidius obtectus, Bruchus spp.,Cassida spp., Cerotoma trifurcata, Ceutorrhynchus spp., Chaetocnemaspp., Cleonus mendicus, Conoderus spp., Cosmopolites spp., Costelytrazealandica, Ctenicera spp., Curculio spp., Cryptolestes ferrugineus,Cryptorhynchus lapathi, Cylindrocopturus spp., Dermestes spp.,Diabrotica spp., Dichocrocis spp., Dicladispa armigera, Diloboderusspp., Epilachna spp., Epitrix spp., Faustinus spp., Gibbium psylloides,Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Heteronyxspp., Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypomecessquamosus, Hypothenemus spp., Lachnosterna consanguinea, Lasiodermaserricorne, Latheticus oryzae, Lathridius spp., Lema spp., Leptinotarsadecemlineata, Leucoptera spp., Lissorhoptrus oryzophilus, Lixus spp.,Luperodes spp., Lyctus spp., Megascelis spp., Melanotus spp., Meligethesaeneus, Melolontha spp., Migdolus spp., Monochamus spp., Naupactusxanthographus, Necrobia spp., Niptus hololeucus, Oryctes rhinoceros,Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorrhynchus spp.,Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga spp., Phyllophagahelleri, Phyllotreta spp., Popillia japonica, Premnotrypes spp.,Prostephanus truncatus, Psylliodes spp., Ptinus spp., Rhizobiusventralis, Rhizopertha dominica, Sitophilus spp., Sitophilus oryzae,Sphenophorus spp., Stegobium paniceum, Sternechus spp., Symphyletesspp., Tanymecus spp., Tenebrio molitor, Tenebrioides mauretanicus,Tribolium spp., Trogoderma spp., Tychius spp., Xylotrechus spp., Zabrusspp.;from the order Diptera, for example, Aedes spp., Agromyza spp.,Anastrepha spp., Anopheles spp., Asphondylia spp., Bactrocera spp.,Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina,Ceratitis capitata, Chironomus spp., Chrysomyia spp., Chrysops spp.,Chrysozona pluvialis, Cochliomyia spp., Contarinia spp., Cordylobiaanthropophaga, Cricotopus sylvestris, Culex spp., Culicoides spp.,Culiseta spp., Cuterebra spp., Dacus oleae, Dasyneura spp., Delia spp.,Dermatobia hominis, Drosophila spp., Echinocnemus spp., Fannia spp.,Gasterophilus spp., Glossina spp., Haematopota spp., Hydrellia spp.,Hydrellia griseola, Hylemya spp., Hippobosca spp., Hypoderma spp.,Liriomyza spp., Lucilia spp., Lutzomyia spp., Mansonia spp., Musca spp.,Oestrus spp., Oscinella frit, Paratanytarsus spp., Paralauterborniellasubcincta, Pegomyia spp., Phlebotomus spp., Phorbia spp., Phormia spp.,Piophila casei, Prodiplosis spp., Psila rosae, Rhagoletis spp.,Sarcophaga spp., Simulium spp., Stomoxys spp., Tabanus spp., Tetanopsspp., Tipula spp.;from the order Heteroptera, for example, Anasa tristis, Antestiopsisspp., Boisea spp., Blissus spp., Calocoris spp., Campylomma livida,Cavelerius spp., Cimex spp., Collaria spp., Creontiades dilutus, Dasynuspiperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp.,Euschistus spp., Eurygaster spp., Heliopeltis spp., Horcias nobilellus,Leptocorisa spp., Leptocorisa varicornis, Leptoglossus phyllopus, Lygusspp., Macropes excavatus, Miridae, Monalonion atratum, Nezara spp.,Oebalus spp., Pentomidae, Piesma quadrata, Piezodorus spp., Psallusspp., Pseudacysta persea, Rhodnius spp., Sahlbergella singularis,Scaptocoris castanea, Scotinophora spp., Stephanitis nashi, Tibracaspp., Triatoma spp.;from the order Homoptera, for example, Acizzia acaciaebaileyanae,Acizzia dodonaeae, Acizzia uncatoides, Acrida turrita, Acyrthosiponspp., Acrogonia spp., Aeneolamia spp., Agonoscena spp., Aleyrodesproletella, Aleurolobus barodensis, Aleurothrixus floccosus,Allocaridara malayensis, Amrasca spp., Anuraphis cardui, Aonidiellaspp., Aphanostigma piri, Aphis spp., Arboridia apicalis, Arytainillaspp., Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacorthum solani,Bemisia tabaci, Blastopsylla occidentalis, Boreioglycaspis melaleucae,Brachycaudus helichrysi, Brachycolus spp., Brevicoryne brassicae,Cacopsylla spp., Calligypona marginata, Carneocephala fulgida,Ceratovacuna lanigera, Cercopidae, Ceroplastes spp., Chaetosiphonfragaefolii, Chionaspis tegalensis, Chlorita onukii, Chondracris rosea,Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila,Coccomytilus halli, Coccus spp., Cryptomyzus ribis, Cryptoneossa spp.,Ctenarytaina spp., Dalbulus spp., Dialeurodes citri, Diaphorina citri,Diaspis spp., Drosicha spp., Dysaphis spp., Dysmicoccus spp., Empoascaspp., Eriosoma spp., Erythroneura spp., Eucalyptolyma spp., Euphylluraspp., Euscelis bilobatus, Ferrisia spp., Geococcus coffeae, Glycaspisspp., Heteropsylla cubana, Heteropsylla spinulosa, Homalodiscacoagulata, Hyalopterus arundinis, lcerya spp., Idiocerus spp.,Idioscopus spp., Laodelphax striatellus, Lecanium spp., Lepidosaphesspp., Lipaphis erysimi, Macrosiphum spp., Macrosteles facifrons,Mahanarva spp., Melanaphis sacchari, Metcalfiella spp., Metopolophiumdirhodum, Monellia costalis, Monelliopsis pecanis, Myzus spp., Nasonoviaribisnigri, Nephotettix spp., Nettigoniclla spectra, Nilaparvata lugens,Oncometopia spp., Orthezia praelonga, Oxya chinensis, Pachypsylla spp.,Parabemisia myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp.,Peregrinus maidis, Phenacoccus spp., Phloeomyzus passerinii, Phorodonhumuli, Phylloxera spp., Pinnaspis aspidistrae, Planococcus spp.,Prosopidopsylla flava, Protopulvinaria pyriformis, Pseudaulacaspispentagona, Pseudococcus spp., Psyllopsis spp., Psylla spp., Pteromalusspp., Pyrilla spp., Quadraspidiotus spp., Quesada gigas, Rastrococcusspp., Rhopalosiphum spp., Saissetia spp., Scaphoideus titanus,Schizaphis graminum, Selenaspidus articulatus, Sogata spp., Sogatellafurcifera, Sogatodes spp., Stictocephala festina, Siphoninus phillyreae,Tenalaphara malayensis, Tetragonocephela spp., Tinocallis caryaefoliae,Tomaspis spp., Toxoptera spp., Trialeurodes vaporariorum, Trioza spp.,Typhlocyba spp., Unaspis spp., Viteus vitifolii, Zygina spp.;from the order Hymenoptera, for example, Acromyrmex spp., Athalia spp.,Atta spp., Diprion spp., Hoplocampa spp., Lasius spp., Monomoriumpharaonis, Sirex spp., Solenopsis invicta, Tapinoma spp., Urocerus spp.,Vespa spp., Xeris spp.;from the order Isopoda, for example, Armadillidium vulgare, Oniscusasellus, Porcellio scaber;from the order Isoptera, for example, Coptotermes spp., Cornitermescumulans, Cryptotermes spp., Incisitermes spp., Microtermes obesi,Odontotermes spp., Reticulitermes spp.;from the order Lepidoptera, for example, Achroia grisella, Acronictamajor, Adoxophyes spp., Aedia leucomelas, Agrotis spp., Alabama spp.,Amyelois transitella, Anarsia spp., Anticarsia spp., Argyroploce spp.,Barathra brassicae, Borbo cinnara, Bucculatrix thurberiella, Bupaluspiniarius, Busseola spp., Cacoecia spp., Caloptilia theivora, Capuareticulana, Carpocapsa pomonella, Carposina niponensis, Cheimatobiabrumata, Chilo spp., Choristoneura spp., Clysia ambiguella,Cnaphalocerus spp., Cnaphalocrocis medinalis, Cnephasia spp.,Conopomorpha spp., Conotrachelus spp., Copitarsia spp., Cydia spp.,Dalaca noctuides, Diaphania spp., Diatraea saccharalis, Earias spp.,Ecdytolopha aurantium, Elasmopalpus lignosellus, Eldana saccharina,Ephestia spp., Epinotia spp., Epiphyas postvittana, Etiella spp., Euliaspp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia spp.,Galleria mellonella, Gracillaria spp., Grapholitha spp., Hedylepta spp.,Helicoverpa spp., Heliothis spp., Hofmannophila pseudospretella,Homoeosoma spp., Homona spp., Hyponomeuta padella, Kakivoriaflavofasciata, Laphygma spp., Laspeyresia molesta, Leucinodes orbonalis,Leucoptera spp., Lithocolletis spp., Lithophane antennata, Lobesia spp.,Loxagrotis albicosta, Lymantria spp., Lyonetia spp., Malacosomaneustria, Maruca testulalis, Mamstra brassicae, Melanitis leda, Modsspp., Monopis obviella, Mythimna separata, Nemapogon cloacellus,Nymphula spp., Oiketicus spp., Oria spp., Orthaga spp., Ostrinia spp.,Oulema oryzae, Panolis flammea, Parnara spp., Pectinophora spp.,Perileucoptera spp., Phthorimaea spp., Phyllocnistis citrella,Phyllonorycter spp., Pieris spp., Platynota stultana, Plodiainterpunctella, Plusia spp., Plutella xylostella, Prays spp., Prodeniaspp., Protoparce spp., Pseudaletia spp., Pseudaletia unipuncta,Pseudoplusia includens, Pyrausta nubilalis, Rachiplusia nu, Schoenobiusspp., Scirpophaga spp., Scirpophaga innotata, Scotia segetum, Sesamiaspp., Sesamia inferens, Sparganothis spp., Spodoptera spp., Spodopterapraefica, Stathmopoda spp., Stomopteryx subsecivella, Synanthedon spp.,Tecia solanivora, Thermesia gemmatalis, Tinea cloacella, Tineapellionella, Tineola bisselliella, Tortrix spp., Trichophaga tapetzella,Trichoplusia spp., Tryporyza incertulas, Tuta absoluta, Virachola spp.;from the order Orthoptera or Saltatoria, for example, Acheta domesticus,Dichroplus spp., Gryllotalpa spp., Hieroglyphus spp., Locusta spp.,Melanoplus spp., Schistocerca gregaria;from the order Phthiraptera, for example, Damalinia spp., Haematopinusspp., Linognathus spp., Pediculus spp., Ptirus pubis, Trichodectes spp.;from the order Psocoptera for example Lepinatus spp., Liposcelis spp.;from the order Siphonaptera, for example, Ceratophyllus spp.,Ctenocephalides spp., Pulex irritans, Tunga penetrans, Xenopsyllacheopsis;from the order Thysanoptera, for example, Anaphothrips obscurus,Baliothrips biformis, Drepanothrips reuteri, Enneothrips flavens,Frankliniella spp., Heliothrips spp., Hercinothrips femoralis,Rhipiphorothrips cruentatus, Scirtothrips spp., Taeniothrips cardamomi,Thrips spp.;from the order Zygentoma (=Thysanura), for example, Ctenolepisma spp.,Lepisma saccharina, Lepismodes inquilinus, Thermobia domestica;from the class Symphyla, for example, Scutigerella spp.;pests from the phylum Mollusca, especially from the class Bivalvia, forexample, Dreissena spp., and from the class Gastropoda, for example,Anion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp.,Lymnaea spp., Oncomelania spp., Pomacea spp., Succinea spp.;animal pests from the phylums Plathelminthes and Nematoda, for example,Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis,Ancylostoma spp., Ascaris spp., Brugia malayi, Brugia timori, Bunostomumspp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp.,Dictyocaulus filaria, Diphyllobothrium latum, Dracunculus medinensis,Echinococcus granulosus, Echinococcus multilocularis, Enterobiusvermicularis, Faciola spp., Haemonchus spp., Heterakis spp., Hymenolepisnana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagostomumspp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp.,Paragonimus spp., Schistosomen spp., Strongyloides fuelleborni,Strongyloides stercoralis, Stronyloides spp., Taenia saginata, Taeniasolium, Trichinella spiralis, Trichinella nativa, Trichinella britovi,Trichinella nelsoni, Trichinella pseudopsiralis, Trichostrongulus spp.,Trichuris trichiura, Wuchereria bancrofti;phytoparasitic pests from the phylum Nematoda, for example,Aphelenchoides spp., Bursaphelenchus spp., Ditylenchus spp., Globoderaspp., Heterodera spp., Longidorus spp., Meloidogyne spp., Pratylenchusspp., Radopholus spp., Trichodorus spp., Tylenchulus spp., Xiphinemaspp., Helicotylenchus spp., Tylenchorhynchus spp., Scutellonema spp.,Paratrichodorus spp., Meloinema spp., Paraphelenchus spp., Aglenchusspp., Belonolaimus spp., Nacobbus spp., Rotylenchulus spp., Rotylenchusspp., Neotylenchus spp., Paraphelenchus spp., Dolichodorus spp.,Hoplolaimus spp., Punctodera spp., Criconemella spp., Quinisulcius spp.,Hemicycliophora spp., Anguina spp., Subanguina spp., Hemicriconemoidesspp., Psilenchus spp., Pseudohalenchus spp., Criconemoides spp.,Cacopaurus spp., Hirschmaniella spp, Tetylenchus spp.

It is furthermore possible to control organisms from the subphylumProtozoa, especially from the order Coccidia, such as Eimeria spp.

Furthermore, the composition according to the present invention haspotent microbiciodal activity and can be used for control of unwantedmicroorganisms, such as fungi and bacteria, in crop protection and inthe protection of materials.

The invention also relates to a method for controlling unwantedmicroorganisms, characterized in that the inventive composition isapplied to the phytopathogenic fungi, phytopathogenic bacteria and/ortheir habitat.

Fungicides can be used in crop protection for control of phytopathogenicfungi. They are characterized by an outstanding efficacy against a broadspectrum of phytopathogenic fungi, including soilborne pathogens, whichare in particular members of the classes Plasmodiophoromycetes,Peronosporomycetes (Syn. Oomycetes), Chytridiomycetes, Zygomycetes,Ascomycetes, Basidiomycetes and Deuteromycetes (Syn. Fungi imperfecti).Some fungicides are systemically active and can be used in plantprotection as foliar, seed dressing or soil fungicide. Furthermore, theyare suitable for combating fungi, which inter alia infest wood or rootsof plant.

Bactericides can be used in crop protection for control ofPseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceaeand Streptomycetaceae.

Non-limiting examples of pathogens of fungal diseases which can betreated in accordance with the invention include:

diseases caused by powdery mildew pathogens, for example Blumeriaspecies, for example Blumeria graminis; Podosphaera species, for examplePodosphaera leucotricha; Sphaerotheca species, for example Sphaerothecafuliginea; Uncinula species, for example Uncinula necator;

diseases caused by rust disease pathogens, for example Gymnosporangiumspecies, for example Gymnosporangium sabinae; Hemileia species, forexample Hemileia vastatrix; Phakopsora species, for example Phakopsorapachyrhizi and Phakopsora meibomiae; Puccinia species, for examplePuccinia recondite, P. triticina, P. graminis or P. striiformis;Uromyces species, for example Uromyces appendiculatus;diseases caused by pathogens from the group of the Oomycetes, forexample Albugo species, for example Algubo candida; Bremia species, forexample Bremia lactucae; Peronospora species, for example Peronosporapisi or P. brassicae; Phytophthora species, for example Phytophthorainfestans; Plasmopara species, for example Plasmopara viticola;Pseudoperonospora species, for example Pseudoperonospora humuli orPseudoperonospora cubensis; Pythium species, for example Pythiumultimum;leaf blotch diseases and leaf wilt diseases caused, for example, byAlternaria species, for example Alternaria solani; Cercospora species,for example Cercospora beticola; Cladiosporium species, for exampleCladiosporium cucumerinum; Cochliobolus species, for exampleCochliobolus sativus (conidia form: Drechslera, Syn: Helminthosporium),Cochliobolus miyabeanus; Colletotrichum species, for exampleColletotrichum lindemuthanium; Cycloconium species, for exampleCycloconium oleaginum; Diaporthe species, for example Diaporthe citri;Elsinoe species, for example Elsinoe fawcettii; Gloeosporium species,for example Gloeosporium laeticolor; Glomerella species, for exampleGlomerella cingulata; Guignardia species, for example Guignardiabidwelli; Leptosphaeria species, for example Leptosphaeria maculans,Leptosphaeria nodorum; Magnaporthe species, for example Magnaporthegrisea; Microdochium species, for example Microdochium nivale;Mycosphaerella species, for example Mycosphaerella graminicola, M.arachidicola and M. fijiensis; Phaeosphaeria species, for examplePhaeosphaeria nodorum; Pyrenophora species, for example Pyrenophorateres, Pyrenophora tritici repentis; Ramularia species, for exampleRamularia collo-cygni, Ramularia areola; Rhynchosporium species, forexample Rhynchosporium secalis; Septoria species, for example Septoriaapii, Septoria lycopersii; Typhula species, for example Typhulaincarnata; Venturia species, for example Venturia inaequalis;root and stem diseases caused, for example, by Corticium species, forexample Corticium graminearum; Fusarium species, for example Fusariumoxysporum; Gaeumannomyces species, for example Gaeumannomyces graminis;Rhizoctonia species, such as, for example Rhizoctonia solani;Sarocladium diseases caused for example by Sarocladium oryzae;Sclerotium diseases caused for example by Sclerotium oryzae; Tapesiaspecies, for example Tapesia acuformis; Thielaviopsis species, forexample Thielaviopsis basicola;ear and panicle diseases (including corn cobs) caused, for example, byAlternaria species, for example Alternaria spp.; Aspergillus species,for example Aspergillus flavus; Cladosporium species, for exampleCladosporium cladosporioides; Claviceps species, for example Clavicepspurpurea; Fusarium species, for example Fusarium culmorum; Gibberellaspecies, for example Gibberella zeae; Monographella species, for exampleMonographella nivalis; Septoria species, for example Septoria nodorum;diseases caused by smut fungi, for example Sphacelotheca species, forexample Sphacelotheca reiliana; Tilletia species, for example Tilletiacaries, T. controversa; Urocystis species, for example Urocystisocculta; Ustilago species, for example Ustilago nuda, U. nuda tritici;fruit rot caused, for example, by Aspergillus species, for exampleAspergillus flavus; Botrytis species, for example Botrytis cinerea;Penicillium species, for example Penicillium expansum and P.purpurogenum; Sclerotinia species, for example Sclerotinia sclerotiorum;Verticilium species, for example Verticilium alboatrum;seed and soilborne decay, mould, wilt, rot and damping-off diseasescaused, for example, by Alternaria species, caused for example byAlternaria brassicicola; Aphanomyces species, caused for example byAphanomyces euteiches; Ascochyta species, caused for example byAscochyta lentis; Aspergillus species, caused for example by Aspergillusflavus; Cladosporium species, caused for example by Cladosporiumherbarum; Cochliobolus species, caused for example by Cochliobolussativus; (Conidiaform: Drechslera, Bipolaris Syn: Helminthosporium);Colletotrichum species, caused for example by Colletotrichum coccodes;Fusarium species, caused for example by Fusarium culmorum; Gibberellaspecies, caused for example by Gibberella zeae; Macrophomina species,caused for example by Macrophomina phaseolina; Monographella species,caused for example by Monographella nivalis; Penicillium species, causedfor example by Penicillium expansum; Phoma species, caused for exampleby Phoma lingam; Phomopsis species, caused for example by Phomopsissojae; Phytophthora species, caused for example by Phytophthoracactorum; Pyrenophora species, caused for example by Pyrenophoragraminea; Pyricularia species, caused for example by Pyricularia oryzae;Pythium species, caused for example by Pythium ultimum; Rhizoctoniaspecies, caused for example by Rhizoctonia solani; Rhizopus species,caused for example by Rhizopus oryzae; Sclerotium species, caused forexample by Sclerotium rolfsii; Septoria species, caused for example bySeptoria nodorum; Typhula species, caused for example by Typhulaincarnata; Verticillium species, caused for example by Verticilliumdahliae;cancers, galls and witches' broom caused, for example, by Nectriaspecies, for example Nectria galligena;wilt diseases caused, for example, by Monilinia species, for exampleMonilinia laxa;leaf blister or leaf curl diseases caused, for example, by Exobasidiumspecies, for example Exobasidium vexans;Taphrina species, for example Taphrina deformans;decline diseases of wooden plants caused, for example, by Esca disease,caused for example by Phaemoniella clamydospora, Phaeoacremoniumaleophilum and Fomitiporia mediterranea; Eutypa dyeback, caused forexample by Eutypa lata;Ganoderma diseases caused for example by Ganoderma boninense;Rigidoporus diseases caused for example by Rigidoporus lignosus;diseases of flowers and seeds caused, for example, by Botrytis species,for example Botrytis cinerea;diseases of plant tubers caused, for example, by Rhizoctonia species,for example Rhizoctonia solani; Helminthosporium species, for exampleHelminthosporium solani;Club root caused, for example, by Plasmodiophora species, for examplePlamodiophora brassicae;diseases caused by bacterial pathogens, for example Xanthomonas species,for example Xanthomonas campestris pv. oryzae; Pseudomonas species, forexample Pseudomonas syringae pv. lachrymans; Erwinia species, forexample Erwinia amylovora.

The following diseases of soya beans can be controlled with preference:

Fungal diseases on leaves, stems, pods and seeds caused, for example, byAlternaria leaf spot (Alternaria spec. atrans tenuissima), Anthracnose(Colletotrichum gloeosporoides dematium var. truncatum), brown spot(Septoria glycines), cercospora leaf spot and blight (Cercosporakikuchii), choanephora leaf blight (Choanephora infundibulifera trispora(Syn.)), dactuliophora leaf spot (Dactuliophora glycines), downy mildew(Peronospora manshurica), drechslera blight (Drechslera glycini),frogeye leaf spot (Cercospora sojina), leptosphaerulina leaf spot(Leptosphaerulina trifolii), phyllostica leaf spot (Phyllostictasojaecola), pod and stem blight (Phomopsis sojae), powdery mildew(Microsphaera diffusa), pyrenochaeta leaf spot (Pyrenochaeta glycines),rhizoctonia aerial, foliage, and web blight (Rhizoctonia solani), rust(Phakopsora pachyrhizi, Phakopsora meibomiae), scab (Sphacelomaglycines), stemphylium leaf blight (Stemphylium botryosum), target spot(Corynespora cassiicola).

Fungal diseases on roots and the stem base caused, for example, by blackroot rot (Calonectria crotalariae), charcoal rot (Macrophominaphaseolina), fusarium blight or wilt, root rot, and pod and collar rot(Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusariumequiseti), mycoleptodiscus root rot (Mycoleptodiscus terrestris),neocosmospora (Neocosmospora vasinfecta), pod and stem blight (Diaporthephaseolorum), stem canker (Diaporthe phaseolorum var. caulivora),phytophthora rot (Phytophthora megasperma), brown stem rot (Phialophoragregata), pythium rot (Pythium aphanidermatum, Pythium irregulare,Pythium debaryanum, Pythium myriotylum, Pythium ultimum), rhizoctoniaroot rot, stem decay, and damping-off (Rhizoctonia solani), sclerotiniastem decay (Sclerotinia sclerotiorum), sclerotinia southern blight(Sclerotinia rolfsii), thielaviopsis root rot (Thielaviopsis basicola).

The inventive compositions can be used for curative orprotective/preventive control of phytopathogenic fungi. The inventiontherefore also relates to curative and protective methods forcontrolling phytopathogenic fungi by the use of the inventivecomposition, which is applied to the seed, the plant or plant parts, thefruit or the soil in which the plants grow.

The fact that the composition is well tolerated by plants at theconcentrations required for controlling plant diseases allows thetreatment of above-ground parts of plants, of propagation stock andseeds, and of the soil.

According to the invention all plants and plant parts can be treated. Byplants is meant all plants and plant populations such as desirable andundesirable wild plants, cultivars and plant varieties (whether or notprotectable by plant variety or plant breeder's rights). Cultivars andplant varieties can be plants obtained by conventional propagation andbreeding methods which can be assisted or supplemented by one or morebiotechnological methods such as by use of double haploids, protoplastfusion, random and directed mutagenesis, molecular or genetic markers orby bioengineering and genetic engineering methods. By plant parts ismeant all above ground and below ground parts and organs of plants suchas shoot, leaf, blossom and root, whereby for example leaves, needles,stems, branches, blossoms, fruiting bodies, fruits and seed as well asroots, corms and rhizomes are listed. Crops and vegetative andgenerative propagating material, for example cuttings, corms, rhizomes,runners and seeds also belong to plant parts.

The inventive composition, when it is well tolerated by plants, hasfavourable homeotherm toxicity and is well tolerated by the environment,is suitable for protecting plants and plant organs, for enhancingharvest yields, for improving the quality of the harvested material. Itcan preferably be used as crop protection composition. It is activeagainst normally sensitive and resistant species and against all or somestages of development.

Plants which can be treated in accordance with the invention include thefollowing main crop plants: maize, soya bean, alfalfa, cotton,sunflower, Brassica oil seeds such as Brassica napus (e.g. canola,rapeseed), Brassica rapa, B. juncea (e.g. (field) mustard) and Brassicacarinata, Arecaceae sp. (e.g. oilpalm, coconut), rice, wheat, sugarbeet, sugar cane, oats, rye, barley, millet and sorghum, triticale,flax, nuts, grapes and vine and various fruit and vegetables fromvarious botanic taxa, e.g. Rosaceae sp. (e.g. pome fruits such as applesand pears, but also stone fruits such as apricots, cherries, almonds,plums and peaches, and berry fruits such as strawberries, raspberries,red and black currant and gooseberry), Ribesioidae sp., Juglandaceaesp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp.,Oleaceae sp. (e.g. olive tree), Actinidaceae sp., Lauraceae sp. (e.g.avocado, cinnamon, camphor), Musaceae sp. (e.g. banana trees andplantations), Rubiaceae sp. (e.g. coffee), Theaceae sp. (e.g. tea),Sterculiceae sp., Rutaceae sp. (e.g. lemons, oranges, mandarins andgrapefruit); Solanaceae sp. (e.g. tomatoes, potatoes, peppers, capsicum,aubergines, tobacco), Liliaceae sp., Cornpositae sp. (e.g. lettuce,artichokes and chicory—including root chicory, endive or commonchicory), Umbelliferae sp. (e.g. carrots, parsley, celery and celeriac),Cucurbitaceae sp. (e.g. cucumbers—including gherkins, pumpkins,watermelons, calabashes and melons), Alliaceae sp. (e.g. leeks andonions), Cruciferae sp. (e.g. white cabbage, red cabbage, broccoli,cauliflower, Brussels sprouts, pak choi, kohlrabi, radishes,horseradish, cress and chinese cabbage), Leguminosae sp. (e.g. peanuts,peas, lentils and beans—e.g. common beans and broad beans),Chenopodiaceae sp. (e.g. Swiss chard, fodder beet, spinach, beetroot),Linaceae sp. (e.g. hemp), Cannabeacea sp. (e.g. cannabis), Malvaceae sp.(e.g. okra, cocoa), Papaveraceae (e.g. poppy), Asparagaceae (e.g.asparagus); useful plants and ornamental plants in the garden and woodsincluding turf, lawn, grass and Stevia rebaudiana; and in each casegenetically modified types of these plants.

Depending on the plant species or plant cultivars, their location andgrowth conditions (soils, climate, vegetation period, diet), using oremploying the composition according to the present invention thetreatment according to the invention may also result in super-additive(“synergistic”) effects. Thus, for example, by using or employinginventive composition in the treatment according to the invention,reduced application rates and/or a widening of the activity spectrumand/or an increase in the activity better plant growth, increasedtolerance to high or low temperatures, increased tolerance to drought orto water or soil salt content, increased flowering performance, easierharvesting, accelerated maturation, higher harvest yields, biggerfruits, larger plant height, greener leaf color, earlier flowering,higher quality and/or a higher nutritional value of the harvestedproducts, higher sugar concentration within the fruits, better storagestability and/or processability of the harvested products are possible,which exceed the effects which were actually to be expected.

At certain application rates of the inventive composition in thetreatment according to the invention may also have a strengtheningeffect in plants. The defense system of the plant against attack byunwanted phytopathogenic fungi and/or microorganisms and/or viruses ismobilized. Plant-strengthening (resistance-inducing) substances are tobe understood as meaning, in the present context, those substances orcombinations of substances which are capable of stimulating the defensesystem of plants in such a way that, when subsequently inoculated withunwanted phytopathogenic fungi and/or microorganisms and/or viruses, thetreated plants display a substantial degree of resistance to thesephytopathogenic fungi and/or microorganisms and/or viruses, Thus, byusing or employing composition according to the present invention in thetreatment according to the invention, plants can be protected againstattack by the abovementioned pathogens within a certain period of timeafter the treatment. The period of time within which protection iseffected generally extends from 1 to 10 days, preferably 1 to 7 days,after the treatment of the plants with the active compounds.

Plants and plant cultivars which are also preferably to be treatedaccording to the invention are resistant against one or more bioticstresses, i.e. said plants show a better defense against animal andmicrobial pests, such as against nematodes, insects, mites,phytopathogenic fungi, bacteria, viruses and/or viroids.

Plants and plant cultivars which may also be treated according to theinvention are those plants which are resistant to one or more abioticstresses, i.e. that already exhibit an increased plant health withrespect to stress tolerance. Abiotic stress conditions may include, forexample, drought, cold temperature exposure, heat exposure, osmoticstress, flooding, increased soil salinity, increased mineral exposure,ozon exposure, high light exposure, limited availability of nitrogennutrients, limited availability of phosphorus nutrients, shadeavoidance. Preferably, the treatment of these plants and cultivars withthe composition of the present invention additionally increases theoverall plant health (cf. above).

Plants and plant cultivars which may also be treated according to theinvention, are those plants characterized by enhanced yieldcharacteristics i.e. that already exhibit an increased plant health withrespect to this feature. Increased yield in said plants can be theresult of, for example, improved plant physiology, growth anddevelopment, such as water use efficiency, water retention efficiency,improved nitrogen use, enhanced carbon assimilation, improvedphotosynthesis, increased germination efficiency and acceleratedmaturation. Yield can furthermore be affected by improved plantarchitecture (under stress and non-stress conditions), including but notlimited to, early flowering, flowering control for hybrid seedproduction, seedling vigor, plant size, internode number and distance,root growth, seed size, fruit size, pod size, pod or ear number, seednumber per pod or ear, seed mass, enhanced seed filling, reduced seeddispersal, reduced pod dehiscence and lodging resistance. Further yieldtraits include seed composition, such as carbohydrate content, proteincontent, oil content and composition, nutritional value, reduction inanti-nutritional compounds, improved processability and better storagestability. Preferably, the treatment of these plants and cultivars withthe composition of the present invention additionally increases theoverall plant health (cf. above).

Plants that may be treated according to the invention are hybrid plantsthat already express the characteristic of heterosis or hybrid vigorwhich results in generally higher yield, vigor, health and resistancetowards biotic and abiotic stress factors. Such plants are typicallymade by crossing an inbred male-sterile parent line (the female parent)with another inbred male-fertile parent line (the male parent). Hybridseed is typically harvested from the male sterile plants and sold togrowers. Male sterile plants can sometimes (e.g. in corn) be produced bydetasseling, i.e. the mechanical removal of the male reproductive organs(or males flowers) but, more typically, male sterility is the result ofgenetic determinants in the plant genome. In that case, and especiallywhen seed is the desired product to be harvested from the hybrid plantsit is typically useful to ensure that male fertility in the hybridplants is fully restored. This can be accomplished by ensuring that themale parents have appropriate fertility restorer genes which are capableof restoring the male fertility in hybrid plants that contain thegenetic determinants responsible for male-sterility. Geneticdeterminants for male sterility may be located in the cytoplasm.Examples of cytoplasmic male sterility (CMS) were for instance describedin Brassica species. However, genetic determinants for male sterilitycan also be located in the nuclear genome. Male sterile plants can alsobe obtained by plant biotechnology methods such as genetic engineering.A particularly useful means of obtaining male-sterile plants isdescribed in WO 89/10396 in which, for example, a ribonuclease such asbarnase is selectively expressed in the tapetum cells in the stamens.Fertility can then be restored by expression in the tapetum cells of aribonuclease inhibitor such as barstar.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may be treated according to the inventionare herbicide-tolerant plants, i.e. plants made tolerant to one or moregiven herbicides. Such plants can be obtained either by genetictransformation, or by selection of plants containing a mutationimparting such herbicide tolerance.

Herbicide-tolerant plants are for example glyphosate-tolerant plants,i.e. plants made tolerant to the herbicide glyphosate or salts thereof.Plants can be made tolerant to glyphosate through different means. Forexample, glyphosate-tolerant plants can be obtained by transforming theplant with a gene encoding the enzyme 5-enolpyruvylshikimate-3-phosphatesynthase (EPSPS). Examples of such EPSPS genes are the AroA gene (mutantCT7) of the bacterium Salmonella typhimurium, the CP4 gene of thebacterium Agrobacterium sp, the genes encoding a Petunia EPSPS, a TomatoEPSPS, or an Eleusine EPSPS. It can also be a mutated EPSPS.Glyphosate-tolerant plants can also be obtained by expressing a genethat encodes a glyphosate oxido-reductase enzyme. Glyphosate-tolerantplants can also be obtained by expressing a gene that encodes aglyphosate acetyl transferase enzyme. Glyphosate-tolerant plants canalso be obtained by selecting plants containing naturally-occurringmutations of the above-mentioned genes.

Other herbicide resistant plants are for example plants that are madetolerant to herbicides inhibiting the enzyme glutamine synthase, such asbialaphos, phosphinothricin or glufosinate. Such plants can be obtainedby expressing an enzyme detoxifying the herbicide or a mutant glutaminesynthase enzyme that is resistant to inhibition. One such efficientdetoxifying enzyme is an enzyme encoding a phosphinothricinacetyltransferase (such as the bar or pat protein from Streptomycesspecies). Plants expressing an exogenous phosphinothricinacetyltransferase are also described.

Further herbicide-tolerant plants are also plants that are made tolerantto the herbicides inhibiting the enzyme hydroxyphenylpyruvatedioxygenase(HPPD). Hydroxyphenylpyruvatedioxygenases are enzymes that catalyze thereaction in which para-hydroxyphenylpyruvate (HPP) is transformed intohomogentisate. Plants tolerant to HPPD-inhibitors can be transformedwith a gene encoding a naturally-occurring resistant HPPD enzyme, or agene encoding a mutated HPPD enzyme. Tolerance to HPPD-inhibitors canalso be obtained by transforming plants with genes encoding certainenzymes enabling the formation of homogentisate despite the inhibitionof the native HPPD enzyme by the HPPD-inhibitor. Tolerance of plants toHPPD inhibitors can also be improved by transforming plants with a geneencoding an enzyme prephenate dehydrogenase in addition to a geneencoding an HPPD-tolerant enzyme.

Still further herbicide resistant plants are plants that are madetolerant to acetolactate synthase (ALS) inhibitors. Known ALS-inhibitorsinclude, for example, sulfonylurea, imidazolinone, triazolopyrimidines,pyrimidinyoxy(thio)benzoates, and/or sulfonylaminocarbonyltriazolinoneherbicides. Different mutations in the ALS enzyme (also known asacetohydroxyacid synthase, AHAS) are known to confer tolerance todifferent herbicides and groups of herbicides. The production ofsulfonylurea-tolerant plants and imidazolinone-tolerant plants isdescribed in WO 1996/033270. Other imidazolinone-tolerant plants arealso described. Further sulfonylurea- and imidazolinone-tolerant plantsare also described in for example WO 2007/024782.

Other plants tolerant to imidazolinone and/or sulfonylurea can beobtained by induced mutagenesis, selection in cell cultures in thepresence of the herbicide or mutation breeding as described for examplefor soybeans, for rice, for sugar beet, for lettuce, or for sunflower.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention are insect-resistant transgenic plants, i.e. plants maderesistant to attack by certain target insects. Such plants can beobtained by genetic transformation, or by selection of plants containinga mutation imparting such insect resistance.

An “insect-resistant transgenic plant”, as used herein, includes anyplant containing at least one transgene comprising a coding sequenceencoding:

-   -   1) An insecticidal crystal protein from Bacillus thuringiensis        or an insecticidal portion thereof, such as the insecticidal        crystal proteins listed online at:        http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/, or        insecticidal portions thereof, e.g., proteins of the Cry protein        classes Cry1Ab, Cry1Ac, Cry1F, Cry2Ab, Cry3Aa, or Cry3Bb or        insecticidal portions thereof; or    -   2) a crystal protein from Bacillus thuringiensis or a portion        thereof which is insecticidal in the presence of a second other        crystal protein from Bacillus thuringiensis or a portion        thereof, such as the binary toxin made up of the Cry34 and Cry35        crystal proteins; or    -   3) a hybrid insecticidal protein comprising parts of different        insecticidal crystal proteins from Bacillus thuringiensis, such        as a hybrid of the proteins of 1) above or a hybrid of the        proteins of 2) above, e.g., the Cry1A.105 protein produced by        corn event MON98034 (WO 2007/027777); or    -   4) a protein of any one of 1) to 3) above wherein some,        particularly 1 to 10, amino acids have been replaced by another        amino acid to obtain a higher insecticidal activity to a target        insect species, and/or to expand the range of target insect        species affected, and/or because of changes introduced into the        encoding DNA during cloning or transformation, such as the        Cry3Bb1 protein in corn events MON863 or MON88017, or the Cry3A        protein in corn event MIR604; 5) an insecticidal secreted        protein from Bacillus thuringiensis or Bacillus cereus, or an        insecticidal portion thereof, such as the vegetative        insecticidal (VIP) proteins listed at:        http://www.lifesci.sussex.ac.uk/home/Neil_Crickmore/Bt/vip.html,        e.g. proteins from the VIP3Aa protein class; or    -   6) secreted protein from Bacillus thuringiensis or Bacillus        cereus which is insecticidal in the presence of a second        secreted protein from Bacillus thuringiensis or B. cereus, such        as the binary toxin made up of the VIP1A and VIP2A proteins; or    -   7) hybrid insecticidal protein comprising parts from different        secreted proteins from Bacillus thuringiensis or Bacillus        cereus, such as a hybrid of the proteins in 1) above or a hybrid        of the proteins in 2) above; or    -   8) protein of any one of 1) to 3) above wherein some,        particularly 1 to 10, amino acids have been replaced by another        amino acid to obtain a higher insecticidal activity to a target        insect species, and/or to expand the range of target insect        species affected, and/or because of changes introduced into the        encoding DNA during cloning or transformation (while still        encoding an insecticidal protein), such as the VIP3Aa protein in        cotton event COT102.

Of course, an insect-resistant transgenic plant, as used herein, alsoincludes any plant comprising a combination of genes encoding theproteins of any one of the above classes 1 to 8. In one embodiment, aninsect-resistant plant contains more than one transgene encoding aprotein of any one of the above classes 1 to 8, to expand the range oftarget insect species affected when using different proteins directed atdifferent target insect species, or to delay insect resistancedevelopment to the plants by using different proteins insecticidal tothe same target insect species but having a different mode of action,such as binding to different receptor binding sites in the insect.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention are tolerant to abiotic stresses. Such plants can be obtainedby genetic transformation, or by selection of plants containing amutation imparting such stress resistance. Particularly useful stresstolerance plants include:

-   -   a. plants which contain a transgene capable of reducing the        expression and/or the activity of poly(ADP-ribose)polymerase        (PARP) gene in the plant cells or plants    -   b. plants which contain a stress tolerance enhancing transgene        capable of reducing the expression and/or the activity of the        poly(ADP-ribose)glycohydrolase (PARG) encoding genes of the        plants or plants cells.    -   c. plants which contain a stress tolerance enhancing transgene        coding for a plant-functional enzyme of the nicotinamide adenine        dinucleotide salvage synthesis pathway including nicotinamidase,        nicotinate phosphoribosyltransferase, nicotinic acid        mononucleotide adenyl transferase, nicotinamide adenine        dinucleotide synthetase or nicotine amide        phosphorybosyltransferase.

Plants or plant cultivars (obtained by plant biotechnology methods suchas genetic engineering) which may also be treated according to theinvention show altered quantity, quality and/or storage-stability of theharvested product and/or altered properties of specific ingredients ofthe harvested product such as:

-   -   1) transgenic plants which synthesize a modified starch, which        in its physical-chemical characteristics, in particular the        amylose content or the amylose/amylopectin ratio, the degree of        branching, the average chain length, the side chain        distribution, the viscosity behaviour, the gelling strength, the        starch grain size and/or the starch grain morphology, is changed        in comparison with the synthesised starch in wild type plant        cells or plants, so that this is better suited for special        applications.    -   2) transgenic plants which synthesize non starch carbohydrate        polymers or which synthesize non starch carbohydrate polymers        with altered properties in comparison to wild type plants        without genetic modification. Examples are plants producing        polyfructose, especially of the inulin and levan-type, plants        producing alpha 1,4 glucans, plants producing alpha-1,6 branched        alpha-1,4-glucans, plants producing alternan,    -   3) transgenic plants which produce hyaluronan.

Plants or plant cultivars (that can be obtained by plant biotechnologymethods such as genetic engineering) which may also be treated accordingto the invention are plants, such as cotton plants, with altered fibercharacteristics. Such plants can be obtained by genetic transformationor by selection of plants contain a mutation imparting such alteredfiber characteristics and include:

-   -   a) Plants, such as cotton plants, containing an altered form of        cellulose synthase genes,    -   b) Plants, such as cotton plants, containing an altered form of        rsw2 or rsw3 homologous nucleic acids,    -   c) Plants, such as cotton plants, with increased expression of        sucrose phosphate synthase,    -   d) Plants, such as cotton plants, with increased expression of        sucrose synthase,    -   e) Plants, such as cotton plants, wherein the timing of the        plasmodesmatal gating at the basis of the fiber cell is altered,        e.g. through downregulation of fiberselective β1,3-glucanase,    -   f) Plants, such as cotton plants, having fibers with altered        reactivity, e.g. through the expression of        N-acteylglucosaminetransferase gene including nodC and        chitinsynthase genes.

Plants or plant cultivars (that can be obtained by plant biotechnologymethods such as genetic engineering) which may also be treated accordingto the invention are plants, such as oilseed rape or related Brassicaplants, with altered oil profile characteristics. Such plants can beobtained by genetic transformation or by selection of plants contain amutation imparting such altered oil characteristics and include:

-   -   a) Plants, such as oilseed rape plants, producing oil having a        high oleic acid content,    -   b) Plants such as oilseed rape plants, producing oil having a        low linolenic acid content,    -   c) Plant such as oilseed rape plants, producing oil having a low        level of saturated fatty acids.

Particularly useful transgenic plants which may be treated according tothe invention are plants which comprise one or more genes which encodeone or more toxins, such as the following which are sold under the tradenames YIELD GARD® (for example maize, cotton, soya beans), KnockOut®(for example maize), BiteGard® (for example maize), Bt-Xtra® (forexample maize), StarLink® (for example maize), Bollgard® (cotton),Nucotn® (cotton), Nucotn 33B® (cotton), NatureGard® (for example maize),Protecta® and NewLeaf® (potato). Examples of herbicide-tolerant plantswhich may be mentioned are maize varieties, cotton varieties and soyabean varieties which are sold under the trade names Roundup Ready®(tolerance to glyphosate, for example maize, cotton, soya bean), LibertyLink® (tolerance to phosphinotricin, for example oilseed rape), IMI®(tolerance to imidazolinones) and STS® (tolerance to sulphonylureas, forexample maize). Herbicide-resistant plants (plants bred in aconventional manner for herbicide tolerance) which may be mentionedinclude the varieties sold under the name Clearfield® (for examplemaize).

Particularly useful transgenic plants which may be treated according tothe invention are plants containing transformation events, or acombination of transformation events, and that are listed for example inthe databases for various national or regional regulatory agenciesincluding Event 1143-14A (cotton, insect control, not deposited,described in WO 06/128569); Event 1143-51B (cotton, insect control, notdeposited, described in WO 06/128570); Event 1445 (cotton, herbicidetolerance, not deposited, described in US-A 2002-120964 or WO02/034946); Event 17053 (rice, herbicide tolerance, deposited asPTA-9843, described in WO 10/117737); Event 17314 (rice, herbicidetolerance, deposited as PTA-9844, described in WO 10/117735); Event281-24-236 (cotton, insect control-herbicide tolerance, deposited asPTA-6233, described in WO 05/103266 or US-A 2005-216969); Event3006-210-23 (cotton, insect control-herbicide tolerance, deposited asPTA-6233, described in US-A 2007-143876 or WO 05/103266); Event 3272(corn, quality trait, deposited as PTA-9972, described in WO 06/098952or US-A 2006-230473); Event 40416 (corn, insect control-herbicidetolerance, deposited as ATCC PTA-11508, described in WO 11/075593);Event 43A47 (corn, insect control-herbicide tolerance, deposited as ATCCPTA-11509, described in WO 11/075595); Event 5307 (corn, insect control,deposited as ATCC PTA-9561, described in WO 10/077816); Event ASR-368(bent grass, herbicide tolerance, deposited as ATCC PTA-4816, describedin US-A 2006-162007 or WO 04/053062); Event B16 (corn, herbicidetolerance, not deposited, described in US-A 2003-126634); EventBPS-CV127-9 (soybean, herbicide tolerance, deposited as NCIMB No. 41603,described in WO 10/080829); Event CE43-67B (cotton, insect control,deposited as DSM ACC2724, described in US-A 2009-217423 or WO06/128573); Event CE44-69D (cotton, insect control, not deposited,described in US-A 2010-0024077); Event CE44-69D (cotton, insect control,not deposited, described in WO 06/128571); Event CE46-02A (cotton,insect control, not deposited, described in WO 06/128572); Event COT102(cotton, insect control, not deposited, described in US-A 2006-130175 orWO 04/039986); Event COT202 (cotton, insect control, not deposited,described in US-A 2007-067868 or WO 05/054479); Event COT203 (cotton,insect control, not deposited, described in WO 05/054480); EventDAS40278 (corn, herbicide tolerance, deposited as ATCC PTA-10244,described in WO 11/022469); Event DAS-59122-7 (corn, insectcontrol-herbicide tolerance, deposited as ATCC PTA 11384, described inUS-A 2006-070139); Event DAS-59132 (corn, insect control-herbicidetolerance, not deposited, described in WO 09/100188); Event DAS68416(soybean, herbicide tolerance, deposited as ATCC PTA-10442, described inWO 11/066384 or WO 11/066360); Event DP-098140-6 (corn, herbicidetolerance, deposited as ATCC PTA-8296, described in US-A 2009-137395 orWO 08/112019); Event DP-305423-1 (soybean, quality trait, not deposited,described in US-A 2008-312082 or WO 08/054747); Event DP-32138-1 (corn,hybridization system, deposited as ATCC PTA-9158, described in US-A2009-0210970 or WO 09/103049); Event DP-356043-5 (soybean, herbicidetolerance, deposited as ATCC PTA-8287, described in US-A 2010-0184079 orWO 08/002872); Event EE-1 (brinjal, insect control, not deposited,described in WO 07/091277); Event F1117 (corn, herbicide tolerance,deposited as ATCC 209031, described in US-A 2006-059581 or WO98/044140); Event GA21 (corn, herbicide tolerance, deposited as ATCC209033, described in US-A 2005-086719 or WO 98/044140); Event GG25(corn, herbicide tolerance, deposited as ATCC 209032, described in US-A2005-188434 or WO 98/044140); Event GHB119 (cotton, insectcontrol-herbicide tolerance, deposited as ATCC PTA-8398, described in WO08/151780); Event GHB614 (cotton, herbicide tolerance, deposited as ATCCPTA-6878, described in US-A 2010-050282 or WO 07/017186); Event GJ11(corn, herbicide tolerance, deposited as ATCC 209030, described in US-A2005-188434 or WO 98/044140); Event GM RZ13 (sugar beet, virusresistance, deposited as NCIMB-41601, described in WO 10/076212); EventH7-1 (sugar beet, herbicide tolerance, deposited as NCIMB 41158 or NCIMB41159, described in US-A 2004-172669 or WO 04/074492); Event JOPLIN1(wheat, disease tolerance, not deposited, described in US-A2008-064032); Event LL27 (soybean, herbicide tolerance, deposited asNCIMB41658, described in WO 06/108674 or US-A 2008-320616); Event LL55(soybean, herbicide tolerance, deposited as NCIMB 41660, described in WO06/108675 or US-A 2008-196127); Event LLcotton25 (cotton, herbicidetolerance, deposited as ATCC PTA-3343, described in WO 03/013224 or US-A2003-097687); Event LLRICE06 (rice, herbicide tolerance, deposited asATCC-23352, described in U.S. Pat. No. 6,468,747 or WO 00/026345); EventLLRICE601 (rice, herbicide tolerance, deposited as ATCC PTA-2600,described in US-A 2008-2289060 or WO 00/026356); Event LY038 (corn,quality trait, deposited as ATCC PTA-5623, described in US-A 2007-028322or WO 05/061720); Event MIR162 (corn, insect control, deposited asPTA-8166, described in US-A 2009-300784 or WO 07/142840); Event MIR604(corn, insect control, not deposited, described in US-A 2008-167456 orWO 05/103301); Event MON15985 (cotton, insect control, deposited as ATCCPTA-2516, described in US-A 2004-250317 or WO 02/100163); Event MON810(corn, insect control, not deposited, described in US-A 2002-102582);Event MON863 (corn, insect control, deposited as ATCC PTA-2605,described in WO 04/011601 or US-A 2006-095986); Event MON87427 (corn,pollination control, deposited as ATCC PTA-7899, described in WO11/062904); Event MON87460 (corn, stress tolerance, deposited as ATCCPTA-8910, described in WO 09/111263 or US-A 2011-0138504); EventMON87701 (soybean, insect control, deposited as ATCC PTA-8194, describedin US-A 2009-130071 or WO 09/064652); Event MON87705 (soybean, qualitytrait—herbicide tolerance, deposited as ATCC PTA-9241, described in US-A2010-0080887 or WO 10/037016); Event MON87708 (soybean, herbicidetolerance, deposited as ATCC PTA9670, described in WO 11/034704); EventMON87754 (soybean, quality trait, deposited as ATCC PTA-9385, describedin WO 10/024976); Event MON87769 (soybean, quality trait, deposited asATCC PTA-8911, described in US-A 2011-0067141 or WO 09/102873); EventMON88017 (corn, insect control-herbicide tolerance, deposited as ATCCPTA-5582, described in US-A 2008-028482 or WO 05/059103); Event MON88913(cotton, herbicide tolerance, deposited as ATCC PTA-4854, described inWO 04/072235 or US-A 2006-059590); Event MON89034 (corn, insect control,deposited as ATCC PTA-7455, described in WO 07/140256 or US-A2008-260932); Event MON89788 (soybean, herbicide tolerance, deposited asATCC PTA-6708, described in US-A 2006-282915 or WO 06/130436); EventMS11 (oilseed rape, pollination control-herbicide tolerance, depositedas ATCC PTA-850 or PTA-2485, described in WO 01/031042); Event MS8(oilseed rape, pollination control-herbicide tolerance, deposited asATCC PTA-730, described in WO 01/041558 or US-A 2003-188347); EventNK603 (corn, herbicide tolerance, deposited as ATCC PTA-2478, describedin US-A 2007-292854); Event PE-7 (rice, insect control, not deposited,described in WO 08/114282); Event RF3 (oilseed rape, pollinationcontrol-herbicide tolerance, deposited as ATCC PTA-730, described in WO01/041558 or US-A 2003-188347); Event RT73 (oilseed rape, herbicidetolerance, not deposited, described in WO 02/036831 or US-A2008-070260); Event T227-1 (sugar beet, herbicide tolerance, notdeposited, described in WO 02/44407 or US-A 2009-265817); Event T25(corn, herbicide tolerance, not deposited, described in US-A 2001-029014or WO 01/051654); Event T304-40 (cotton, insect control-herbicidetolerance, deposited as ATCC PTA-8171, described in US-A 2010-077501 orWO 08/122406); Event T342-142 (cotton, insect control, not deposited,described in WO 06/128568); Event TC1507 (corn, insect control-herbicidetolerance, not deposited, described in US-A 2005-039226 or WO04/099447); Event VIP1034 (corn, insect control-herbicide tolerance,deposited as ATCC PTA-3925., described in WO 03/052073), Event 32316(corn, insect control-herbicide tolerance, deposited as PTA-11507,described in WO 11/084632), Event 4114 (corn, insect control-herbicidetolerance, deposited as PTA-11506, described in WO 11/084621).

Particularly useful transgenic plants which may be treated according tothe invention are plants containing transformation events, orcombination of transformation events, that are listed for example in thedatabases from various national or regional regulatory agencies (see forexample http://gmoinfo.jrc.it/gmp_browse.aspx andhttp://www.agbios.com/dbase.php).

In a final aspect the present invention relates to a method ofcontrolling nematodes or insects in the soil surrounding a plantcomprising applying an effective amount of the composition according tothe invention to said soil.

The examples illustrate the invention.

Formula for the efficacy of the combination of two compounds

-   -   The expected efficacy of a given combination of two compounds is        calculated as follows (see Colby, S. R., Calculating Synergistic        and antagonistic Responses of Herbicide Combinations”, Weeds 15,        pp. 20-22, 1967):

If

-   -   X is the efficacy expressed in % mortality of the untreated        control for test compound A at a concentration of m ppm        respectively m g/ha,    -   Y is the efficacy expressed in % mortality of the untreated        control for test compound B at a concentration of n ppm        respectively n g/ha,    -   E is the efficacy expressed in % mortality of the untreated        control using the mixture of A and B at m and n ppm respectively        m and n g/ha,        then is

$E = {X + Y - \frac{X \times Y}{100}}$

If the observed insecticidal efficacy of the combination is higher thanthe one calculated as, “E”, then the combination of the two compounds ismore than additive, i.e., there is a synergistic effect.

EXAMPLE A Phaedon cochleariae—Spray Test

Solvent: 78.0 parts by weight of acetone

-   -   1.5 parts by weight of dimethylformamide

Emulsifier: alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvents and isdiluted with water, containing an emulsifier concentration of 1000 ppm,to the desired concentration. To produce a suitable preparation of aspore suspension the spores are diluted with emulsifier containing waterto the desired concentration. Further test concentrations are preparedby dilution with emulsifier containing water.

Chinese cabbage (Brassica pekinensis) leaf-disks are sprayed with apreparation of the active ingredient of the desired concentration. Oncedry, the leaf disks are infested with mustard beetle larvae (Phaedoncochleariae).

After the specified period of time, mortality in % is determined. 100%means all beetle larvae have been killed and 0% means none of the beetlelarvae have been killed. The mortality values determined thus arerecalculated using the Colby-formula (see sheet 1).

According to the present application in this test e.g. the followingcombinations show a synergistic effect in comparison to the singlecompounds:

TABLE A Phaedon cochleariae - test Concentration Efficacy ActiveIngredient in g ai/ha in % after 6^(d) BioAct WG Paecilomyces 4000 0lilacinus strain 251 (BioAct, 1 × 1010 spores/g) Contans WG Coniothyrium2500 0 minitans 2000 0 (1 × 10⁹ spores/g) BCS-CO80363 (Compound (I- 0.1667  1-1/I-1-7) from 11-3079) obs.* cal.** BioAct WG + BCS-CO80363 4000 +0.16 100  67  (25.000:1) according to the invention BCS-CL73507 0.08 0obs.* cal.** Contans WG + BCS-CL73507 2500 + 0.08 67 0 (31.250:1)according to the invention Fluopyram 100 0 obs.* cal.** Contans WG +Fluopyram 2000 + 100  33 0 (20:1) according to the invention *obs. =observed insecticidal efficacy, **cal. = efficacy calculated withColby-formula

EXAMPLE B Spodoptera frugiperda—Spray Test

Solvent: 78.0 parts by weight acetone

-   -   1.5 parts by weight dimethylformamide

Emulsifier: alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvents and isdiluted with water, containing an emulsifier concentration of 1000 ppm,to the desired concentration. To produce a suitable preparation of aspore suspension the spores are diluted with emulsifier containing waterto the desired concentration. Further test concentrations are preparedby dilution with emulsifier containing water.

Maize (Zea mais) leaf sections are sprayed with a preparation of theactive ingredient of the desired concentration. Once dry, the leafsections are infested with fall armyworm larvae (Spodoptera frugiperda).

After the specified period of time, mortality in % is determined. 100%means all caterpillars have been killed and 0% means none of thecaterpillars have been killed. The mortality values determined thus arerecalculated using the Colby-formula (see sheet 1).

According to the present application in this test e.g. the followingcombinations show a synergistic effect in comparison to the singlecompounds:

TABLE B-1 Spodoptera frugiperda - test Concentration Efficacy ActiveIngredient in g ai/ha in % after 2^(d) BioAct WG Paecilomyces 4000 0lilacinus strain 251 (BioAct, 1 × 1010 spores/g) BCS-CO80363 (Compound(I- 0.16 0 1-1/I-1-7) from 11-3079) obs.* cal.** BioAct WG + BCS-CO803634000 + 0.16 100 0 (25.000:1) according to the invention *obs. = observedinsecticidal efficacy, **cal. = efficacy calculated with Colby-formula

EXAMPLE C Myzus persicae—Spray Test

Solvent: 78.0 parts by weight acetone

-   -   1.5 parts by weight dimethylformamide

Emulsifier: alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvents and isdiluted with water, containing an emulsifier concentration of 1000 ppm,to the desired concentration. To produce a suitable preparation of aspore suspension the spores are diluted with emulsifier containing waterto the desired concentration. Further test concentrations are preparedby dilution with emulsifier containing water.

Chinese cabbage (Brassica pekinensis) leaf-disks infected with allinstars of the green peach aphid (Myzus persicae) are sprayed with apreparation of the active ingredient of the desired concentration.

After the specified period of time, mortality in % is determined. 100%means all aphids have been killed; 0% means none of the aphids have beenkilled. The mortality values determined thus are recalculated using theColby-formula (see sheet 1).

According to the present application in this test e.g. the followingcombinations show a synergistic effect in comparison to the singlecompounds:

TABLE C-1 Myzus persicae - test Concentration Efficacy Active Ingredientin g ai/ha in % after 1^(d) BioAct WG Paecilomyces 5000 0 lilacinusstrain 251 (BioAct, 1 × 1010 spores/g) Fluopyram 1000 0 gef.* ber.**BioAct WG + Fluopyram 5000 + 1000 70 0 (5:1) according to the inventionFlupyradifurone  20 0 obs.* cal.** BioAct WG + 5000 + 20  70 0Flupyradifurone (250:1) according to the invention

TABLE C-2 Myzus persicae - test Concentration Efficacy Active Ingredientin g ai/ha in % after 6^(d) Contans WG Coniothyrium 4000 0 minitans 25000 (1 × 10⁹ spores/g) BCS-CL73507 0.4 0 obs.* cal.** Contans WG +BCS-CL73507 2500 + 0.4 100 0 (6.250:1) according to the inventionSpirotetramat 0.4 0 obs.* cal.** Contans WG + Spirotetramat 4000 + 0.4 90 0 (10.000:1) according to the invention *obs. = observedinsecticidal efficacy, **cal. = efficacy calculated with Colby-formula

EXAMPLE D Tetranychus urticae—Spray Test, OP-Resistant

Solvent: 78.0 parts by weight acetone

-   -   1.5 parts by weight dimethylformamide

Emulsifier: alkylaryl polyglycol ether

To produce a suitable preparation of active compound, 1 part by weightof active compound is mixed with the stated amount of solvents and isdiluted with water, containing an emulsifier concentration of 1000 ppm,to the desired concentration. To produce a suitable preparation of aspore suspension the spores are diluted with emulsifier containing waterto the desired concentration. Further test concentrations are preparedby dilution with emulsifier containing water.

French beans (Phaseolus vulgaris) which are heavily infested with allstages of the two spotted spidermite (Tetranychus urticae), are sprayedwith a preparation of the active ingredient of the desiredconcentration.

After the specified period of time, mortality in % is determined. 100%means all spider mites have been killed and 0% means none of the spidermites have been killed. The mortality values determined thus arerecalculated using the Colby-formula (see sheet 1).

According to the present application in this test e.g. the followingcombinations show a synergistic effect in comparison to the singlecompounds:

TABLE D-1 Tetranychus urticae - test Concentration Efficacy ActiveIngredient in g ai/ha in % after 2^(d) BioAct WG Paecilomyces 4000  0lilacinus strain 251 (BioAct, 1 × 10¹⁰ spores/g) AMSI 378 4 30 obs.*cal.** BioAct WG + AMSI 378 4000 + 4 70 30 (1000:1) according to theinvention *obs. = observed insecticidal efficacy, **cal. = efficacycalculated with Colby-formula

TABLE D-2 Tetranychus urticae - test Concentration Efficacy ActiveIngredient in g ai/ha in % after 6^(d) BioAct WG Paecilomyces 4000 0lilacinus strain 251 2000 0 (BioAct, 1 × 10¹⁰ spores/g) Contans WGConiothyrium 4000 0 minitans 2500 0 (1 × 10⁹ spores/g) 2000 0 AMSI 378  4 0 obs.* cal.** BioAct WG + AMSI 378 2000 + 4  100  0 (500:1)according to the invention obs.* cal.** Contans WG + AMSI 378 2000 + 4 70 0 (500:1) according to the invention Flupyradifurone  250 0 obs.*cal.** Contans WG +  2500 + 250 70 0 Flupyradifurone (10:1) according tothe invention Spiromesifen    0.5 0 obs.* cal.** BioAct WG +Spiromesifen 4000 + 0.5 70 0 (8000:1) according to the invention obs.*cal.** Contans WG + Spiromesifen 4000 + 0.5 70 0 (8000:1) according tothe invention *obs. = observed insecticidal efficacy, **cal. = efficacycalculated with Colby-formula

1-16. (canceled)
 17. A composition comprising at least one biologicalcontrol agent selected from the group consisting of Paecilomyceslilacinus strain 251 (AGAL No. 89/030550) and Coniothyrium minitansCON/M/91-08 (DSM 9660), and/or a mutant of these strains having all theidentifying characteristics of the respective strain, and/or ametabolite produced by the respective strain that exhibits activityagainst nematodes, insects and/or phytopathogens, and at least oneinsecticide (I) selected from the group consisting of juvenile hormonemimics, miscellaneous non-specific (multi-site) inhibitors, selectivehomopteran feeding blockers, mite growth inhibitors, microbialdisruptors of insect midgut membranes, inhibitors of mitochondrial ATPsynthase, uncouplers of oxidative phosphorylation via disruption of theproton gradient, inhibitors of chitin biosynthesis (type 0), inhibitorsof chitin biosynthesis (type 1), moulting disruptors, ecdysone receptoragonists, octopamine receptor agonists, mitochondrial complex IIIelectron transport inhibitors, mitochondrial complex I electrontransport inhibitors, inhibitors of acetyl CoA carboxylase,mitochondrial complex IV electron transport inhibitors, mitochondrialcomplex II electron transport inhibitors, and further insecticides in asynergistically effective amount, with the proviso that the compositiondoes not comprise Coniothyrium minitans CON/M/91-08 (DSM 9660) andFluopyram (I247).
 18. The composition according to claim 1, wherein thejuvenile hormone mimic is a juvenile hormone analogue selected from thegroup consisting of Hydroprene (I156), Kinoprene (I157), and Methoprene(I158); or Fenoxycarb (I159); and Pyriproxyfen (I160); the miscellaneousnon-specific (multi-site) inhibitor are alkyl halides; or Chloropicrin(I162); or Sulfuryl fluoride (I163); or Borax (I164); or Tartar emetic(I165); the mite growth inhibitors are Clofentezine (I168), Hexythiazox(I169), Diflovidazin (I170); or Etoxazole (I171); the microbialdisruptors of insect midgut membranes are Bacillus thuringiensissubspecies israelensis (I172), Bacillus thuringiensis subspecies aizawai(I173), Bacillus thuringiensis subspecies kurstaki (I174), Bacillusthuringiensis subspecies tenebrionis (I175), and B.t. crop proteins:Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab,Cry3Bb, Cry34 Ab1/35Ab1 (I176); or Bacillus sphaericus (I177); theinhibitors of mitochondrial ATP synthase are Diafenthiuron (I178); ororganotin miticides, such as Azocyclotin (I179), Cyhexatin (I180),Fenbutatin oxide (I181); Propargite (I182); or Tetradifon (I183); theuncouplers of oxidative phoshorylation via disruption of the protongradient are Chlorfenapyr (I184), DNOC (I185), or Sulfluramid (I186);the inhibitors of chitin biosynthesis, type 0, are Bistrifluron (I191),Chlorfluazuron (I192), Diflubenzuron (I193), Flucycloxuron (I194),Flufenoxuron (I195), Hexaflumuron (I196), Lufenuron (I197), Novaluron(I198), Noviflumuron (I199), Teflubenzuron (I200), or Triflumuron(I201); the inhibitor of chitin biosynthesis, type 1, is Buprofezin(I202); the moulting disruptors is Cyromazine (I203); the ecdysonereceptor agonists are Chromafenozide (I204), Halofenozide (I205),Methoxyfenozide (I206), or Tebufenozide (I207); the octopamine receptoragonist is Amitraz (I208); the mitochondrial complex III electrontransport inhibitors are Hydramethylnon (I209); Acequinocyl (I210); orFluacrypyrim (I211); the mitochondrial complex I electron transportinhibitors are METI acaricides, such as Fenazaquin (I212), Fenpyroximate(I213), Pyrimidifen (I214), Pyridaben (I215), Tebufenpyrad (I216),Tolfenpyrad (I217); or Rotenone (Denis) (I218); the inhibitors of acetylCoA carboxylase are tetronic and tetramic acid derivatives, such asSpirodiclofen (I221), Spiromesifen (I222), or Spirotetramat (I223); themitochondrial complex IV electron transport inhibitors are phosphines,such as Aluminium phosphide (I224), Calcium phosphide (I225), Phosphine(I226), Zinc phosphide (I227); or Cyanide (I228); the mitochondrialcomplex II electron transport inhibitors are beta-ketonitrilederivatives, such as Cyenopyrafen (I229) and Cyflumetofen (I230); andthe further active ingredients with unknown or uncertain mode of actionare Amidoflumet (I234), Azadirachtin (I235), Benclothiaz (I236),Benzoximate (I237), Bifenazate (I238), Bromopropylate (I239),Chinomethionat (I240), Cryolite (I241), Dicofol (I242), Diflovidazin(I243), Fluensulfone (I244), Flufenerim (I245), Flufiprole (I246),Fluopyram (I247), Fufenozide (I248), Imidaclothiz (I249), Iprodione(I250), Meperfluthrin (I251), Pyridalyl (I252), Pyrifluquinazon (I253),Tetramethylfluthrin (I254), and Iodomethane (I255); furthermore productsbased on Bacillus firmus (including but not limited to strain CNCM1-1582, such as, for example, VOTiVO™, BioNem) (I256) or one of thefollowing known active compounds:3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I257) (known from WO2005/077934),4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I258) (known from WO2007/115644),4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one(I259) (known from WO2007/115644),4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I260) (known from WO2007/115644),4-{[(6-chlorpyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I261) (known from WO2007/115644), Flupyradifurone (I262),4-{[(6-chlor-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one(I263) (known from WO2007/115643),4-{[(5,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I264) (known from WO2007/115646),4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I265) (known from WO2007/115643),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I266) (known from EP-A-0 539 588),4-{[(6-chlorpyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I267)(known from EP-A-0 539 588),{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(I268) (known from WO2007/149134) and its diastereomers{[(1R)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(A) (I269), and{[(1S)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(B) (I270) (also known from WO2007/149134) as well as diastereomers[(R)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A1) (I271), and[(S)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A2) (I272), referred to as group of diastereomers A (known fromWO2010/074747, WO2010/074751),[(R)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B1) (I273), and[(S)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B2) (I274), referred to as group of diastereomers B (also known fromWO2010/074747, WO2010/074751), and11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one(I275) (known from WO2006/089633),3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one(I276) (known from WO2008/067911),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277) (known from WO2006/043635), AfidopyropenR3S,4aR,12R,12a5,12b5)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate (I278) (known from WO2008/066153),2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide (I279) (knownfrom WO2006/056433),2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide (I280) (knownfrom WO2006/100288),2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (I281) (known fromWO2005/035486),4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine1,1-dioxide (I282) (known from WO2007/057407),N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine(I283) (known from WO2008/104503),{1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1 (2H)-yl}(2-chloropyridin-4-yl)methanone (I284)(known from WO2003/106457),3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one(I285) (known from WO2009/049851),3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (I286) (known from WO2009/049851),4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine(I287) (known from WO2004/099160),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile(I288) (known from WO2005/063094),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile(I289) (known from WO2005/063094),8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6-(trifluoromethyl)pyridazin-3-yl]-3-azabicyclo[3.2.1]octane(I290) (known from WO2007/040280), Flometoquin (I291), PF1364 (CAS-Reg.No. 1204776-60-2) (I292) (known from JP2010/018586),5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I293) (known from WO2007/075459),5-[5-(2-chloropyridin-4-yl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I294) (known from WO2007/075459),4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamide(I295) (known from WO2005/085216),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one(I296),4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one(I297),4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one(I298),4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one(I299) (all known from WO2010/005692), PyflubumideN-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H-pyrazole-4-carboxamide(I300) (known from WO2002/096882), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I301) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate(I302) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I303) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate(I304) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate(I305) (known from WO2005/085216), (5RS,7RS;5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine(I306) (known from WO2007/101369),2-{6-[2-(5-fluoropyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine(I307) (known from WO2010/006713),2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine (I308)(known from WO2010/006713),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I311) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I312) (known from WO2010/069502),(1E)-N-[(6-chloropyridin-3-yl)methyl]-N′-cyano-N-(2,2-difluoroethyl)ethanimidamide(I313) (known from WO2008/009360),N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I314) (known from CN102057925), and methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylate(I315) (known from WO2011/049233).
 19. The composition according toclaim 17, wherein the inhibitor of mitochondrial ATP synthase isDiafenthiuron (I178); the uncoupler of oxidative phoshorylation viadisruption of the proton gradient is Chlorfenapyr (I184); the inhibitorof chitin biosynthesis, type 0, is selected from the group consisting ofLufenuron (I197), and Triflumuron (I201); the inhibitor of chitinbiosynthesis, type 1, is Buprofezin (I202); the ecdysone receptoragonist is Methoxyfenozide (I206); the mitochondrial complex I electrontransport inhibitor is selected from the group consisting ofFenpyroximate (I213), and Tebufenpyrad (I216); the inhibitor of acetylCoA carboxylase is selected from the group consisting of Spirodiclofen(I221), Spiromesifen (I222), and Spirotetramate (I223); themitochondrial complex II electron transport inhibitor is selected fromthe group consisting of Cyenopyrafen (I229), and Cyflumentofen (I230);and/or the further insecticide is selected from the group consisting ofFlometoquin (I291), Fluensulfone (I244), Fluopyram (I247),Flupyradifurone (I262), Pyflubumide (I300), Pyrifluquinazone (I253),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277) and Afidopyropen (I278).
 20. The composition according to claim17, wherein said insecticide (I) is selected from the group consistingof Spirotetramat (I223), Spiromesifen (I222), Fluopyram (I247),Flupyradifurone (I262),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(frifluoromefhyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) and a mixture of 1309 and
 1310. 21. The composition according toclaim 17, further comprising at least one additional insecticide (II)and/or at least one fungicide, with the proviso that insecticide (II) isnot identical to insecticide (I) and the biological control agent is notidentical to the fungicide.
 22. The composition according to claim 21,wherein the at least one fungicide is selected from the group consistingof inhibitors of the ergosterol biosynthesis, inhibitors of therespiratory chain at complex I or II, inhibitors of the respiratorychain at complex III, inhibitors of the mitosis and cell division,compounds capable to induce a host defense, inhibitors of the amino acidand/or protein biosynthesis, inhibitors of the ATP production,inhibitors of the cell wall synthesis, inhibitors of the lipid andmembrane synthesis, inhibitors of the melanine biosynthesis, inhibitorsof the nucleic acid synthesis, inhibitors of the signal transduction,compounds capable to act as an uncoupler such as binapacryl, dinocap,ferimzone, fluazinam, meptyldinocap and further compounds, like forexample benthiazole, bethoxazin, capsimycin, carvone, chinomethionat,pyriofenone (chlazafenone), cufraneb, cyflufenamid, cymoxanil,cyprosulfamide, dazomet, debacarb, dichlorophen, diclomezine,difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomate,fenpyrazamine, flumetover, fluoroimide, flusulfamide, flutianil,fosetyl-aluminium, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene,irumamycin, methasulfocarb, methyl isothiocyanate, metrafenone,mildiomycin, natamycin, nickel dimethyldithiocarbamate,nitrothal-isopropyl, octhilinone, oxamocarb, oxyfenthiin,pentachlorophenol and salts, phenothrin, phosphorous acid and its salts,propamocarb-fosetylate, propanosine-sodium, proquinazid, pyrimorph,(2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one,(2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one,pyrrolnitrine, tebufloquin, tecloftalam, tolnifanide, triazoxide,trichlamide, zarilamid,(3S,6S,7R,8R)-8-benzyl-3-[({3-[(isobutyryloxy)methoxy]-4-methoxypyridin-2-yl}carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl2-methylpropanoate,1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[(5S)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-{4-[5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone,1-(4-methoxyphenoxy)-3,3-dimethylbutan-2-yl 1H-imidazole-1-carboxylate,2,3,5,6-tetrachloro-4-(methylsulfonyl)pyridine,2,3-dibutyl-6-chlorothieno[2,3-d]pyrimidin-4(3H)-one,2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c]dipyrrole-1,3,5,7(2H,6H)-tetrone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5R)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-(4-{4-[(5S)-5-phenyl-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)ethanone,2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(5-phenyl-4,5-dihydro-1,2-oxazol-3-yl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone,2-butoxy-6-iodo-3-propyl-4H-chromen-4-one,2-chloro-5-[2-chloro-1-(2,6-difluoro-4-methoxyphenyl)-4-methyl-1H-imidazol-5-yl]pyridine,2-phenylphenol and salts,3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolone,3,4,5-trichloropyridine-2,6-dicarbonitrile,3-[5-(4-chlorophenyl)-2,3-dimethyl-1,2-oxazolidin-3-yl]pyridine,3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine,4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine,5-amino-1,3,4-thiadiazole-2-thiol,5-chloro-N′-phenyl-N′-(prop-2-yn-1-yl)thiophene-2-sulfonohydrazide,5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine,5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine,5-methyl-6-octyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine, ethyl(2Z)-3-amino-2-cyano-3-phenylprop-2-enoate,N′-(4-{[3-(4-chlorobenzyl)-1,2,4-thiadiazol-5-yl]oxy}-2,5-dimethylphenyl)-N-ethyl-N-methylimidoformamide,N-(4-chlorobenzyl)-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(4-chlorophenyl)(cyano)methyl]-3-[3-methoxy-4-(prop-2-yn-1-yloxy)phenyl]propanamide,N-[(5-bromo-3-chloropyridin-2-yl)methyl]-2,4-dichloropyridine-3-carboxamide,N-[1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2,4-dichloropyridine-3-carboxamide,N-[-1-(5-bromo-3-chloropyridin-2-yl)ethyl]-2-fluoro-4-iodopyridine-3-carboxamide,N-{(E)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N-{(Z)-[(cyclopropylmethoxy)imino][6-(difluoromethoxy)-2,3-difluorophenyl]methyl}-2-phenylacetamide,N′-{4-[(3-tert-butyl-4-cyano-1,2-thiazol-5-yl)oxy]-2-chloro-5-methylphenyl}-N-ethyl-N-methylimidoformamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,N-methyl-2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-N-[(1S)-1,2,3,4-tetrahydronaphthalen-1-yl]-1,3-thiazole-4-carboxamide,pentyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylidene]amino}oxy)methyl]pyridin-2-yl}carbamate,phenazine-1-carboxylic acid, quinolin-8-ol, quinolin-8-ol sulfate (2:1),tert-butyl{6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate,1-methyl-3-(trifluoromethyl)-N-[2′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(4′-chlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,N-(2′,4′-dichlorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,N-(2′,5′-difluorobiphenyl-2-yl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-1-methyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,5-fluoro-1,3-dimethyl-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(prop-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,3-(difluoromethyl)-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,3-(difluoromethyl)-N-(4′-ethynylbiphenyl-2-yl)-1-methyl-1H-pyrazole-4-carboxamide,N-(4′-ethynylbiphenyl-2-yl)-5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-(4′-ethynylbiphenyl-2-yl)pyridine-3-carboxamide,2-chloro-N-[4′-(3,3-dimethylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,4-(difluoromethyl)-2-methyl-N-[4′-(trifluoromethyl)biphenyl-2-yl]-1,3-thiazole-5-carboxamide,5-fluoro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(3-hydroxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,3-(difluoromethyl)-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1-methyl-1H-pyrazole-4-carboxamide,5-fluoro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]-1,3-dimethyl-1H-pyrazole-4-carboxamide,2-chloro-N-[4′-(3-methoxy-3-methylbut-1-yn-1-yl)biphenyl-2-yl]pyridine-3-carboxamide,(5-bromo-2-methoxy-4-methylpyridin-3-yl)(2,3,4-trimethoxy-6-methylphenyl)methanone,N-[2-(4-{[3-(4-chlorophenyl)prop-2-yn-1-yl]oxy}-3-methoxyphenyl)ethyl]-N2-(methylsulfonyl)valinamide4-oxo-4-[(2-phenylethyl)amino]butanoic acid, but-3-yn-1-yl{6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate,4-Amino-5-fluoropyrimidin-2-ol, propyl 3,4,5-trihydroxybenzoate andoryzastrobin.
 23. The composition according to claim 21, wherein the atleast one additional insecticide (II) is selected from the groupconsisting of acetylcholinesterase (AChE) inhibitors, GABA-gatedchloride channel antagonists, sodium channelmodulators/voltage-dependent sodium channel blockers, nicotinicacetylcholine receptor (nAChR) agonists, nicotinic acetylcholinereceptor (nAChR) allosteric activators, chloride channel activators,juvenile hormone mimics, for example juvenile hormone analogues,miscellaneous non-specific (multi-site) inhibitors, selective homopteranfeeding blockers, mite growth inhibitors, microbial disruptors of insectmidgut membranes, inhibitors of mitochondrial ATP synthase, uncouplersof oxidative phoshorylation via disruption of the proton gradient,nicotinic acetylcholine receptor (nAChR) channel blockers, inhibitors ofchitin biosynthesis, type 0, inhibitors of chitin biosynthesis, type 1,moulting disruptors, ecdysone receptor agonists, octopamine receptoragonists, mitochondrial complex III electron transport inhibitors,mitochondrial complex I electron transport inhibitors, voltage-dependentsodium channel blockers, inhibitors of acetyl CoA carboxylase,mitochondrial complex IV electron transport inhibitors, mitochondrialcomplex II electron transport inhibitors, ryanodine receptor modulators,Amidoflumet, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate,Bromopropylate, Chinomethionat, Cryolite, Dicofol, Diflovidazin,Fluensulfone, Flufenerim, Flufiprole, Fluopyram, Fufenozide,Imidaclothiz, Iprodione, Meperfluthrin, Pyridalyl, Pyrifluquinazon,Tetramethylfluthrin, Iodomethane, products based on Bacillus firmus,3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide,4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one,4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one,4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one,4-{[(6-chlorpyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one,Flupyradifurone,4-{[(6-chlor-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one,4-{[(5,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one,4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one,4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one,4-{[(6-chlorpyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one,{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide,its diastereomers{[(1R)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-A4-sulfanylidene}cyanamide(A), and{[(1S)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(B),[(R)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A1),[(S)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A2), [(R)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide,[(S)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide,11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one,3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one,1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3(trifluoromethyl)-1H-1,2,4-triazol-5-amine,AfidopyropenR3S,4aR,12R,12a5,12b5)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate,2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide,2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide,2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide,4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine1,1-dioxide,N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine,{1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1(2H)-yl}(2-chloropyridin-4-yl)methanone,3(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one,3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate,4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine,(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile,(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile,8-[2(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6-(trifluoromethyl)pyridazin-3-yl]-3-azabicyclo[3.2.1]octane,Flometoquin, PF1364 (CAS-Reg. No. 1204776-60-2),5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile,5-[5-(2-chloropyridin-4-yl)-5(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile,4-[5(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamid),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one,4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one,4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one,4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one,PyflubumideN-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H-pyrazole-4-carboxamide,methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate,methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate,methyl2-[2({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate,methyl2-[3,5-dibromo-2-({[3-bromo-1(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate, methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate,(5RS,7RS;5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine,2-{6-[2-(5-fluoropyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine,2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine,1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide,1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide,N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide,N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide,(1E)-N-[(6-chloropyridin-3-yl)methyl]-N′-cyano-N-(2,2-difluoroethyl)ethanimidamide,N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide,and methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylate.24. The composition according to claim 17 additionally comprising atleast one auxiliary selected from the group consisting of extenders,solvents, spontaneity promoters, carriers, emulsifiers, dispersants,frost protectants, thickeners and adjuvants.
 25. A seed treated with acomposition comprising at least one biological control agent selectedfrom the group consisting of Paecilomyces lilacinus strain 251 (AGAL No.89/030550) and Coniothyrium minitans CON/M/91-08 (DSM 9660), and/or amutant of these strains having all the identifying characteristics ofthe respective strain, and/or a metabolite produced by the respectivestrain that exhibits activity against nematodes, insects and/orphytopathogens, and at least one insecticide (I) selected from the groupconsisting of juvenile hormone mimics, miscellaneous non-specific(multi-site) inhibitors, selective homopteran feeding blockers, mitegrowth inhibitors, microbial disruptors of insect midgut membranes,inhibitors of mitochondrial ATP synthase, uncouplers of oxidativephoshorylation via disruption of the proton gradient, inhibitors ofchitin biosynthesis (type 0), inhibitors of chitin biosynthesis (type1), moulting disruptors, ecdysone receptor agonists, octopamine receptoragonists, mitochondrial complex III electron transport inhibitors,mitochondrial complex I electron transport inhibitors, inhibitors ofacetyl CoA carboxylase, mitochondrial complex IV electron transportinhibitors, mitochondrial complex II electron transport inhibitors, andfurther insecticides in a synergistically effective amount, with theproviso that the composition does not comprise Coniothyrium minitansCON/M/91-08 (DSM 9660) and Fluopyram (I247).
 26. A seed according toclaim 25, wherein the juvenile hormone mimic is a juvenile hormoneanalogue selected from the group consisting of Hydroprene (I156),Kinoprene (I157), and Methoprene (I158); or Fenoxycarb (I159); andPyriproxyfen (I160); the miscellaneous non-specific (multi-site)inhibitor are alkyl halides; or Chloropicrin (I162); or Sulfurylfluoride (I163); or Borax (I164); or Tartar emetic (I165); the mitegrowth inhibitors are Clofentezine (I168), Hexythiazox (I169),Diflovidazin (I170); or Etoxazole (I171); the microbial disruptors ofinsect midgut membranes are Bacillus thuringiensis subspeciesisraelensis (I172), Bacillus thuringiensis subspecies aizawai (I173),Bacillus thuringiensis subspecies kurstaki (I174), Bacillusthuringiensis subspecies tenebrionis (I175), and B.t. crop proteins:Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab,Cry3Bb, Cry34 Ab1/35Ab1 (I176); or Bacillus sphaericus (I177); theinhibitors of mitochondrial ATP synthase are Diafenthiuron (I178); ororganotin miticides, such as Azocyclotin (I179), Cyhexatin (I180),Fenbutatin oxide (I181); Propargite (I182); or Tetradifon (I183); theuncouplers of oxidative phoshorylation via disruption of the protongradient are Chlorfenapyr (I184), DNOC (I185), or Sulfluramid (I186);the inhibitors of chitin biosynthesis, type 0, are Bistrifluron (I191),Chlorfluazuron (I192), Diflubenzuron (I193), Flucycloxuron (I194),Flufenoxuron (I195), Hexaflumuron (I196), Lufenuron (I197), Novaluron(I198), Noviflumuron (I199), Teflubenzuron (I200), or Triflumuron(I201); the inhibitor of chitin biosynthesis, type 1, is Buprofezin(I202); the moulting disruptors is Cyromazine (I203); the ecdysonereceptor agonists are Chromafenozide (I204), Halofenozide (I205),Methoxyfenozide (I206), or Tebufenozide (I207); the octopamine receptoragonist is Amitraz (I208); the mitochondrial complex III electrontransport inhibitors are Hydramethylnon (I209); Acequinocyl (I210); orFluacrypyrim (I211); the mitochondrial complex I electron transportinhibitors are METI acaricides, such as Fenazaquin (I212), Fenpyroximate(I213), Pyrimidifen (I214), Pyridaben (I215), Tebufenpyrad (I216),Tolfenpyrad (I217); or Rotenone (Denis) (I218); the inhibitors of acetylCoA carboxylase are tetronic and tetramic acid derivatives, such asSpirodiclofen (I221), Spiromesifen (I222), or Spirotetramat (I223); themitochondrial complex IV electron transport inhibitors are phosphines,such as Aluminium phosphide (I224), Calcium phosphide (I225), Phosphine(I226), Zinc phosphide (I227); or Cyanide (I228); the mitochondrialcomplex II electron transport inhibitors are beta-ketonitrilederivatives, such as Cyenopyrafen (I229) and Cyflumetofen (I230); andthe further active ingredients with unknown or uncertain mode of actionare Amidoflumet (I234), Azadirachtin (I235), Benclothiaz (I236),Benzoximate (I237), Bifenazate (I238), Bromopropylate (I239),Chinomethionat (I240), Cryolite (I241), Dicofol (I242), Diflovidazin(I243), Fluensulfone (I244), Flufenerim (I245), Flufiprole (I246),Fluopyram (I247), Fufenozide (I248), Imidaclothiz (I249), Iprodione(I250), Meperfluthrin (I251), Pyridalyl (I252), Pyrifluquinazon (I253),Tetramethylfluthrin (I254), and Iodomethane (I255); furthermore productsbased on Bacillus firmus (including but not limited to strain CNCM1-1582, such as, for example, VOTiVO™, BioNem) (I256) or one of thefollowing known active compounds:3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I257) (known from WO2005/077934),4-{[(6-bromopyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I258) (known from WO2007/115644),4-{[(6-fluoropyridin-3-yl)methyl](2,2-difluoroethyl)amino}furan-2(5H)-one(I259) (known from WO2007/115644),4-{[(2-chloro-1,3-thiazol-5-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I260) (known from WO2007/115644),4-{[(6-chlorpyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I261) (known from WO2007/115644), Flupyradifurone (I262),4-{[(6-chlor-5-fluoropyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one(I263) (known from WO2007/115643),4-{[(5,6-dichloropyridin-3-yl)methyl](2-fluoroethyl)amino}furan-2(5H)-one(I264) (known from WO2007/115646),4-{[(6-chloro-5-fluoropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I265) (known from WO2007/115643),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}furan-2(5H)-one(I266) (known from EP-A-0 539 588),4-{[(6-chlorpyridin-3-yl)methyl](methyl)amino}furan-2(5H)-one (I267)(known from EP-A-0 539 588),{[1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(I268) (known from WO2007/149134) and its diastereomers{[(1R)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(A) (I269), and{[(1S)-1-(6-chloropyridin-3-yl)ethyl](methyl)oxido-λ4-sulfanylidene}cyanamide(B) (I270) (also known from WO2007/149134) as well as diastereomers[(R)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A1) (I271), and[(S)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(A2) (I272), referred to as group of diastereomers A (known fromWO2010/074747, WO2010/074751),[(R)-methyl(oxido){(1S)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B1) (I273), and[(S)-methyl(oxido){(1R)-1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-λ4-sulfanylidene]cyanamide(B2) (I274), referred to as group of diastereomers B (also known fromWO2010/074747, WO2010/074751), and11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]tetradec-11-en-10-one(I275) (known from WO2006/089633),3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one(I276) (known from WO2008/067911),1-{2-fluoro-4-methyl-5-[(2,2,2-trifluorethyl)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine(I277) (known from WO2006/043635), AfidopyropenR3S,4aR,12R,12a5,12b5)-3-[(cyclopropylcarbonyl)oxy]-6,12-dihydroxy-4,12b-dimethyl-11-oxo-9-(pyridin-3-yl)-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-2H,11H-benzo[f]pyrano[4,3-b]chromen-4-yl]methylcyclopropanecarboxylate (I278) (known from WO2008/066153),2-cyano-3-(difluoromethoxy)-N,N-dimethylbenzenesulfonamide (I279) (knownfrom WO2006/056433),2-cyano-3-(difluoromethoxy)-N-methylbenzenesulfonamide (I280) (knownfrom WO2006/100288),2-cyano-3-(difluoromethoxy)-N-ethylbenzenesulfonamide (I281) (known fromWO2005/035486),4-(difluoromethoxy)-N-ethyl-N-methyl-1,2-benzothiazol-3-amine1,1-dioxide (I282) (known from WO2007/057407),N-[1-(2,3-dimethylphenyl)-2-(3,5-dimethylphenyl)ethyl]-4,5-dihydro-1,3-thiazol-2-amine(I283) (known from WO2008/104503),{1′-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4′-piperidin]-1 (2H)-yl}(2-chloropyridin-4-yl)methanone (I284)(known from WO2003/106457),3-(2,5-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one(I285) (known from WO2009/049851),3-(2,5-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-ylethyl carbonate (I286) (known from WO2009/049851),4-(but-2-yn-1-yloxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine(I287) (known from WO2004/099160),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,3-trifluoropropyl)malononitrile(I288) (known from WO2005/063094),(2,2,3,3,4,4,5,5-octafluoropentyl)(3,3,4,4,4-pentafluorobutyl)malononitrile(I289) (known from WO2005/063094),8-[2-(cyclopropylmethoxy)-4-(trifluoromethyl)phenoxy]-3-[6-(trifluoromethyl)pyridazin-3-yl]-3-azabicyclo[3.2.1]octane(I290) (known from WO2007/040280), Flometoquin (I291), PF1364 (CAS-Reg.No. 1204776-60-2) (I292) (known from JP2010/018586),5-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I293) (known from WO2007/075459),5-[5-(2-chloropyridin-4-yl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-(1H-1,2,4-triazol-1-yl)benzonitrile(I294) (known from WO2007/075459),4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-2-methyl-N-{2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl}benzamide(I295) (known from WO2005/085216),4-{[(6-chloropyridin-3-yl)methyl](cyclopropyl)amino}-1,3-oxazol-2(5H)-one(I296),4-{[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino}-1,3-oxazol-2(5H)-one(I297),4-{[(6-chloropyridin-3-yl)methyl](ethyl)amino}-1,3-oxazol-2(5H)-one(I298),4-{[(6-chloropyridin-3-yl)methyl](methyl)amino}-1,3-oxazol-2(5H)-one(I299) (all known from WO2010/005692), PyflubumideN-[4-(1,1,1,3,3,3-hexafluoro-2-methoxypropan-2-yl)-3-isobutylphenyl]-N-isobutyryl-1,3,5-trimethyl-1H-pyrazole-4-carboxamide(I300) (known from WO2002/096882), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-chloro-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I301) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-ethylhydrazinecarboxylate(I302) (known from WO2005/085216), methyl2-[2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)-5-cyano-3-methylbenzoyl]-2-methylhydrazinecarboxylate(I303) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-diethylhydrazinecarboxylate(I304) (known from WO2005/085216), methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethylhydrazinecarboxylate(I305) (known from WO2005/085216), (5RS,7RS;5RS,7SR)-1-(6-chloro-3-pyridylmethyl)-1,2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo[1,2-a]pyridine(I306) (known from WO2007/101369),2-{6-[2-(5-fluoropyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine(I307) (known from WO2010/006713),2-{6-[2-(pyridin-3-yl)-1,3-thiazol-5-yl]pyridin-2-yl}pyrimidine (I308)(known from WO2010/006713),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I309) (known from WO2010/069502),1-(3-chloropyridin-2-yl)-N-[4-cyano-2-methyl-6-(methylcarbamoyl)phenyl]-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I310) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl}-1H-pyrazole-5-carboxamide(I311) (known from WO2010/069502),N-[2-(tert-butylcarbamoyl)-4-cyano-6-methylphenyl]-1-(3-chloropyridin-2-yl)-3-{[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl}-1H-pyrazole-5-carboxamide(I312) (known from WO2010/069502),(1E)-N-[(6-chloropyridin-3-yl)methyl]-N′-cyano-N-(2,2-difluoroethyl)ethanimidamide(I313) (known from WO2008/009360),N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide(I314) (known from CN102057925), and methyl2-[3,5-dibromo-2-({[3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-2-ethyl-1-methylhydrazinecarboxylate(I315) (known from WO2011/049233).
 27. A kit of parts comprising atleast one biological control agent selected from the group consisting ofPaecilomyces lilacinus strain 251 (AGAL No. 89/030550 and Coniothyriumminitans CON/M/91-08 (DSM 9660), and/or a mutant of these strains havingall the identifying characteristics of the respective strain, and/or ametabolite produced by the respective strain that exhibits activityagainst nematodes, insects and/or phytopathogens, and at least oneinsecticide (I) selected from the group consisting of juvenile hormonemimics, miscellaneous non-specific (multi-site) inhibitors, selectivehomopteran feeding blockers, mite growth inhibitors, microbialdisruptors of insect midgut membranes, inhibitors of mitochondrial ATPsynthase, uncouplers of oxidative phoshorylation via disruption of theproton gradient, inhibitors of chitin biosynthesis (type 0), inhibitorsof chitin biosynthesis (type 1), moulting disruptors, ecdysone receptoragonists, octopamine receptor agonists, mitochondrial complex IIIelectron transport inhibitors, mitochondrial complex I electrontransport inhibitors, inhibitors of acetyl CoA carboxylase,mitochondrial complex IV electron transport inhibitors, mitochondrialcomplex II electron transport inhibitors, and further insecticides in asynergistically effective amount in a spatially separated arrangement,with the proviso that the composition does not comprise Coniothyriumminitans CON/M/91-08 (DSM 9660) and Fluopyram (I247).
 28. A method forreducing overall damage of plants and plant parts as well as losses inharvested fruits or vegetables caused by insects, mites, nematodesand/or phytopathogens comprising the step of simultaneously orsequentially applying at least one biological control agent selectedfrom the group consisting of Paecilomyces lilacinus strain 251 (AGAL No.89/030550) and Coniothyrium minitans CON/M/91-08 (DSM 9660), and/or amutant of these strains having all the identifying characteristics ofthe respective strain, and/or a metabolite produced by the respectivestrain that exhibits activity against nematodes, insects and/orphytopathogens, and at least one insecticide (I) selected from the groupconsisting of juvenile hormone mimics, miscellaneous non-specific(multi-site) inhibitors, selective homopteran feeding blockers, mitegrowth inhibitors, microbial disruptors of insect midgut membranes,inhibitors of mitochondrial ATP synthase, uncouplers of oxidativephoshorylation via disruption of the proton gradient, inhibitors ofchitin biosynthesis (type 0), inhibitors of chitin biosynthesis (type1), moulting disruptors, ecdysone receptor agonists, octopamine receptoragonists, mitochondrial complex III electron transport inhibitors,mitochondrial complex I electron transport inhibitors, inhibitors ofacetyl CoA carboxylase, mitochondrial complex IV electron transportinhibitors, mitochondrial complex II electron transport inhibitors, andfurther insecticides, and optionally at least one additional insecticide(II) and/or at least one fungicide on the plant, plant parts, harvestedfruits, vegetables and/or plant's locus of growth in a synergisticallyeffective amount, with the proviso that the composition does notcomprise Coniothyrium minitans CON/M/91-08 (DSM 9660) and Fluopyram(I247).
 29. A method of controlling nematodes or insects in the soilsurrounding a plant comprising applying an effective amount of thecomposition according to claim 17 to said soil.